rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTTAGCGGGAGAAGCTCCGAAGAGCTGTTTTTTGGAGAA	CASSFSGRSSEELFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	5	2	11	2	10	23	35	46	37	56			01,02										Vb 1	CASSFSGRSSEELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGATCTTACAGAGAACACTGAAGCTTTCTTTGGACAA	CASSDLTENTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	1	7	1	23	34	45	41	46			01,02										Vb 1	CASSDLTENTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCTATCAGGGACAGCTTACGAGCAGTACTTCGGGCCG	CASSPLSGTAYEQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	4	9	2	23	35	51	44	53			01,02										Vb 1	CASSPLSGTAYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAACACGACTAGCGGGAGGGCGGGGACGGGCCA	CASSEHD*REGGD	Stop	VDJ	1	7	1.0928108656623214E-4		39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02			5	2	0	21	7	6	23	34	55	41	61			01,02					TCRBJ02-01,TCRBJ02-05					Vb 1	CASSEHD*REGGD+TCRBV09-01+TCRBJ02-X	TCRBV09-01	TCRBD02-01*02	TCRBJ02	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAGGAGGGGGCGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSEEGASYNEQFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	0	1	5	1	23	34	46	39	47			01,02										Vb 1	CASSEEGASYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCATTCGGGGGGCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSIRGAGTGELFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	8	1	4	3	4	23	35	45	38	49			01,02										Vb 1	CASSIRGAGTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTTCAGGGCAAGGTGAAAAACTGTTTTTTGGCAGT	CASSVASGQGEKLFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	3	7	3	5	23	39	47	42	52			01,02										Vb 1	CASSVASGQGEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAACGACGGGACCCCTCACAGATACGCAGTATTTTGGCCCA	CASSVTTGPLTDTQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	1	0	7	2	5	4	23	38	48	43	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVTTGPLTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTACGTAGTGGGTCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVRSGSSGANVLTF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	51	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-06	01	1	0	9	0	6	2	23	38	47	44	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVRSGSSGANVLTF+TCRBV09-01+TCRBJ02-06	TCRBV09-01		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGGTTAGCGGAGATACGCAGTATTTTGGCCCA	CASSVEVSGDTQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	5	5	4	0	23	39	-1	43	49			01,02			01,02							Vb 1	CASSVEVSGDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTCTCTCGGGAGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLSGGANVLTF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	8	3	4	5	0	23	34	-1	39	44			01,02										Vb 1	CASSLSGGANVLTF+TCRBV09-01+TCRBJ02-06	TCRBV09-01	TCRBD02-01*02	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCCACGATGGGGCACAGGGGTATACAGATACGCAGTATTTTGGCCCA	CASSVHDGAQGYTDTQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	54	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	2	3	12	3	23	37	56	49	59			01,02										Vb 1	CASSVHDGAQGYTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCAACGGAGATAGTGAACACTGAAGCTTTCTTTGGACAA	CASSPTEIVNTEAFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	2	0	5	4	23	35	44	40	48			01,02										Vb 1	CASSPTEIVNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCCATCGCACCGGTCTGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	17	2.6539692451799237E-4		50	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	8	5	0	10	4	23	33	46	43	50			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD02-01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGAACTAGCGGGAGGGCCCAGTACTTCGGGCCA	CASSVGTSGRAQYF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	3	0	9	2	0	23	39	-1	41	54			01,02										Vb 1	CASSVGTSGRAQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTCAATGCGGTGACTAGGTCTCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	2.966200921083444E-4		53	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	8	4	10	4	23	39	55	49	59			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGACAGATACGCAGTATTTTGGCCCA	CASSVETDTQYF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	36	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	0	5	5	3	0	0	23	-1	-1	39	41			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVETDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTCGGACCGACAGGGCATGGAAACACCATATATTTTGGAGAG	CASSFGPTGHGNTIYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	3	3	8	2	23	35	50	43	52			01,02										Vb 1	CASSFGPTGHGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCGGGGACAGCAACGAGCAGTACTTCGGGCCG	CASSPGDSNEQYF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	5	4	2	23	35	46	39	48			01,02										Vb 1	CASSPGDSNEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGAAACCGGGACTCTATCACAGATACGCAGTATTTTGGCCCA	CASRNRDSITDTQYF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	2	5	4	23	34	45	39	49			01,02			01,02							Vb 1	CASRNRDSITDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAAGCGGGGAGGGGGAGACCCAGTACTTCGGGCCA	CASSVSGEGETQYF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	6	3	5	0	5	23	-1	45	38	50			01,02			01,02							Vb 1	CASSVSGEGETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAACCGGGACAGGCAACTATGGCTACACCTTCGGTTCG	CASSVTGTGNYGYTF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	4	2	3	1	23	38	49	41	50			01,02										Vb 1	CASSVTGTGNYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCCTAGGACTAGCTTAGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	41	6.400749356022168E-4		41	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	1	7	3	3	5	23	32	43	35	48			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTTGGGGGAGGCTAGCGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	43	6.712981031925689E-4		47	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	4	5	9	0	23	37	-1	46	54			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCGCGGAGGGGTTTAGCACAGATACGCAGTATTTTGGCCCA	CASSPAEGFSTDTQYF	In	VDJ	3	49	7.649676059636251E-4	9.028596698113208E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	10	0	0	5	4	23	35	46	40	50			01,02										Vb 1	CASSPAEGFSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTACAGAGCCAGGGAAGGAACACTGAAGCTTTCTTTGGACAA	CASSVQSQGRNTEAFF	In	VDJ	4	77	0.0012020919522285536	0.0014187794811320754	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	1	6	3	23	38	49	44	52			01,02										Vb 1	CASSVQSQGRNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCATAGCGGGAGAGCAGTTCTTCGGGCCA	CASSVIAGEQFF	In	VDJ	5	94	0.0014674888767465459	0.0017320165094339623	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	5	3	10	2	0	23	37	-1	39	47			01,02										Vb 1	CASSVIAGEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCAGAGCGGGGGACAGGGAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	18	321	0.005011318398251503		47	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	3	7	1	23	35	51	42	52			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTTAGCGGGAGAAGCTCCGGGGAGCTGTTTTTTGGAGAA	CASSFSGRSSGELFF	In	VDJ	41	726	0.011334009835297792	0.013377063679245283	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	5	2	6	2	5	23	35	46	37	51			01,02										Vb 1	CASSFSGRSSGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCAATCTAGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASTNLAGSYNEQFF	In	VDJ	82	1452	0.022668019670595584	0.026754127358490566	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	1	5	0	23	33	-1	38	47			01,02										Vb 1	CASTNLAGSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTAGTGCTCACAGTGGTCCAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	8	1.2489267036140816E-4		49	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	5	2	5	6	19	35	44	40	50														X+TCRBV11-01+TCRBJ01-01	TCRBV11-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCCTACGACGAATAGCGGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	26	4.0590117867457656E-4		50	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	4	0	10	0	19	31	-1	41	48						01,02								X+TCRBV11-01+TCRBJ02-03	TCRBV11-01*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCGGAGGGACAGGGGGTTTAGATACGCAGTATTTTGGCCCA	CASSGGTGGLDTQYF	In	VDJ	2	39	6.088517680118648E-4	7.186025943396226E-4	45	TCRBV11	TCRBV11-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	1	5	3	3	19	31	45	34	48														CASSGGTGGLDTQYF+TCRBV11-01+TCRBJ02-03	TCRBV11-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGTCCAGGGCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQSRAGANVLTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	4	3	4	3	2	29	43	51	46	53													Vb 16	CASSQSRAGANVLTF+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCTAGCAGCCACAGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	6	9.366950277105613E-5		34	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	7	0	0	29	-1	-1	43	48													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGACTAGTTTTTCAGAGTGAACAGTTCTTCGGGCCA	CASSQGLVFQSEQFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	8	13	0	14	29	-1	51	45	65						01,02							Vb 16	CASSQGLVFQSEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGACTAGCGGGAGGTTGATCTTCGGGCCA	CASSQGTSGRLIF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	1	1	17	0	4	29	-1	59	45	63													Vb 16	CASSQGTSGRLIF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGTTATTCGGGAGCACCCTCCTACGAGCAGTACTTCGGGCCG	CASSQGYSGAPSYEQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	8	2	0	6	4	29	45	57	51	61													Vb 16	CASSQGYSGAPSYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACTCTCGAAGACTAGCGGGAGGGCCCTATGAGCAGTTCTTCGGGCCA	CASSQDSRRLAGGPYEQFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	57	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	2	0	8	8	4	18	35	57	43	61													Vb 16	CASSQDSRRLAGGPYEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCCAGAGACAGCCGGGACAGATACGCAGTATTTTGGCCCA	CASSPPETAGTDTQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	5	3	7	5	29	42	54	49	59													Vb 16	CASSPPETAGTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGATGAACGGGAAACCAACTACGAGCAGTACTTCGGGCCG	CASSDERETNYEQYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	3	3	6	6	29	41	52	47	58													Vb 16	CASSDERETNYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATTCCGGACTGTTCAAATGTACTTCGGGCCA	CASSQFRTVQMYF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	1	10	13	4	8	29	44	53	48	61						01,02							Vb 16	CASSQFRTVQMYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATATTTTCTCTACGAGCAGTACTTCGGGCCG	CASSQYFLYEQYF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	10	3	6	0	29	44	-1	50	52						01,02							Vb 16	CASSQYFLYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATTGGGCAGGGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQLGRGSGANVLTF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	51	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	4	1	1	5	0	29	44	-1	49	56													Vb 16	CASSQLGRGSGANVLTF+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTTAAGGGGACAGGTATTTTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	19	2.966200921083444E-4		49	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	4	1	5	5	29	41	54	46	59													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGCGATCGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	21	3.2784325969869644E-4		40	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	7	6	4	1	4	29	42	46	43	50						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGGCCGACGAAGGGGCAATGAGCAGTTCTTCGGGCCA	CASSGRRRGNEQFF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	2	6	9	0	29	41	-1	50	55													Vb 16	CASSGRRRGNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGTCGGCCCGGACTAGCATAATGAGCAGTTCTTCGGGCCA	CASSVGPD*HNEQFF	Stop	VDJ	1	24	3.746780110842245E-4		45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	7	7	8	2	29	41	57	49	59						01,02							Vb 16	CASSVGPD*HNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCCGGGACAGATGAACACTGAAGCTTTCTTTGGACAA	CASSQDPGQMNTEAFF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	5	0	3	1	29	46	56	49	57													Vb 16	CASSQDPGQMNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTATTTACGGGGACAGGGCAGCGAGCAGTACTTCGGGCCG	CASSYLRGQGSEQYF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	6	8	3	29	41	58	49	61													Vb 16	CASSYLRGQGSEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTGGAGTTTATTTCTGTGCCAGCAGCCAATCAAACCGGGACTAGCGGGAGGAGAGAACGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	30	4.683475138552806E-4		59	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	0	1	5	7	7	14	29	51	36	58													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATAACAGGGGAATAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	33	5.151822652408087E-4		43	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	3	2	3	2	3	29	43	52	45	55													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTATGGCATGGGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSQVWHGGGETQYF	In	VDJ	2	37	5.776286004215128E-4	6.81751179245283E-4	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	9	1	4	10	0	29	45	-1	55	61													Vb 16	CASSQVWHGGGETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATACCCGACAGGGCTATACGAGCAGTACTTCGGGCCG	CASSQYPTGLYEQYF	In	VDJ	2	38	5.932401842166888E-4	7.001768867924528E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	3	4	5	3	29	44	56	49	59													Vb 16	CASSQYPTGLYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGCCAACAGGGGGACATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	44	6.869096869877449E-4		46	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	1	6	5	2	29	43	56	48	58													Vb 16	X+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGACCCGGATGAAGGCTAGCGGAGAAAACATTCAGTACTTCGGCGCC		Out	VDJ	3	46	7.18132854578097E-4		58	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	4	5	5	15	2	16	33	55	48	57						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01	TCRBD02-01	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCACTCGAGGAGAGACGCACACTGAAGCTTTCTTTGGACAA	CATRGETHTEAFF	In	VDJ	4	67	0.0010459761142767934	0.0012345224056603773	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	10	10	2	3	5	6	29	36	45	41	51													Vb 16	CATRGETHTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGCCTAATGACAATGAGCAGTTCTTCGGGCCA	CASSQEPNDNEQFF	In	VDJ	4	67	0.0010459761142767934	0.0012345224056603773	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	9	5	2	3	29	46	51	48	54						01,02							Vb 16	CASSQEPNDNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGGAGGGCCCGAGCAGTACTTCGGGCCG	CASSGGPEQYF	In	VDJ	5	86	0.0013425962063851379	0.0015846108490566039	33	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	0	6	0	2	29	-1	47	41	49													Vb 16	CASSGGPEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTTGGTGTTGTGGCAGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSQVGVVAGMNTEAFF	In	VDJ	5	88	0.0013738193739754898	0.0016214622641509435	54	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	0	12	1	27	43	60	55	61													Vb 16	CASSQVGVVAGMNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTCTCCCCGAGTTACTATGGCTACACCTTCGGTTCG	CASSLSPSYYGYTF	In	VDJ	6	109	0.0017016626336741863	0.0020084021226415096	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	2	3	7	2	29	42	52	49	54													Vb 16	CASSLSPSYYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCAGGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	8	143	0.0022324564827101707		40	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	6	1	0	29	46	-1	47	53													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACCCTCGAAGACTAGCGGGAGGGCCCTATGAGCAGTTCTTCGGGCCA	CASSQDPRRLAGGPYEQFF	In	VDJ	10	171	0.0026695808289750995	0.0031507959905660377	57	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	2	0	8	8	4	18	35	57	43	61													Vb 16	CASSQDPRRLAGGPYEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAGACGGACAAACGGGGAGCTGTTTTTTGGAGAA	CASSQRRTNGELFF	In	VDJ	12	209	0.0032628210131917883	0.0038509728773584904	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	6	7	4	2	29	44	53	48	55													Vb 16	CASSQRRTNGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGTCCCACTAGACGGGAGACCCAGTACTTCGGGCCA	CASSRPTRRETQYF	In	VDJ	20	353	0.005510889079697135	0.006504274764150943	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	3	8	5	5	4	29	42	52	47	56						01,02							Vb 16	CASSRPTRRETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCCGGACTAGCGGATTCCAAGAGACCCAGTACTTCGGGCCA	CASSPRTSGFQETQYF	In	VDJ	20	361	0.005635781750058543	0.0066516804245283015	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	5	1	3	3	29	42	55	45	58						01,02							Vb 16	CASSPRTSGFQETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTTTCCGGGACATCCGACGAGCAGTACTTCGGGCCG	CASSLSGTSDEQYF	In	VDJ	38	681	0.01063148856451487	0.012547906839622642	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	5	5	4	29	42	53	47	57													Vb 16	CASSLSGTSDEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCATCGAGGAGGGGGGGAACCAATGAGCAGTTCTTCGGGCCA	CASSASRRGGTNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	9	0	6	10	3	24	36	53	46	56														CASSASRRGGTNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAGCCGGGACTGAAGCTTTCTTTGGACAA	CASSLAGTEAFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	5	7	5	2	4	24	35	41	37	45						01,02								CASSLAGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTCTCGCCGGGTCAGCCCCAGCATTTTGGTGAT	CASSVVSPGQPQHF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	4	6	10	0	24	36	-1	46	50						01,02								CASSVVSPGQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTCGTAGCGGGAGCCCCGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSFVAGAPGTGELFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	5	2	5	5	8	24	35	49	40	57														CASSFVAGAPGTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAATAAAAGGGGGACCTCATCCTACGAGCAGTACTTCGGGCCG	CASNKRGTSSYEQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	5	1	1	8	6	24	31	45	39	51														CASNKRGTSSYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCAAAGGGCAGGGACCACTGAAGCTTTCTTTGGACAA	CASSQRAGTTEAFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	6	0	7	4	10	0	24	35	-1	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRAGTTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACGTGACTAGCGGGAGTAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	16	2.497853407228163E-4		47	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	2	2	3	3	2	24	37	52	40	54														X+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCCGGGGGAATGAGCAGTTCTTCGGGCCA	CASSPRGNEQFF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	2	7	3	0	24	36	-1	39	45														CASSPRGNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCGGCGGGACTAGCGGGAGAGGGGCAGTTCTTCGGGCCA	CASSVAAGLAGEGQFF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	2	12	8	4	24	36	58	44	62														CASSVAAGLAGEGQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGTATCAGGTTGAGCAGTTCTTCGGGCCA	CASSVGYQVEQFF	In	VDJ	3	48	7.49356022168449E-4	8.84433962264151E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	5	4	4	9	9	1	24	36	49	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGYQVEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCCCTTGGCCTTAGCGGGAGGCCATACGAGCAGTTCTTCGGGCCA	CASSEALGLSGRPYEQFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	54	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	5	1	10	9	6	23	40	59	49	65														CASSEALGLSGRPYEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTGAAGCCTACGTAAGCGGGAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	8	1.2489267036140816E-4		52	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	6	4	0	7	0	23	40	-1	47	53						01,02								X+TCRBV06-01+TCRBJ02-04	TCRBV06-01*01	TCRBD02-01	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAGCTAGCGGGAGGAACCGGTAAGGAGCAGTTCTTCGGGCCA	CASSEELAGGTGKEQFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	51	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	1	10	2	10	23	39	52	41	62														CASSEELAGGTGKEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTGGGGACAGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	11	1.7172742174693622E-4		43	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	2	2	1	23	39	48	41	49														X+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGCCCGGACAGGGGGGATGCAGCCCCAGCATTTTGGTGAT	CASSEARTGGMQPQHF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	48	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	1	7	2	4	23	40	52	42	56														CASSEARTGGMQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCTCCGCAGGGTAAGCTACGAGCAGTACTTCGGGCCG	CASSEALRRVSYEQYF	In	VDJ	3	47	7.337444383732729E-4	8.660082547169812E-4	48	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	3	6	4	23	40	51	46	55														CASSEALRRVSYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAAGCGAAGGACCATGGCTACACCTTCGGTTCG	CAISEAKDHGYTF	In	VDJ	6	101	0.001576769963312778	0.001860996462264151	39	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-02	01	0	1	7	6	3	1	23	40	47	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISEAKDHGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCCGGGACAGAGATTGGCTACACCTTCGGTTCG		Out	VDJ	1	6	9.366950277105613E-5		38	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	7	2	4	22	34	43	36	47														X+TCRBV07-04+TCRBJ01-02	TCRBV07-04*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCGGCGCTACAGGGGGAACGAACGCCTACAATGAGCAGTTCTTCGGGCCA	CASGATGGTNAYNEQFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	51	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	3	1	2	6	8	22	31	45	37	53														CASGATGGTNAYNEQFF+TCRBV07-04+TCRBJ02-01	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCAGGGGAGACTGAGGGAGCAGTACTTCGGGCCG	CASSQGRLREQYF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	39	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	7	0	9	22	-1	40	34	49														CASSQGRLREQYF+TCRBV07-04+TCRBJ02-07	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGACTTTAGATGAGCAGTTCTTCGGGCCA	CAWSGTLDEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	10	8	0	4	26	-1	44	39	48						01,02							Vb 20	CAWSGTLDEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGGAGTATCTGGAAACACCATATATTTTGGAGAG	CAWSVGVSGNTIYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	9	2	1	0	2	26	-1	45	40	47													Vb 20	CAWSVGVSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCTCAGCATGAGCAGTTCTTCGGGCCA	CAWSPQHEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	2	4	5	8	3	1	26	38	44	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPQHEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAACAGATGAACACTGAAGCTTTCTTTGGACAA	CAWSEQMNTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	5	0	1	1	26	39	44	40	45													Vb 20	CAWSEQMNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTGGACGGGGGGAATGGAGGAAACACCATATATTTTGGAGAG	CALDGGNGGNTIYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	7	8	1	4	4	6	26	33	44	37	50													Vb 20	CALDGGNGGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCCTGGGAGTACAGGCCAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CACLGVQASSGANVLTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	51	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-06	01	6	3	4	0	9	4	26	34	48	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CACLGVQASSGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*02		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCGGGGGCAGGGGTAGGAGAAAAACTGTTTTTTGGCAGT	CAWSPGAGVGEKLFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-04	01	3	4	2	8	8	5	26	37	51	45	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPGAGVGEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01		TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGGACAAGTGAGGGGGGCTCTGGCTACACCTTCGGTTCG	CAWSRTSEGGSGYTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	2	5	1	7	10	4	26	38	54	48	58			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSRTSEGGSGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCCCAGGGAGGAACTGAAGCTTTCTTTGGACAA	CAWSSQGGTEAFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	1	5	5	1	26	38	49	43	50			unresolved										Vb 20	CAWSSQGGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCGACAGGGGGCGGTGGAAACCCAGTACTTCGGGCCA	CAWRQGAVETQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	0	8	1	7	26	35	46	36	53													Vb 20	CAWRQGAVETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGACAGGGGGGACACAGATACGCAGTATTTTGGCCCA	CAWSDRGDTDTQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	3	1	2	0	2	26	-1	47	39	49													Vb 20	CAWSDRGDTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGACGACAGTCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	8	1.2489267036140816E-4		44	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	2	5	0	2	1	26	39	46	41	47													Vb 20	X+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTCTTGTCGAACGAGCAGTACTTCGGGCCG	CAWSVLLSNEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	10	5	0	8	26	-1	43	40	51						01,02							Vb 20	CAWSVLLSNEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGACGGAACTAGCGATATGGAGACCCAGTACTTCGGGCCA	CAWSDGTSDMETQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	3	6	5	5	5	26	39	51	44	56						01,02							Vb 20	CAWSDGTSDMETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAGAGGGAGGAGGGGAACCCTGAAGCTTTCTTTGGACAA	CAWEREEGNPEAFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	1	6	4	9	26	35	45	39	54													Vb 20	CAWEREEGNPEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGGGACACGAGGAACACTGAAGCTTTCTTTGGACAA	CAWSVRDTRNTEAFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	6	1	2	4	26	40	48	42	52			unresolved										Vb 20	CAWSVRDTRNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTAGCGGGAGGGTACAATGAGCAGTTCTTCGGGCCA	CAWSVLAGGYNEQFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	3	0	4	0	0	26	-1	-1	40	53													Vb 20	CAWSVLAGGYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAGGGGAGACAACAAGAGACCCAGTACTTCGGGCCA	CAWEGRQQETQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-05	01	5	5	2	2	1	6	26	35	41	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWEGRQQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGAGACAGGGGTGGAACTGAAGCTTTCTTTGGACAA	CAWSVRDRGGTEAFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	2	5	4	4	26	40	52	44	56													Vb 20	CAWSVRDRGGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCGACGGGACACTCGAACACTGAAGCTTTCTTTGGACAA	CASTGHSNTEAFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	6	1	4	3	26	33	43	37	46													Vb 20	CASTGHSNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCTAGGGATTATTATGGCTACACCTTCGGTTCG	CAWSPRDYYGYTF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	2	0	8	5	4	4	26	38	46	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPRDYYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGACAGGGGAGCGGAGACCCAGTACTTCGGGCCA	CAWSGDRGAETQYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	2	5	0	4	26	-1	49	39	53			unresolved										Vb 20	CAWSGDRGAETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGACGGGGTAATGAAAAACTGTTTTTTGGCAGT	CAWSGRGNEKLFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	1	8	3	4	2	0	26	39	-1	41	46													Vb 20	CAWSGRGNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAGGGGGGCGGGAACCTCGGCGGAGCAATACTTCGGGCCG	CAWSVRGAGTSAEQYF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	48	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-07	01	0	5	1	13	1	21	26	40	47	41	68			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVRGAGTSAEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCTCCCGTCGGGGTTAGCTGGAAACACCATATATTTTGGAGAG	CAWSLPSGLAGNTIYF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	3	8	3	2	8	4	26	37	50	45	54													Vb 20	CAWSLPSGLAGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGATCAGGGGTGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	2.497853407228163E-4		38	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	3	3	3	26	35	44	38	47													Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGTCCAGCCCAATCAGCCTCAGCATTTTGGTGAT	CAWSVQPNQPQHF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	3	4	5	13	4	12	26	37	44	41	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVQPNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCTTCTAAGACGGCCGTAAGAAGCTACACCTTCGGTTCG	CAWSASKTAVRSYTF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	1	2	7	9	7	11	26	39	49	46	60			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSASKTAVRSYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGTAGCGGGAGTGCGGGGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	19	2.966200921083444E-4		49	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	5	2	5	2	7	26	39	50	41	57													Vb 20	X+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGTACGGGAAATGATGGCTACACCTTCGGTTCG	CAWSRTGNDGYTF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	8	3	6	4	4	26	38	47	42	51													Vb 20	CAWSRTGNDGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGTTCGACTAGCGGGAGAGACACCGGGGAGCTGTTTTTTGGAGAA	CACSTSGRDTGELFF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	2	2	3	3	2	26	34	49	37	51			unresolved										Vb 20	CACSTSGRDTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGCGGGACTCCTGGAAACACCATATATTTTGGAGAG	CAWGGTPGNTIYF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	0	10	2	3	1	26	35	44	38	45						01,02							Vb 20	CAWGGTPGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD02-01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACCTCAGGGGAGATGGACTGAAGCTTTCTTTGGACAA	CAWRPQGRWTEAFF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	5	4	6	26	37	47	41	53													Vb 20	CAWRPQGRWTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCGGGGACAGCAAATTCAAAGCAGTACTTCGGGCCG	CAWSVPGTANSKQYF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	5	8	4	9	26	40	51	44	60													Vb 20	CAWSVPGTANSKQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCAATCGGGGGGGTCTGAAGAGACCCAGTACTTCGGGCCA	CAWQSGGSEETQYF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	3	4	4	26	35	47	39	51													Vb 20	CAWQSGGSEETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTAACAGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CALTGSGANVLTF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	7	3	3	1	2	0	26	33	-1	35	41													Vb 20	CALTGSGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCTTCTGGGACGGCCGTAAGAAGCTACACCTTCGGTTCG	CAWSASGTAVRSYTF	In	VDJ	2	30	4.683475138552806E-4	5.527712264150943E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	1	0	7	9	5	11	26	39	49	44	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSASGTAVRSYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCTTACGCCCGGGACACTGAAGCTTTCTTTGGACAA	CAWSSYARDTEAFF	In	VDJ	2	30	4.683475138552806E-4	5.527712264150943E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	8	4	3	9	0	26	38	-1	47	51						01,02							Vb 20	CAWSSYARDTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACACCCCGGGGATGAGCAGTTCTTCGGGCCA	CAWSVHPGDEQFF	In	VDJ	2	32	4.995706814456326E-4	5.896226415094339E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	3	8	6	0	26	40	-1	46	51													Vb 20	CAWSVHPGDEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCGCCAATGAGCAGTTCTTCGGGCCA	CAWSPANEQFF	In	VDJ	2	38	5.932401842166888E-4	7.001768867924528E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	2	10	0	6	3	0	26	38	-1	41	43			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPANEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGGGTGGCGGTTCAGAGACCCAGTACTTCGGGCCA	CAWKGGGSETQYF	In	VDJ	2	41	6.400749356022168E-4	7.554540094339623E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-05	01	4	5	3	4	0	9	26	-1	40	36	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKGGGSETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGTGACAGGGGGCTAAACACCGGGGAGCTGTTTTTTGGAGAA	CAGDRGLNTGELFF	In	VDJ	3	45	7.025212707829209E-4	8.291568396226415E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	2	0	2	3	2	26	32	45	35	47													Vb 20	CAGDRGLNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCCACTGGACAGGGGCTGGCTACGAGCAGTACTTCGGGCCG	CAHWTGAGYEQYF	In	VDJ	3	52	8.118023573491531E-4	9.581367924528302E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	1	2	3	4	4	26	32	45	36	49			unresolved										Vb 20	CAHWTGAGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCGACTATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	53	8.274139411443291E-4		37	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	2	9	0	2	0	26	36	-1	38	43						01,02							Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCCGGGACAGGGCGTACTGCAGCTTTCTTTGGACAA	CAWSSGTGRTAAFF	In	VDJ	3	53	8.274139411443291E-4	9.765625E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	10	3	8	26	38	50	41	58													Vb 20	CAWSSGTGRTAAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGACAGCACTAGCCAAAAACATTCAGTACTTCGGCGCC	CAWSGTALAKNIQYF	In	VDJ	3	57	8.898602763250332E-4	0.0010502653301886792	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	1	5	0	0	4	26	-1	45	39	49													Vb 20	CAWSGTALAKNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGCGGGACCCCGGGCAGCCCCAGCATTTTGGTGAT	CAWGRDPGQPQHF	In	VDJ	3	58	9.054718601202092E-4	0.001068691037735849	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	7	3	7	2	7	26	35	43	37	50													Vb 20	CAWGRDPGQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCCAACCAGGGGAATCTGGGACCAACGTCCTGACTTTCGGGGCC	CAQPGESGTNVLTF	In	VDJ	3	60	9.366950277105613E-4	0.0011055424528301887	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	4	2	8	4	9	26	32	42	36	51													Vb 20	CAQPGESGTNVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCTTGGATGCTTGGGGGAGGGACCATCCAACAAAAACTGTTTTTTGGCAGT	CAWMLGGGTIQQKLFF	In	VDJ	4	65	0.0010147529466864413	0.0011976709905660377	48	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	9	0	9	7	10	26	36	50	43	60													Vb 20	CAWMLGGGTIQQKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCGATCTAGGAGGACCTGGGATACGCAGTATTTTGGCCCA	CAWRSRRTWDTQYF	In	VDJ	4	68	0.0010615876980719695	0.0012529481132075471	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	1	6	7	6	26	35	47	42	53			unresolved										Vb 20	CAWRSRRTWDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACAGGGGGCTAGATGCGAATGAGCAGTTCTTCGGGCCA	CAWDRGLDANEQFF	In	VDJ	5	80	0.0012489267036140817	0.001474056603773585	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	0	7	0	8	26	-1	45	35	53													Vb 20	CAWDRGLDANEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGCTCCGGGACAGGTTACAATGAGCAGTTCTTCGGGCCA	CAWGSGTGYNEQFF	In	VDJ	5	81	0.0012645382874092576	0.0014924823113207548	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	4	6	1	26	35	49	41	50													Vb 20	CAWGSGTGYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGCAGGTTGGAAACACCATATATTTTGGAGAG	CAWSGQVGNTIYF	In	VDJ	5	94	0.0014674888767465459	0.0017320165094339623	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	4	3	2	1	26	39	45	41	46			unresolved										Vb 20	CAWSGQVGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCAGTCGGAGGCCAACCCGAGCAGTACTTCGGGCCG	CAWAVGGQPEQYF	In	VDJ	5	94	0.0014674888767465459	0.0017320165094339623	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	1	6	6	6	26	35	46	41	52			unresolved										Vb 20	CAWAVGGQPEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGAGAACACTGAAGCTTTCTTTGGACAA	CAWSENTEAFF	In	VDJ	5	97	0.001514323628132074	0.0017872936320754717	33	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	3	2	8	1	1	0	26	37	-1	38	40			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSENTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAAGACTAGCGGGAGTTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	105	0.001639216298493482		43	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	2	2	4	2	1	26	39	53	41	54													Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCCTTACCCCTAGCGGAGCCTACGAGCAGTACTTCGGGCCG	CALTPSGAYEQYF	In	VDJ	8	136	0.002123175396143939	0.0025058962264150942	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	4	5	2	7	2	26	32	46	39	48			unresolved			01,02							Vb 20	CALTPSGAYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTCGGTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQVGATNEKLFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	8	5	0	1	2	23	39	43	40	45						01,02								CASSQVGATNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD02-01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TATCTCTGCACCAGCAGCCAAGATCTTCCGGACTAGCGGGACTCCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CTSSQDLPD*RDSSSYNEQFF	Stop	VDJ	1	9	1.405042541565842E-4		63	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	1	3	0	6	6	6	23	41	29	47														CTSSQDLPD*RDSSSYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCATCCGACAGGGGGAAACACCATATATTTTGGAGAG	CASSHPTGGNTIYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	2	3	4	3	0	23	37	-1	40	47														CASSHPTGGNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTCCAACAAGGGTGGGACGAGCAGTACTTCGGGCCG	CASSLQQGWDEQYF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	42	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	4	5	3	5	7	4	23	36	47	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQQGWDEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCCCCCGACAGCTCTGGAAACACCATATATTTTGGAGAG	CASSQAPDSSGNTIYF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	2	5	0	5	0	23	39	-1	44	49														CASSQAPDSSGNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGTTCTAGCGGGAGGTACGAGCAGTACTTCGGGCCG	CASSQGSSGRYEQYF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	4	1	4	3	0	23	39	-1	42	53														CASSQGSSGRYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGTGGGGGGTAGATACGCAGTATTTTGGCCCA	CASSQGWGVDTQYF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	9	1	5	3	1	23	39	48	42	49														CASSQGWGVDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGACAGGGGAAGACCCAGTACTTCGGGCCA		Out	VDJ	1	25	3.902895948794005E-4		38	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	2	6	0	1	23	-1	46	40	47														X+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCGCAGACAGGGATTAACTACGAGCAGTACTTCGGGCCG	CASSPQTGINYEQYF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	3	3	4	5	23	36	47	40	52														CASSPQTGINYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTAGGTTGGAGCTACACCTTCGGTTCG	CASSQVGWSYTF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	36	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-02	01	1	1	8	9	6	0	23	39	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGWSYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCATTGACAGGGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	29	4.527359300601046E-4		50	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	2	1	5	1	23	40	53	45	54														X+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATAACCGACAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDNRQNTGELFF	In	VDJ	3	48	7.49356022168449E-4	8.84433962264151E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	6	1	5	0	23	40	-1	45	49														CASSQDNRQNTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGGAATCGACTAGAGCGGGGGACCCAGTACTTCGGGCCA	CASSRNRLERGTQYF	In	VDJ	3	50	7.80579189758801E-4	9.212853773584906E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	6	3	7	12	0	23	36	-1	48	55														CASSRNRLERGTQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGAAAACGCCCCGGGGACTGAAGCTTTCTTTGGACAA	CASSQENAPGTEAFF	In	VDJ	4	67	0.0010459761142767934	0.0012345224056603773	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	3	5	11	0	23	37	-1	48	53														CASSQENAPGTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAATACGGACAGGGGAACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	21	380	0.005932401842166888		46	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	2	5	3	1	23	38	50	41	51														X+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGACCCGGGACTAGCGGGAGACACTACGAGCAGTACTTCGGGCCG	CASRPGTSGRHYEQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	2	3	4	3	19	30	48	34	51													Vb 5.1	CASRPGTSGRHYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGGACAGATTATTACGAGCAGTACTTCGGGCCG	CASSPGTDYYEQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	4	3	5	19	31	41	34	46													Vb 5.1	CASSPGTDYYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTAGACAGGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CASSLDRTGNEKLFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	3	5	7	0	19	31	-1	38	46													Vb 5.1	CASSLDRTGNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGGACTAGCGGGGCTCTCCTACGAGCAGTACTTCGGGCCG	CASSSGLAGLSYEQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	0	2	2	19	32	46	34	48													Vb 5.1	CASSSGLAGLSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGCAGGGCGGACGAGAGACCCAGTACTTCGGGCCA	CASSSQGGRETQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	3	4	2	6	19	32	39	34	45													Vb 5.1	CASSSQGGRETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGACAGGGGGCTCTTCCGAGCAGTACTTCGGGCCG	CASSLTGGSSEQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	0	6	0	5	19	-1	43	34	48													Vb 5.1	CASSLTGGSSEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCTAACCCGAACAATGAGCAGTTCTTCGGGCCA	CASSLANPNNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	9	5	0	6	19	-1	38	35	44						01,02							Vb 5.1	CASSLANPNNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAGGGGCAAGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSQGQAGTDTQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	2	1	0	7	19	-1	37	31	44													Vb 5.1	CASSQGQAGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCCTATCCGGGCCCAACTATGGCTACACCTTCGGTTCG	CASSLLSGPNYGYTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-02	01	4	8	0	2	9	2	19	31	44	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLLSGPNYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCCGTTAGGGCAGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSSPLGQGTGELFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	2	5	11	0	19	32	-1	43	49													Vb 5.1	CASSSPLGQGTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCGTGCGGTAGCGGGCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSRAVAGNTGELFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	5	4	2	9	1	19	32	48	41	49						01,02							Vb 5.1	CASSSRAVAGNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGCAACCGACAGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSSQPTGATDTQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	2	2	7	1	19	32	47	39	48													Vb 5.1	CASSSQPTGATDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAAGGGGGCAGGTCAGCCCCAGCATTTTGGTGAT	CASSLKGAGQPQHF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	5	0	6	1	3	19	34	42	35	45													Vb 5.1	CASSLKGAGQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGACAGGGGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGQGSTGELFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	2	4	0	2	19	-1	43	35	45													Vb 5.1	CASSLGQGSTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTGGGTTTTCCAGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	6	9.366950277105613E-5		43	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-05	01	1	0	9	6	1	8	19	34	38	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTTTAGCGGGACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGPNTGELFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	5	3	0	2	1	19	30	40	32	41													Vb 5.1	CASSLAGPNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCGGTCCTGGGACTAGCGGGAGTTCCGAGCAGTACTTCGGGCCG	CASGPGTSGSSEQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	0	2	6	6	3	19	28	48	34	51													Vb 5.1	CASGPGTSGSSEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTGCGCCAGCGGTTAGGTATCGGTTCACAAAGTCGGGGGTTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASG*VSVHKVGGSQSRANVLTF	Stop	VDJ	1	6	9.366950277105613E-5		69	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	7	8	2	5	23	11	1	10	39	33	50													Vb 5.1	CASG*VSVHKVGGSQSRANVLTF+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCACCTCATCTGCAGGGGACGGTTCCTACGAGCAGTACTTCGGGCCG	CATSSAGDGSYEQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	4	2	1	9	5	19	26	41	35	46													Vb 5.1	CATSSAGDGSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGATCCACAGGTTCATCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	7	1.0928108656623214E-4		44	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	4	3	4	5	19	30	39	34	44													Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGGCAGGGGGTTACGAGCAGTACTTCGGGCCG	CASSLEAGGYEQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	1	4	3	1	19	35	45	38	46													Vb 5.1	CASSLEAGGYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGATACGACTAGCGTGTACGAGCAGTACTTCGGGCCG	CASSLDTTSVYEQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	6	4	4	2	19	35	47	39	49						01,02							Vb 5.1	CASSLDTTSVYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTCTGGGGGGAGGAGACTAGCGGAGACAAGCAGTACTTCGGGCCG		Out	VDJ	1	7	1.0928108656623214E-4		53	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	5	8	13	5	19	34	56	47	61						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCTACCTGGACCACAAGGGGGAAAACTGTTTTTTGGCAGT		Out	VDJ	1	7	1.0928108656623214E-4		41	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	5	1	10	13	0	19	28	-1	41	47													Vb 5.1	X+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAAAACTGACTCGAGGACCGGGGAGCTGTTTTTTGGAGAA	CASSKTDSRTGELFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	2	10	5	6	5	19	31	41	37	46						01,02							Vb 5.1	CASSKTDSRTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCACAGGGGGGAGCTAACTATGGCTACACCTTCGGTTCG	CASSPQGGANYGYTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	1	0	2	3	19	31	41	33	44													Vb 5.1	CASSPQGGANYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCTCCACTCACGGGGTACGCAGTATTTTGGCCCA	CASSSLHSRGTQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	3	8	11	0	19	32	-1	43	48													Vb 5.1	CASSSLHSRGTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGGGGGAGGAAATAACTACGAGCAGTACTTCGGGCCG	CASSWGGGNNYEQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	9	0	3	0	9	19	-1	39	32	48													Vb 5.1	CASSWGGGNNYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCGAAGTATCAGCGGGACAAGAGACCCAGTACTTCGGGCCA	CASTEVSAGQETQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	6	3	2	10	0	19	29	-1	39	46													Vb 5.1	CASTEVSAGQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCATTATTGACAGGGTCTGGAAACACCATATATTTTGGAGAG	CASSPLLTGSGNTIYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	2	3	1	8	0	19	31	-1	39	46													Vb 5.1	CASSPLLTGSGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAAACAGCTAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLETASSGANVLTF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	51	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-06	01	0	3	5	0	2	4	19	35	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLETASSGANVLTF+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCGTGGGGAGTAGGCCAAGAGACCCAGTACTTCGGGCCA	CASSLAWGVGQETQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	9	2	1	4	4	19	35	44	39	48													Vb 5.1	CASSLAWGVGQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGACTAGCGGGACCAAAGAGACCCAGTACTTCGGGCCA	CASSLGTSGTKETQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	1	3	3	0	3	19	-1	47	35	50													Vb 5.1	CASSLGTSGTKETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTGGGATCTTGAGGGACACTGAAGCTTTCTTTGGACAA	CASSFGILRDTEAFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	11	0	3	9	0	19	33	-1	42	47													Vb 5.1	CASSFGILRDTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCGGGGAGGGTTTGTATGAAAACACCATATATTTTGGAGAG	CASGEGLYENTIYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	7	9	0	6	1	9	19	28	36	29	45													Vb 5.1	CASGEGLYENTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCGCCGGGGGCCCTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFAGGPNTGELFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	2	6	0	2	4	3	19	33	43	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSFAGGPNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCGACAATCGGGAGGGCCCCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	1.8733900554211225E-4		47	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	0	8	9	4	19	31	48	40	52													Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGGGACAGGGTAGGAACAATGAGCAGTTCTTCGGGCCA	CASSSGQGRNNEQFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	5	1	5	19	32	42	33	47													Vb 5.1	CASSSGQGRNNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTTCAGACTAGTCTTGTGGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	2.497853407228163E-4		43	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	2	8	7	4	7	19	33	43	37	50						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCAACGGGCGGGAGGGCCCCGGGAGCTGTTTTTTGGAGAA	CASSSQRAGGPRELFF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	7	0	9	8	4	19	32	49	40	53													Vb 5.1	CASSSQRAGGPRELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTAGGCAGCCACGACGAAAAACTGTTTTTTGGCAGT	CASSLVGSHDEKLFF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	0	2	7	8	11	0	19	35	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLVGSHDEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGCTCGATTCAGGGGGATACGCAGTATTTTGGCCCA	CASSLGSIQGDTQYF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	2	6	8	0	19	35	-1	43	49													Vb 5.1	CASSLGSIQGDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCTCCGGGACAGGGCCGGGAGAGCAGTTCTTCGGGCCA	CASSLASGTGPGEQFF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	10	5	6	19	35	49	40	55													Vb 5.1	CASSLASGTGPGEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGTACAAAGGGTCGGCGTGGGTGGATACGCAGTATTTTGGCCCA	CASSLGYKGSAWVDTQYF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	54	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	0	5	3	6	7	12	19	35	46	42	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGYKGSAWVDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCCTTTATCTTTGCGCCAGCAGCGCCCCTAGGGGTTTCGGGACTAGCGGGAGATGGGGAGAGACCCAGTACTTCGGGCCA	CASSAPRGFGTSGRWGETQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	63	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	0	2	4	15	6	18	30	59	45	65													Vb 5.1	CASSAPRGFGTSGRWGETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGACAGCCAACTACGAGCAGTACTTCGGGCCG	CASSLGTANYEQYF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	5	3	0	4	19	-1	41	35	45													Vb 5.1	CASSLGTANYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGCAGGGGAACGGGGATACGCAGTATTTTGGCCCA	CASSLGQGNGDTQYF	In	VDJ	2	40	6.244633518070409E-4	7.370283018867925E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	2	6	2	6	19	35	43	37	49													Vb 5.1	CASSLGQGNGDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCGCATCGTCTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASASSSNTGELFF	In	VDJ	7	129	0.002013894309577707	0.0023769162735849058	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	7	4	6	0	1	7	19	28	31	29	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASASSSNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGGGACTAGCGGGTACAATGAGCAGTTCTTCGGGCCA	CASSSGTSGYNEQFF	In	VDJ	15	259	0.0040434002029505894	0.004772258254716981	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	4	4	2	0	19	32	-1	34	46						01,02							Vb 5.1	CASSSGTSGYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCATTCGGCATATTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	8	1.2489267036140816E-4		50	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	12	5	22	31	47	43	52														X+TCRBV17-01+TCRBJ02-06	TCRBV17-01*01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCCGATTGAATTTCTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	15	2.341737569276403E-4		52	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	13	5	22	31	49	44	54														X+TCRBV17-01+TCRBJ02-06	TCRBV17-01*01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCAGACATCTATGTACCTCTGTGCCAGCCGGGACAGGGTCCCCTCTCTCTCCCTTTCTAGCACAGATACGCAGTATTTTGGCCCA	CASRDRVPSLSLSSTDTQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	60	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	3	0	1	20	21	30	40	31	60													Vb 3	CASRDRVPSLSLSSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTCTTCTCGAGGGGGCGCACACTGAAGCTTTCTTTGGACAA	CASTLLEGAHTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	5	0	3	9	2	25	35	51	44	53													Vb 3	CASTLLEGAHTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAACAGGACAGGGCCGGGTAAACACTGAAGCTTTCTTTGGACAA	CASSPTGQGRVNTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	2	7	7	25	36	51	43	58													Vb 3	CASSPTGQGRVNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGGGGCGGGACGCTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRGAGRYSGANVLTF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	51	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-06	01	6	6	0	0	0	9	25	-1	42	36	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRGAGRYSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACAAGGAGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	5	7.805791897588011E-5		34	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	10	2	8	4	0	25	37	-1	41	45													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCTACAGGGGGGCTAGCACTGAAGCTTTCTTTGGACAA	CASSPYRGASTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	1	4	4	5	25	37	49	41	54													Vb 3	CASSPYRGASTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTCCCGGGAGAACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSPGRTGANVLTF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	4	8	2	2	4	2	25	38	48	42	50													Vb 3	CASSSPGRTGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGGGGAGGTCACAGTTCTTCGGGCCA	CASSLWGRSQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	1	13	1	3	25	42	49	43	52													Vb 3	CASSLWGRSQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATCAACTGGGAGGGGCGCGGAAAACTGTTTTTTGGCAGT	CASINWEGRGKLFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	9	0	10	6	6	25	35	48	41	54													Vb 3	CASINWEGRGKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGCGACACCCTCCACGATCAGCCCCAGCATTTTGGTGAT	CASSRDTLHDQPQHF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	6	5	4	9	25	36	44	40	53													Vb 3	CASSRDTLHDQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTACTAGCGCCAAGCAGTACTTCGGGCCG	CASSPTSAKQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	6	8	3	3	25	37	47	40	50						01,02							Vb 3	CASSPTSAKQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTCGGGGCGAAAGAGACCCAGTACTTCGGGCCA	CASSLLGAKETQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	2	7	0	3	3	2	25	40	48	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLLGAKETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGGCAGTCGGGGATGCCAAGTAGAGGCTACACCTTCGGTTCG	CASSRQSGMPSRGYTF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	3	8	7	12	25	37	49	44	61													Vb 3	CASSRQSGMPSRGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTACCAGAAACCGGATCCGGGACTACGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	7	1.0928108656623214E-4		55	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	9	5	16	2	25	38	61	54	63						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTACCCAGGGGCGAGCGGTGGCTACACCTTCGGTTCG	CASSYPGASGGYTF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	7	3	7	25	38	47	41	54													Vb 3	CASSYPGASGGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGCCCTTTGCGGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSSPFAGTNTEAFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	7	3	1	8	2	25	38	52	46	54													Vb 3	CASSSPFAGTNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGTGGGTTCCTACGAGCAGTACTTCGGGCCG	CASSFVGSYEQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	0	9	11	3	11	25	39	45	42	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFVGSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGTGGGTTCCTACGAGTAGTACTTCGGGCCG	CASSFVGSYE*YF	Stop	VDJ	1	7	1.0928108656623214E-4		39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	0	9	11	3	11	25	39	45	42	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFVGSYE*YF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCTTCCCACTAGCGGATAGACTTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	8	1.2489267036140816E-4		46	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	3	5	3	7	8	25	32	47	39	55						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAGATCCGGGTACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPDPGTTNEKLFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	8	4	0	8	2	25	36	48	44	50						01,02							Vb 3	CASSPDPGTTNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGAGGGAGTCAGCCCCAGCATTTTGGTGAT	CASSRGSQPQHF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	9	2	6	3	0	25	37	-1	40	45													Vb 3	CASSRGSQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAGGGAGGTGTCTTTACCCAGTACTTCGGGCCA	CASSLQGGVFTQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	9	1	8	2	7	25	40	48	42	55													Vb 3	CASSLQGGVFTQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGCAAAGGGGTCAACTAATGAAAAACTGTTTTTTGGCAGT	CAAKGSTNEKLFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	5	2	0	4	1	25	31	40	35	41													Vb 3	CAAKGSTNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAAAGGGAGGGGCTAGTGACACCATATATTTTGGAGAG	CASRKGGASDTIYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	9	0	8	3	7	25	36	46	39	53													Vb 3	CASRKGGASDTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGGGAGTTGTATTATTGGACCGCCTGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	9	1.405042541565842E-4		55	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	9	2	2	1	20	25	36	42	37	62													Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGGACAAAGATCAGCCCCAGCATTTTGGTGAT	CASSPDKDQPQHF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	6	5	2	3	25	37	44	39	47													Vb 3	CASSPDKDQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTATGGTTATATCCACACTGAAGCTTTCTTTGGACAA	CASSYGYIHTEAFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	4	0	10	3	2	8	25	38	42	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSYGYIHTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTTACTAGCGGGAGAGGCTACGAGCAGTACTTCGGGCCG	CASSLLTSGRGYEQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	3	2	3	3	3	25	40	54	43	57													Vb 3	CASSLLTSGRGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGCCGGCGGGGCTACACCTTCGGTTCG	CASSLGRRGYTF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	7	5	8	5	0	25	40	-1	45	49						01,02							Vb 3	CASSLGRRGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGGGCAGGGGGTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	9	1.405042541565842E-4		44	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	4	1	3	4	0	25	39	-1	43	50													Vb 3	X+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCATACAGGGGGCCAGGGAACACTGAAGCTTTCTTTGGACAA	CASRPYRGPGNTEAFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	0	1	5	4	25	36	50	41	54													Vb 3	CASRPYRGPGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGAGACAGGGGGCGACTATGGCTACACCTTCGGTTCG	CASRETGGDYGYTF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	0	3	3	1	25	36	49	39	50													Vb 3	CASRETGGDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGTTAGGGGGCGGCATCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRLGGGISYNEQFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	6	0	0	0	5	25	-1	46	40	51													Vb 3	CASRLGGGISYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCGGGACAACGGAATCTATGGCTACACCTTCGGTTCG	CASSPRDNGIYGYTF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	6	4	4	7	25	37	47	41	54													Vb 3	CASSPRDNGIYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTCAAGGGGGCAACTATGGCTACACCTTCGGTTCG	CASSSQGGNYGYTF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	5	0	2	4	0	25	38	-1	42	49													Vb 3	CASSSQGGNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCAAGTCTGAACAGTTCCACTGAAGCTTTCTTTGGACAA	CASLNSSTEAFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	3	5	4	8	3	25	30	42	38	45													Vb 3	CASLNSSTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTCTTTCCCGCCGGGAGACCCAGTACTTCGGGCCA	CASSPLSRRETQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	8	5	5	12	0	25	37	-1	49	52						01,02							Vb 3	CASSPLSRRETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGGGCCAGTCCACAGATACGCAGTATTTTGGCCCA	CASSLWGQSTDTQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	8	0	2	0	5	25	-1	46	42	51													Vb 3	CASSLWGQSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGATGGGGGGCTATCTCGAGCAGTACTTCGGGCCG	CASSLMGGYLEQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	6	0	6	4	5	25	39	49	43	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLMGGYLEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGGTTCGGAGGCAAAAACATTCAGTACTTCGGCGCC	CASSLRFGGKNIQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	2	10	1	3	6	0	25	40	-1	46	51													Vb 3	CASSLRFGGKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCCGGGACAGGGCCACTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLPGTGPLNTGELFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	3	1	3	5	25	40	52	43	57													Vb 3	CASSLPGTGPLNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTAGCCCTCCGGACAGGGTGCGGGGCTACACCTTCGGTTCG	CASSPPDRVRGYTF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	1	3	8	9	5	25	33	50	42	55													Vb 3	CASSPPDRVRGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAATGGGAAAGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	13	2.0295058933728828E-4		43	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	7	0	8	0	3	3	25	35	42	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGGATCAAGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASKDQAGANVLTF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-06	01	7	1	8	2	1	5	25	35	39	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASKDQAGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAGGGACAGGCGTGTCCTACGAGCAGTACTTCGGGCCG	CASRGTGVSYEQYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	1	1	4	25	36	45	37	49													Vb 3	CASRGTGVSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCACCGAGAACCGGGGTTAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	13	2.0295058933728828E-4		49	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	3	2	10	3	25	38	53	48	56													Vb 3	X+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGTATGAACTATGGCTACACCTTCGGTTCG	CASSLGMNYGYTF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	3	0	9	2	0	4	25	-1	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGMNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTTCTTCATCTTTTGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	13	2.0295058933728828E-4		40	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	8	0	10	4	13	0	25	34	-1	47	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTATGTGAGGAGACAGGGTCCTGAAAAACTGTTTTTTGGCAGT	CASSYVRRQGPEKLFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	3	7	11	3	25	36	54	47	57													Vb 3	CASSYVRRQGPEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGAAGACGATCAGCCCCAGCATTTTGGTGAT	CASREDDQPQHF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	6	1	8	5	0	5	25	-1	39	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASREDDQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCCAGGGGGGGTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	2.1856217313246428E-4		40	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	5	4	1	4	2	3	25	37	46	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGAAGGGGCCGGATCCTACGAGCAGTACTTCGGGCCG	CASSLEGAGSYEQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	5	2	1	2	5	25	40	47	42	52													Vb 3	CASSLEGAGSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGGACTGTCTTAGGTGGTGAGCAGTTCTTCGGGCCA	CASSLGTVLGGEQFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	9	1	11	25	39	46	40	57						01,02							Vb 3	CASSLGTVLGGEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGCGGTCCTCACAATCAGCCCCAGCATTTTGGTGAT	CASSLSGPHNQPQHF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	6	5	3	0	6	25	-1	45	40	51						01,02							Vb 3	CASSLSGPHNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGCCTTTGGAGCGGGAGGGAACAGATACGCAGTATTTTGGCCCA	CASSLWPLEREGTDTQYF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	6	0	3	8	1	25	42	60	50	61													Vb 3	CASSLWPLEREGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGGGATCCGAGAGACCCAGTACTTCGGGCCA	CASSGIRETQYF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	8	3	4	0	4	25	-1	41	36	45													Vb 3	CASSGIRETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAAAGCCGCCCTACAGGGGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSESRPTGGGNQPQHF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	1	2	12	2	25	37	57	49	59													Vb 3	CASSESRPTGGGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTTGGTAGCGGGAGGCTCCGGGGAGCTGTTTTTTGGAGAA	CASSFLVAGGSGELFF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	5	1	6	5	2	25	39	54	44	56													Vb 3	CASSFLVAGGSGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATGGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLMASTDTQYF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	9	0	0	2	1	25	40	45	42	46													Vb 3	CASSLMASTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCCCCCTTTCGGCGAGCAGTACTTCGGGCCG	CASSFPPFGEQYF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	5	6	9	0	25	39	-1	48	51						01,02							Vb 3	CASSFPPFGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCAGGGGTACAATCAGCCCCAGCATTTTGGTGAT	CASSFQGYNQPQHF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	3	1	2	25	39	46	40	48													Vb 3	CASSFQGYNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCGAATTAGCGGGGGGCCCACTTACGAGCAGTACTTCGGGCCG	CASRISGGPTYEQYF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	5	1	4	5	6	25	34	49	39	55													Vb 3	CASRISGGPTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGAACTCGGAGGGATCCTACGAGCAGTACTTCGGGCCG	CASSSNSEGSYEQYF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	0	1	7	1	25	38	51	45	52													Vb 3	CASSSNSEGSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTCTAGCGAAGAGCACAGATACGCAGTATTTTGGCCCA	CASSSLAKSTDTQYF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	6	0	2	3	25	38	46	40	49						01,02							Vb 3	CASSSLAKSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTATGCAGGGGATAGGCTACACCTTCGGTTCG	CASSFMQGIGYTF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	2	8	4	3	25	39	49	43	52													Vb 3	CASSFMQGIGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGAAGGCAGACTGAAGCTTTCTTTGGACAA	CASSLRRQTEAFF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	2	4	5	5	6	0	25	40	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLRRQTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCATTTGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	3.4345484349387244E-4		35	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	6	3	1	4	25	37	40	38	44													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCTCGGGACAGGGGACAGATACGCAGTATTTTGGCCCA	CASSPSGQGTDTQYF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	3	5	0	25	37	-1	42	52													Vb 3	CASSPSGQGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGAATTGATCGTCCATGAAGCGGGAGGGACAGATACGCAGTATTTTGGCCCA	CASSELIVHEAGGTDTQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	57	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	6	0	3	17	0	24	36	-1	53	63													Vb 3	CASSELIVHEAGGTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCCCCATGGAGGGGACATTCAGTACTTCGGCGCC	CASTPHGGDIQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	7	10	0	8	8	1	25	35	49	43	50													Vb 3	CASTPHGGDIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCTCTAGTCCCCCGGGACAGGGGTTTTCGTACTTCGGGCCG	CASSPSSPPGQGFSYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	12	14	5	25	37	61	51	66													Vb 3	CASSPSSPPGQGFSYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGCAGACAGGGGGAGGGCTTTCTTTGGACAA	CASSLADRGRAFF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	1	11	3	3	25	40	52	43	55													Vb 3	CASSLADRGRAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTACCTCGAAAGTGGAACTGAAGCTTTCTTTGGACAA	CASSYLESGTEAFF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	4	1	8	5	11	0	25	38	-1	49	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSYLESGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCCCGAGATCAGCCCCAGCATTTTGGTGAT	CASSLSRDQPQHF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	11	2	5	3	0	25	41	-1	44	47													Vb 3	CASSLSRDQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATTCTTGGGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASILGGLNTEAFF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	9	1	0	5	1	25	35	46	40	47													Vb 3	CASILGGLNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGTCAGCAGTCTCGGTTTGTCCGGAGAGCCCAAAAACATTCAGTACTTCGGCGCC	CVSSLGLSGEPKNIQYF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	10	2	2	12	3	25	37	53	49	56													Vb 3	CVSSLGLSGEPKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGGACAGGTCTATGGCTACACCTTCGGTTCG	CASSSGQVYGYTF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	4	4	2	1	25	38	47	40	48													Vb 3	CASSSGQVYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCCTTAGCGGGAGGGCACTAGCACAGATACGCAGTATTTTGGCCCA	CASRP*REGTSTDTQYF	Stop	VDJ	2	27	4.2151276246975256E-4		51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	5	0	0	4	4	25	36	51	40	55													Vb 3	CASRP*REGTSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGATCCTTCACTCGGGGATGGCTACACCTTCGGTTCG	CASSDPSLGDGYTF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	3	6	11	0	25	37	-1	48	53													Vb 3	CASSDPSLGDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGTCAGTAGTAGAGGTCCGGCTAGTAGCACCGGGGAGCTGTTTTTTGGAGAA	CVSSRGPASSTGELFF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	8	4	10	3	25	37	51	47	54						01,02							Vb 3	CVSSRGPASSTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCAGGGGGGACTAGCGGTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	28	4.3712434626492857E-4		50	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	5	1	7	1	25	37	55	44	56						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATTTGTCAGGATCCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	28	4.3712434626492857E-4		47	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	4	2	6	5	25	40	50	46	55													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGGGGAGGGTGTGATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	29	4.527359300601046E-4		40	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	0	8	4	4	25	36	47	40	51													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGTGTTAGCTATAAGAATAATGAGCAGTTCTTCGGGCCA	CASSRVSYKNNEQFF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	7	7	6	9	25	36	46	42	55						01,02							Vb 3	CASSRVSYKNNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGTGGGTAGCGGGAGCCCCCTACGAGCAGTACTTCGGGCCG	CASSPWVAGAPYEQYF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	2	2	7	3	25	37	53	44	56													Vb 3	CASSPWVAGAPYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGGGCGGTCGCACCCGTACGCAGTATTTTGGCCCA	CASSLWGGRTRTQYF	In	VDJ	2	30	4.683475138552806E-4	5.527712264150943E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	0	8	0	8	0	11	25	-1	46	42	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLWGGRTRTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATATCCCTCAGTACTGTCGAACACTGAAGCTTTCTTTGGACAA	CASSLYPSVLSNTEAFF	In	VDJ	2	31	4.8395909765045663E-4	5.711969339622641E-4	51	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	1	4	5	1	6	7	25	41	50	47	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLYPSVLSNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRSSGANVLTF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	11	2	0	0	0	25	-1	-1	36	39													Vb 3	CASRSSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATAGGTCCATACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASIGPYSGANVLTF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-06	01	7	5	4	0	1	6	25	35	39	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASIGPYSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCCGGGTAGCGGGAAGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	35	5.464054328311607E-4		47	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	3	4	6	3	25	37	51	43	54													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCGGAGGGGGCTAACTATGGCTACACCTTCGGTTCG	CASSAEGANYGYTF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	5	5	1	0	4	0	25	37	-1	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSAEGANYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATTAGTGCGTCAGGACACTACGAGCAGTACTTCGGGCCG	CASISASGHYEQYF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	6	3	11	0	25	35	-1	46	51													Vb 3	CASISASGHYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTAACTCCCGGCGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASNSRRSGANVLTF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	9	7	5	1	9	0	25	33	-1	42	46						01,02							Vb 3	CASNSRRSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGCGGACTAGCGGGAATGAACAGTTCTTCGGGCCA		Out	VDJ	2	36	5.620170166263368E-4		41	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	1	3	13	2	5	25	38	52	40	57													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTAACAGGGTGAGATCCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	37	5.776286004215128E-4		50	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	3	0	1	7	25	38	45	39	52													Vb 3	X+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCACTCCATTTAGCGGGAACCCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	41	6.400749356022168E-4		41	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	12	5	3	6	8	4	25	30	46	38	50													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTCGACAGGGGATGAAGCTTTCTTTGGACAA	CASTSTGDEAFF	In	VDJ	2	42	6.556865193973929E-4	7.738797169811321E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	2	7	4	1	25	35	47	39	48													Vb 3	CASTSTGDEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGACTCATCAATGAGCAGTTCTTCGGGCCA	CASSLGLINEQFF	In	VDJ	2	42	6.556865193973929E-4	7.738797169811321E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	6	0	3	25	-1	45	39	48						01,02							Vb 3	CASSLGLINEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCTGGACTAGCGGAAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLSGLAENTGELFF	In	VDJ	2	43	6.712981031925689E-4	7.923054245283019E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	1	5	2	2	2	25	41	53	43	55						01,02							Vb 3	CASSLSGLAENTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCTCCAGGGCCGTGGGCCCCAGCATTTTGGTGAT	CASSFLQGRGPQHF	In	VDJ	2	43	6.712981031925689E-4	7.923054245283019E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	9	4	6	25	39	48	43	54													Vb 3	CASSFLQGRGPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGACAGGGGGAAGTGAAACAGATACGCAGTATTTTGGCCCA	CASKTGGSETDTQYF	In	VDJ	3	48	7.49356022168449E-4	8.84433962264151E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	2	1	3	1	7	25	35	45	36	52													Vb 3	CASKTGGSETDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCGCACAGATACGCAGTATTTTGGCCCA	CASSFRTDTQYF	In	VJ	3	49	7.649676059636251E-4	9.028596698113208E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	3	0	0	1	0	2	25	-1	39	-1	41													Vb 3	CASSFRTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTAGAGCAAGAGACCCAGTACTTCGGGCCA	CASSLLEQETQYF	In	VDJ	3	50	7.80579189758801E-4	9.212853773584906E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	8	2	0	2	25	-1	44	40	46						01,02							Vb 3	CASSLLEQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRHSNQPQHF	In	VDJ	3	51	7.961907735539771E-4	9.397110849056604E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	6	0	0	0	25	-1	-1	36	39													Vb 3	CASRHSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCGCGGACAGGGAAGAATGAAAAACTGTTTTTTGGCAGT	CASSRTGKNEKLFF	In	VDJ	3	51	7.961907735539771E-4	9.397110849056604E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	1	3	5	4	3	25	34	46	38	49													Vb 3	CASSRTGKNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGCCTGCAGGGGGCGGGGGCTATGGCTACACCTTCGGTTCG	CASRPAGGGGYGYTF	In	VDJ	3	54	8.430255249395051E-4	9.949882075471698E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	0	4	5	5	25	36	49	41	54													Vb 3	CASRPAGGGGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTCGGGGGCGGGTCAGCCCCAGCATTTTGGTGAT	CASSFSGAGQPQHF	In	VDJ	3	54	8.430255249395051E-4	9.949882075471698E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	3	6	0	6	3	3	25	39	48	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFSGAGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTGGGGGGGGTTGGGACTATGGCTACACCTTCGGTTCG	CASSPGGGWDYGYTF	In	VDJ	3	56	8.742486925298571E-4	0.0010318396226415094	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	9	0	3	4	6	25	36	47	40	53													Vb 3	CASSPGGGWDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGGAGGGGAGGGTTCGCTGAAGCTTTCTTTGGACAA	CASSLRRGGFAEAFF	In	VDJ	3	60	9.366950277105613E-4	0.0011055424528301887	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	0	6	5	4	25	40	52	45	56													Vb 3	CASSLRRGGFAEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTCCAGGGGGCGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFQGASYNEQFF	In	VDJ	4	66	0.0010303645304816174	0.0012160966981132075	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	0	1	4	1	25	36	48	40	49													Vb 3	CASSFQGASYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCAACAGGGCTACGAGCAGTACTTCGGGCCG	CASSQQGYEQYF	In	VDJ	4	69	0.0010771992818671453	0.001271373820754717	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	3	2	0	25	37	-1	39	45													Vb 3	CASSQQGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCAGGGGAGGGTTCATGGCTACACGTTCGGTTCG	CASSFQGRVHGYTF	In	VDJ	4	79	0.0012333151198189057	0.001455630896226415	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	0	17	4	14	25	39	50	43	64													Vb 3	CASSFQGRVHGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGATCGGGACAGGGGGCGCTCTTGAAGCTTTCTTTGGACAA	CASRIGTGGALEAFF	In	VDJ	5	81	0.0012645382874092576	0.0014924823113207548	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	0	7	4	5	25	36	52	40	57													Vb 3	CASRIGTGGALEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCAACAGAATACCAGGGAGACCCAGTACTTCGGGCCA	CASSSQQNTRETQYF	In	VDJ	5	83	0.0012957614549996097	0.0015293337264150944	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	5	5	4	9	25	38	46	42	55													Vb 3	CASSSQQNTRETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTAGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSFRAGELFF	In	VDJ	6	104	0.0016236047146983062	0.0019162735849056604	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-02	01	3	5	3	6	1	0	25	39	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFRAGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCGGACTTCCTAAATCAGCCCCAGCATTTTGGTGAT	CASSPDFLNQPQHF	In	VDJ	6	110	0.0017172742174693624	0.0020268278301886792	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	1	10	4	3	5	25	36	44	39	49						01,02							Vb 3	CASSPDFLNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGAGGTCCGGCTAGTAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSRGPASSTGELFF	In	VDJ	13	237	0.003699945359456717	0.004366892688679245	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	8	4	10	3	25	37	51	47	54						01,02							Vb 3	CASSRGPASSTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTCCCAGGTCCAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLFPGPSSYEQYF	In	VDJ	17	293	0.004574194051986574	0.005398732311320755	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	4	0	3	6	25	41	48	44	54													Vb 3	CASSLFPGPSSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGCCGTACGACTAGCGGGGTTGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	5	7.805791897588011E-5		44	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	9	6	3	23	34	51	40	54													Vb 14	X+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTCCCTACAGGGGGGGATCCAAAAACATTCAGTACTTCGGCGCC	CASSPYRGGSKNIQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	3	1	2	4	4	23	35	47	39	51													Vb 14	CASSPYRGGSKNIQYF+TCRBV27-01+TCRBJ02-04	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTGTCTGGACAGGGGTGAACAGATACGCAGTATTTTGGCCCA	CASSLSGQG*TDTQYF	Stop	VDJ	1	5	7.805791897588011E-5		48	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	2	3	4	3	23	37	50	41	53													Vb 14	CASSLSGQG*TDTQYF+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTAGCGACAGATACGCAGTATTTTGGCCCA	CASSLATDTQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	36	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	7	6	3	0	0	23	-1	-1	38	41						01,02							Vb 14	CASSLATDTQYF+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTCGCCGACAGGGCTAACTATGGCTACACCTTCGGTTCG	CASSFADRANYGYTF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	0	4	0	23	37	-1	41	48													Vb 14	CASSFADRANYGYTF+TCRBV27-01+TCRBJ01-02	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGAGACAGCGTCTATGGCTACACCTTCGGTTCG	CASRDSVYGYTF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	36	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	5	4	1	3	23	34	40	35	43													Vb 14	CASRDSVYGYTF+TCRBV27-01+TCRBJ01-02	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTCTAAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLNSGANVLTF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	42	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	4	9	0	0	2	23	-1	38	35	40						01,02							Vb 14	CASSLNSGANVLTF+TCRBV27-01+TCRBJ02-06	TCRBV27-01*01	TCRBD02-01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTCCCTGGGGAGGGGCCTTGGACCCCCAAGAGACCCAGTACTTCGGGCCA	CASSPWGGALDPQETQYF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	54	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	9	0	1	5	11	23	35	47	40	58													Vb 14	CASSPWGGALDPQETQYF+TCRBV27-01+TCRBJ02-05	TCRBV27-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTCCCCAACTGGGAAGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	27	4.2151276246975256E-4		46	TCRBV27	TCRBV27-01	01				TCRBJ02	TCRBJ02-07	01	3	0	8	2	8	3	23	37	49	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	X+TCRBV27-01+TCRBJ02-07	TCRBV27-01*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGACTCGGAGTAACAACCGGAGAGCTGTTTTTTGGAGAA	CASRLGVTTGELFF	In	VDJ	2	36	5.620170166263368E-4	6.633254716981132E-4	42	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	10	2	11	4	11	23	34	42	38	53													Vb 14	CASRLGVTTGELFF+TCRBV27-01+TCRBJ02-02	TCRBV27-01*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTATTAGGTTTTGGGACTAGCGGGAGAGGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	44	6.869096869877449E-4		59	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	0	2	0	10	4	22	34	58	44	62													Vb 14	X+TCRBV27-01+TCRBJ02-07	TCRBV27-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGGCCAGTTGGGCCGAGCAGTACTTCGGGCCG	CSVEGASWAEQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	8	0	6	0	9	25	-1	42	38	51													Vb 4	CSVEGASWAEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGTTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	5	7.805791897588011E-5		40	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	1	0	10	0	0	3	25	-1	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGTTAGGGTGAACACTGAAGCTTTCTTTGGACAA	CSVDVRVNTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	3	5	3	0	4	0	25	36	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVDVRVNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGACCAGGGGGCCTTCAAGAGACCCAGTACTTCGGGCCA	CSVGPGGLQETQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	0	2	3	3	25	35	46	38	49													Vb 4	CSVGPGGLQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCGTAGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	6	9.366950277105613E-5		46	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	0	5	8	0	3	1	25	39	45	42	46						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD02-01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAAGCGGGAGGTTGTCGCAAGAGACCCAGTACTTCGGGCCA	CSVASGRLSQETQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	6	1	2	2	6	25	35	46	37	52													Vb 4	CSVASGRLSQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCGGACAGTTACCTACGAGCAGTACTTCGGGCCG	CSARTVTYEQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	5	2	3	3	25	32	41	35	44													Vb 4	CSARTVTYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGTAACAGGGAGGGCGGCTACGAGCAGTACTTCGGGCCG	CSVEGNREGGYEQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	9	0	3	6	3	25	38	51	44	54													Vb 4	CSVEGNREGGYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCACAGGGTGGAACCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAQGGTSYNEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	3	0	1	6	25	32	39	33	45													Vb 4	CSAQGGTSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCCAGGGCGTTGGGGACTAGAGGGGGGAAATGAGCAGTTCTTCGGGCCA	CSAPGRWGLEGGNEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	8	7	13	8	25	32	53	45	61						01,02							Vb 4	CSAPGRWGLEGGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACGGCGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	8	1.2489267036140816E-4		37	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	7	5	1	2	0	25	37	-1	39	43						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTGGTGGGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	9	1.405042541565842E-4		35	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-06	01	7	0	10	4	2	3	25	32	36	34	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGCCCGGGACTCGAACACTGAAGCTTTCTTTGGACAA	CSVARDSNTEAFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	0	10	1	5	1	25	33	44	38	45						01,02							Vb 4	CSVARDSNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAGAACTAAACACTGAAGCTTTCTTTGGACAA	CSVGELNTEAFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	3	9	2	0	0	25	-1	-1	39	43						01,02							Vb 4	CSVGELNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGTGTTGCCCCGATGAACACTGAAGCTTTCTTTGGACAA	CSVAPMNTEAFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	4	2	8	0	4	0	25	35	-1	39	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVAPMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCCCCCCCCGCACTAGCGGCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	1.5611583795176022E-4		47	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	5	2	10	0	25	34	-1	44	52						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCTTCATAGGCAAGAAGAGTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	10	1.5611583795176022E-4		55	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-06	01	1	5	4	1	6	9	25	38	47	44	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGTACGGGGACAGGGGGCGAGAAGAGACCCAGTACTTCGGGCCA	CSVEYGDRGREETQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	0	3	5	3	25	36	53	41	56													Vb 4	CSVEYGDRGREETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCCCTGGGGCTCCAAATCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	11	1.7172742174693622E-4		41	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	7	0	2	4	7	25	31	40	35	47													Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCGGGGACTAGCGGGAGGCAATGAGCAGTTCTTCGGGCCA	CSVRGLAGGNEQFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	1	6	3	0	25	33	-1	36	51													Vb 4	CSVRGLAGGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAAGCGGGAGATTCACGGCGAGCAGTACTTCGGGCCG	CSVKREIHGEQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	6	2	6	1	8	25	34	43	35	51													Vb 4	CSVKREIHGEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTATTCGTTACGACCCCACCGCTGAAGCTTTCTTTGGACAA	CSVIRYDPTAEAFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	5	2	7	6	9	7	25	34	46	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVIRYDPTAEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGGTCTTGGAAAAGAACACTGAAGCTTTCTTTGGACAA	CSVEGVLEKNTEAFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	1	0	9	1	0	10	25	-1	41	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGVLEKNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGTGTTTATTCAGGGGTTACAGGGGCCAACGTCCTGACTTTCGGGGCC	CSVYSGVTGANVLTF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	2	4	4	5	25	34	44	38	49													Vb 4	CSVYSGVTGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAACGCCAGATCGGCAGGGACAGGGTCAGGCTACACCTTCGGTTCG	CNARSAGTGSGYTF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	0	3	8	14	3	25	29	52	43	55													Vb 4	CNARSAGTGSGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGACTAGCGGAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	14	2.1856217313246428E-4		38	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	3	5	1	0	1	25	-1	40	32	41						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCAACCGGGACTAGCGGGTACGAGCAGTACTTCGGGCCG	CSATGTSGYEQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	4	4	5	0	25	32	-1	37	49						01,02							Vb 4	CSATGTSGYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGAGGAGGCGCGGACCCGGCGCAATGAGCAGTTCTTCGGGCCA	CSAEEARTRRNEQFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	10	1	6	4	13	25	32	41	36	54													Vb 4	CSAEEARTRRNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTTATCGTCAGCCCGAATGAAAAACTGTTTTTTGGCAGT	CSVLIVSPNEKLFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-04	01	5	4	5	5	8	4	25	34	45	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVLIVSPNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01		TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTAGGGGTAAACACTGAAGCTTTCTTTGGACAA	CSVEVGVNTEAFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	2	1	2	25	38	44	39	46													Vb 4	CSVEVGVNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATCTCAGACGAGAGACTGAAGCTTTCTTTGGACAA	CSVDLRRETEAFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	3	2	7	5	5	5	25	36	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVDLRRETEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAACTACCCGAGGGAGGAAGAAACTGTTTTTTGGCAGT	CSVETTRGRKKLFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	9	1	11	9	3	25	37	52	46	55													Vb 4	CSVETTRGRKKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGGGGCGTGGAGAGACCCAGTACTTCGGGCCA	CSVEGGRGETQYF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	6	0	4	0	4	25	-1	44	38	48													Vb 4	CSVEGGRGETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACGTGACAGTCGTAAAGCTTTCTTTGGACAA	CSVERDSRKAFF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	5	9	3	5	25	37	45	40	50													Vb 4	CSVERDSRKAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGTTCCCCCCCGGGGAGCTGTTTTTTGGAGAA	CSVGFPPGELFF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	4	0	10	6	0	7	25	-1	37	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGFPPGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCGCCAGCAAATACAGGGGGCTATTGTTCTCTTCGGGCCA		Out	VDJ	1	16	2.497853407228163E-4		35	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	3	0	17	10	8	25	28	47	38	55													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATAGCGGAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	17	2.6539692451799237E-4		41	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	5	5	1	0	1	25	-1	43	37	44						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTACACAGCATGAACACTGAAGCTTTCTTTGGACAA	CSVVHSMNTEAFF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	5	0	3	2	25	35	42	38	44													Vb 4	CSVVHSMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAAAAGGCCGGACCGGTGGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	20	3.1223167590352044E-4		47	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	5	1	7	2	8	7	25	34	46	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCCCCGGGAGGAAGCGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	20	3.1223167590352044E-4		43	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	8	1	4	4	4	25	35	46	39	50													Vb 4	X+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGTAGCCTAAGGGAGGGGACTAAAGCTTTCTTTGGACAA	CSGSLREGTKAFF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	0	9	9	14	0	25	32	-1	46	53						01,02							Vb 4	CSGSLREGTKAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTGGTGGACATGAACACTGAAGCTTTCTTTGGACAA	CSVLVDMNTEAFF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	6	0	5	0	25	34	-1	39	44													Vb 4	CSVLVDMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTTGGACAGGGGCAGATACGCAGTATTTTGGCCCA	CSAWTGADTQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	1	2	4	3	0	25	32	-1	35	44													Vb 4	CSAWTGADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGAACAGTCCGACCTACGAGCAGTACTTCGGGCCG	CSVEGNSPTYEQYF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	5	2	3	5	25	38	45	41	50													Vb 4	CSVEGNSPTYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGCGGACATCATCCCTAAACTATGGCTACACCTTCGGTTCG	CSVGRTSSLNYGYTF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	6	2	3	9	25	35	43	38	52													Vb 4	CSVGRTSSLNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCGGGACATGAACACTGAAGCTTTCTTTGGACAA	CSVVRDMNTEAFF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	6	0	3	0	25	35	-1	38	44													Vb 4	CSVVRDMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGGTCGACTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVEGSTSNTGELFF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	3	6	2	0	0	7	25	-1	40	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGSTSNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTACTACTAGCGGGAGCCTCTACGAGCAGTACTTCGGGCCG	CSVTTSGSLYEQYF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	3	2	3	3	3	25	34	48	37	51													Vb 4	CSVTTSGSLYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGACCCTCTAGCGGGAGGGCGGAATGAGCAGTTCTTCGGGCCA	CSVEDPLAGGRNEQFF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	0	7	4	3	25	39	55	43	58													Vb 4	CSVEDPLAGGRNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCCCCAGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVAPRANTGELFF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	0	4	0	25	35	-1	39	44													Vb 4	CSVAPRANTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAGGCCAGGGAGGGGACTGAAGCTTTCTTTGGACAA	CSVQAREGTEAFF	In	VDJ	2	31	4.8395909765045663E-4	5.711969339622641E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	5	7	1	25	34	48	41	49													Vb 4	CSVQAREGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATTACAACCAGGACAGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	31	4.8395909765045663E-4		47	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	4	1	9	0	25	37	-1	46	53													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCCGAAGGGATCGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	31	4.8395909765045663E-4		37	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-04	01	5	0	8	8	6	3	25	34	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01		TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVEGPNTGELFF	In	VDJ	2	34	5.307938490359847E-4	6.264740566037736E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	9	0	0	0	0	25	-1	-1	38	41													Vb 4	CSVEGPNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGTCGAGGGGGCGCGAGTGAAAAACTGTTTTTTGGCAGT	CSVGGRGGASEKLFF	In	VDJ	2	34	5.307938490359847E-4	6.264740566037736E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	0	7	7	5	25	35	49	42	54													Vb 4	CSVGGRGGASEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAGCGGGCAAGTGCTATGAGCAGTTCTTCGGGCCA	CSVGAGKCYEQFF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	6	4	8	1	8	25	35	42	36	50						01,02							Vb 4	CSVGAGKCYEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGCAGCACAGATACGCAGTATTTTGGCCCA	CSVEGSTDTQYF	In	VDJ	2	36	5.620170166263368E-4	6.633254716981132E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	1	10	0	0	0	0	25	-1	-1	38	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGTGGACAGGGTGGCTCCTACGAGCAGTACTTCGGGCCG	CSVGGQGGSYEQYF	In	VDJ	2	39	6.088517680118648E-4	7.186025943396226E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	3	0	4	3	25	33	45	37	48													Vb 4	CSVGGQGGSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGGTAAGGAGGACAGTGGAAGGGCTTTCTTTGGACAA		Out	VDJ	2	39	6.088517680118648E-4		40	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	11	9	7	25	34	49	43	56													Vb 4	X+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTATTACAGGGGAACACTGAAGCTTTCTTTGGACAA	CSVLQGNTEAFF	In	VDJ	2	40	6.244633518070409E-4	7.370283018867925E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	1	3	0	25	33	-1	36	42													Vb 4	CSVLQGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGACAGTTCAAGAGACCCAGTACTTCGGGCCA	CSVRTVQETQYF	In	VDJ	2	40	6.244633518070409E-4	7.370283018867925E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	5	2	1	2	25	34	41	35	43													Vb 4	CSVRTVQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGAAAGGTAATAGGGTACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	41	6.400749356022168E-4		46	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	3	5	3	2	10	2	25	36	50	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAACGGATGGACAGTCTGGGCACTTGGCTTTCTTTGGACAA	CSVTDGQSGHLAFF	In	VDJ	2	42	6.556865193973929E-4	7.738797169811321E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	11	7	12	25	33	46	40	58													Vb 4	CSVTDGQSGHLAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGTCGGACTAGCGGGAGGGAATAGACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	51	7.961907735539771E-4		50	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	1	0	3	3	6	25	32	50	35	56													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACCCCCACAACCAAGAGTCAGCTAGCACAGATACGCAGTATTTTGGCCCA	CSVDPHNQESASTDTQYF	In	VDJ	3	52	8.118023573491531E-4	9.581367924528302E-4	54	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	3	3	6	0	5	14	25	36	44	41	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVDPHNQESASTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCGACTAGCGGGAAGGAATGAGCAGTTCTTCGGGCCA	CSARLAGRNEQFF	In	VDJ	3	54	8.430255249395051E-4	9.949882075471698E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	2	3	7	3	3	25	32	46	35	49													Vb 4	CSARLAGRNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGGGGGGGTCCTCCCAACCTGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	57	8.898602763250332E-4		46	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	9	0	4	1	13	25	34	42	35	55													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCACCACAACAGCGCAGGAAACATTCAGTACTTCGGCGCC	CSHHNSAGNIQYF	In	VDJ	3	60	9.366950277105613E-4	0.0011055424528301887	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-04	01	8	3	5	6	7	6	25	31	42	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSHHNSAGNIQYF+TCRBV29-01+TCRBJ02-04	TCRBV29-01*01		TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCACCCATTGGAGGGGGAACCAAGAGACCCAGTACTTCGGGCCA	CSTHWRGNQETQYF	In	VDJ	4	63	9.835297790960892E-4	0.001160819575471698	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	8	5	1	0	9	1	25	31	46	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSTHWRGNQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGTCTACGGGAGGCGACCCAAGCTTTCTTTGGACAA	CSVRLREATQAFF	In	VDJ	4	67	0.0010459761142767934	0.0012345224056603773	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	1	9	6	6	25	34	47	40	53													Vb 4	CSVRLREATQAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGAGGGACTAGCGGGAGGGCCAGAAATGAGCAGTTCTTCGGGCCA	CSVEGGTSGRARNEQFF	In	VDJ	5	85	0.0013269846225899618	0.001566185141509434	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	0	0	7	2	5	25	38	56	40	61													Vb 4	CSVEGGTSGRARNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAGACTCCGGGTGGAGACTGAAGCTTTCTTTGGACAA	CSVRLRVETEAFF	In	VDJ	5	95	0.001483100460541722	0.0017504422169811321	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	2	10	5	2	10	25	33	39	35	49						01,02							Vb 4	CSVRLRVETEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTGCAGGGGAACACTGAAGCTTTCTTTGGACAA	CSVLQGNTEAFF	In	VDJ	6	98	0.0015299352119272501	0.0018057193396226415	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	1	3	0	25	34	-1	37	42													Vb 4	CSVLQGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCGAGGTGGTGGGGGCCAACGTCCTGACTTTCGGGGCC	CSVGEVVGANVLTF	In	VDJ	6	99	0.001545546795722426	0.0018241450471698113	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	4	11	1	4	2	5	25	35	41	37	46													Vb 4	CSVGEVVGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGATCGGCAGGGACAGGGTCAGGCTACACCTTCGGTTCG	CSAGSAGTGSGYTF	In	VDJ	6	108	0.0016860510498790103	0.0019899764150943396	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	3	8	11	3	25	32	52	43	55													Vb 4	CSAGSAGTGSGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATGCGAGGAGGGGACAGTTCTTCGGGCCA	CSVEDARRGQFF	In	VDJ	7	125	0.0019514479743970026	0.0023032134433962266	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	10	0	13	5	2	25	39	50	44	52													Vb 4	CSVEDARRGQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCGACGGGAACACTGAAGCTTTCTTTGGACAA	CSVLDGNTEAFF	In	VDJ	7	127	0.0019826711419873547	0.002340064858490566	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	5	2	7	1	3	2	25	34	40	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVLDGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCACTAGCGGGAGTGAATTCTTGGCCCAGTACTTCGGGCCA	CSVGTSGSEFLAQYF	In	VDJ	9	159	0.002482241823432987	0.0029296875	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	3	2	9	2	11	25	35	48	37	59													Vb 4	CSVGTSGSEFLAQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCGAAAAGGACTACTCAAGAGACCCAGTACTTCGGGCCA	CSAKRTTQETQYF	In	VDJ	34	594	0.009273280774334557	0.010944870283018868	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	1	9	2	6	2	25	32	44	38	46						01,02							Vb 4	CSAKRTTQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGAACCGGGACTAGCGTCTACAATGAGCAGTTCTTCGGGCCA	CSGTGTSVYNEQFF	In	VDJ	37	650	0.010147529466864414	0.011976709905660377	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	6	3	5	1	25	32	47	37	48						01,02							Vb 4	CSGTGTSVYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCGGCCGTGTATGTCTGTGCAAGTCGCTACGGACAGGGGATCCCCACATACTAGCGGGAGGGAGTGGATGAGCAGTTCTTCGGGCCA	CASRYGQGIPTY*REGVDEQFF	Stop	VDDJ	1	10	1.5611583795176022E-4		66	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	3	0	8	10	5	15	39	62	49	67														CASRYGQGIPTY*REGVDEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGTCACGACTAGCACACCATCTGGGAATGAGCAGTTCTTCGGGCCA	CASSVTTSTPSGNEQFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	51	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	7	7	6	12	23	34	47	40	59						01,02							Vb 22	CASSVTTSTPSGNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCACCCCTAAACCAGAGACTAACTATGGCTACACCTTCGGTTCG	CATPKPETNYGYTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	10	4	5	0	9	3	23	30	42	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CATPKPETNYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAACGACGGGGCGAAGCTTTCTTTGGACAA	CASSERRGEAFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-01	01	2	7	0	8	4	0	23	38	-1	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSERRGEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAATCCGGACAGGGGACCCACGAGCAGTACTTCGGGCCG	CASSESGQGTHEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	2	5	3	4	23	38	50	41	54													Vb 22	CASSESGQGTHEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGATCCCAGGAGGGATGGGACAGGGGGGGAAAAACTGTTTTTTGGCAGT	CASSDPRRDGTGGEKLFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	54	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	1	8	13	1	23	37	61	50	62													Vb 22	CASSDPRRDGTGGEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTTTGGGATGATTGAAGCTTTCTTTGGACAA	CASSFGMIEAFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-01	01	5	0	8	7	3	4	23	35	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSFGMIEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACCAGACAGGGGGCGAGTTTGGAGACCCAGTACTTCGGGCCA	CASTRQGASLETQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	2	0	5	3	7	23	33	46	36	53													Vb 22	CASTRQGASLETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCTTAAGGTGTAGGAGTCCAGGGGAGGTGAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	9	1.405042541565842E-4		53	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-05	01	6	4	2	8	17	5	23	34	57	51	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	X+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAGGAAGGCTCCACTGAAGCTTTCTTTGGACAA	CASKEGSTEAFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-01	01	7	1	8	4	1	6	23	33	37	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASKEGSTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCGAAAAGTAAGGACAGGGGCCTCATCTTGGGAGGGCTACACCTTCGGTTCG	CASSRKVRTGASSWEGYTF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	57	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	8	11	14	23	34	54	45	68													Vb 22	CASSRKVRTGASSWEGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGACGGCTCTGGAAACACCATATATTTTGGAGAG	CASSDGSGNTIYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-03	01	6	2	7	0	1	2	23	34	38	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSDGSGNTIYF+TCRBV02-01+TCRBJ01-03	TCRBV02-01*01		TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGCGGACAGGGGGCGGCAGTACTTCGGGCCG	CASSADRGRQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	0	9	3	1	23	34	48	37	49													Vb 22	CASSADRGRQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAACGCCCGGCGTACAGGGGAGACCCAGTACTTCGGGCCA	CASNARRTGETQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	3	3	5	11	0	23	33	-1	44	50													Vb 22	CASNARRTGETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGATCAGGATCCACAGATACGCAGTATTTTGGCCCA	CASRSGSTDTQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	4	2	2	3	23	34	40	36	43													Vb 22	CASRSGSTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGTACAGGTACACAATGAGCAGTTCTTCGGGCCA	CASSVQVHNEQFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	4	5	3	3	23	34	42	37	45													Vb 22	CASSVQVHNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGCCTACTAGCGGGAGTTCCAATGAGCAGTTCTTCGGGCCA	CASRPTSGSSNEQFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	2	6	4	3	23	34	49	38	52													Vb 22	CASRPTSGSSNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCACGGGCGAGTCCTCCTACGAGCAGTACTTCGGGCCG	CASTGESSYEQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	7	8	0	0	1	5	23	33	38	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASTGESSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAACGGCAGGATGACCGATACGCAGTATTTTGGCCCA	CASNGRMTDTQYF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	4	6	4	6	23	33	41	37	47													Vb 22	CASNGRMTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAAAGACTAGCTCGGGCGTTACAGATACGCAGTATTTTGGCCCA	CASRKTSSGVTDTQYF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	7	3	3	9	23	34	44	37	53						01,02							Vb 22	CASRKTSSGVTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGGGGGACAGACTTTTGGCGAGCAGTTCTTCGGGCCA	CASGGQTFGEQFF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	39	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	5	10	2	9	23	32	41	34	50													Vb 22	CASGGQTFGEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTTTAGCGCGGGGTCTAGCGGACTACGAGCAGTACTTCGGGCCG	CASSLARGLADYEQYF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	5	3	12	1	23	35	54	47	55						01,02							Vb 22	CASSLARGLADYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGATGGCGTGCACCGCCCTGAAGCTTTCTTTGGACAA	CASSDGVHRPEAFF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-01	01	3	9	0	6	1	10	23	37	41	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSDGVHRPEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGGTTTCGAACTATGGCTACACCTTCGGTTCG	CASSEVSNYGYTF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	3	0	10	2	0	5	23	-1	39	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSEVSNYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCCGACTAGCGGGCTTAACAGATACGCAGTATTTTGGCCCA	CASSRLAGLTDTQYF	In	VDJ	2	42	6.556865193973929E-4	7.738797169811321E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	4	3	2	4	23	34	46	36	50						01,02							Vb 22	CASSRLAGLTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCGCACCACACTAGCGGGAGGCAAATACGAGCAGTACTTCGGGCCG	CASSRTTLAGGKYEQYF	In	VDJ	3	50	7.80579189758801E-4	9.212853773584906E-4	51	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	3	1	4	8	4	23	35	55	43	59													Vb 22	CASSRTTLAGGKYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGACAGGGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	6	106	0.0016548278822886581		40	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	1	0	0	23	-1	-1	37	42													Vb 22	X+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAGAGGGAGCGAGATGGCTACACCTTCGGTTCG	CASKRERDGYTF	In	VDJ	12	220	0.0034345484349387247	0.0040536556603773585	36	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	9	2	6	3	4	23	33	41	36	45													Vb 22	CASKRERDGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGACGGGGGGCAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSDGGQSSYNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-01	01	2	6	0	0	1	4	28	43	50	44	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGGQSSYNEQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGCGAGCGGAGCCTGCCTACGAGCAGTACTTCGGGCCG	CASSERAEPAYEQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	6	5	2	3	6	28	42	50	45	56			01,02			01,02								CASSERAEPAYEQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGCCCCATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	7	1.0928108656623214E-4		32	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	6	4	3	1	28	39	44	42	45			01,02											X+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAACCACAGACTAGCGAGAGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	7	1.0928108656623214E-4		50	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	2	6	3	7	5	28	42	57	49	62			01,02			01,02								X+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCGTAGGGGGGCGCGAGCAGTACTTCGGGCCG	CASVGGREQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	33	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-07	01	8	5	1	6	2	3	28	37	45	39	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASVGGREQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCACCGCCGAAGGCCCCCAGCATTTTGGTGAT	CASTAEGPQHF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	33	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-05	01	7	5	4	10	7	1	28	38	48	45	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTAEGPQHF+TCRBV06-04+TCRBJ01-05	TCRBV06-04		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACAGACTAGCGGGAGGCTACGAGCAGTACTTCGGGCCG	CASSYRLAGGYEQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	1	3	4	0	28	40	-1	44	57			01,02											CASSYRLAGGYEQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGCGTCGGGACACGGGGTGAGCAGTTCTTCGGGCCA	CASSVGTRGEQFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	39	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	6	9	4	5	28	39	49	43	54			01,02											CASSVGTRGEQFF+TCRBV06-04+TCRBJ02-01	TCRBV06-04	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCATCGCGACGGGAAATACGCAGTATTTTGGCCCA	CAIATGNTQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	33	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	10	8	3	7	6	1	28	35	46	41	47			01,02											CAIATGNTQYF+TCRBV06-04+TCRBJ02-03	TCRBV06-04	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCTGGACAGGGTGAAGCTTTCTTTGGACAA	CASSDSGQGEAFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	39	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	3	7	1	0	28	45	-1	46	54			01,02											CASSDSGQGEAFF+TCRBV06-04+TCRBJ01-01	TCRBV06-04	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTACCAGCAGTGACGGGCGGAGCTCCTACGAGCAGTACTTCGGGCCG	CTSSDGRSSYEQYF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	42	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-07	01	2	8	0	0	0	4	28	-1	47	43	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSDGRSSYEQYF+TCRBV06-04+TCRBJ02-07	TCRBV06-04		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGCGGGAGGGCCCAGATACGCAGTATTTTGGCCCA	CASSEREGPDTQYF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	42	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	0	4	0	2	28	-1	51	42	53			01,02											CASSEREGPDTQYF+TCRBV06-04+TCRBJ02-03	TCRBV06-04	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCGGCGGATAGCACAGATACGCAGTATTTTGGCCCA	CASSDSADSTDTQYF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	45	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	5	0	1	2	28	45	50	46	52			01,02			01,02								CASSDSADSTDTQYF+TCRBV06-04+TCRBJ02-03	TCRBV06-04	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACCCCAGGACAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTPGQSSYNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	5	0	5	2	26	36	47	41	49														CASTPGQSSYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCTATGGACAGGGCGGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	5	7.805791897588011E-5		41	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	5	4	3	26	37	49	41	52														X+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCAAGACGGAGGTTAGAGGATACGAGCAGTACTTCGGGCCG	CASSKTEVRGYEQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	10	1	4	6	8	26	37	48	43	56														CASSKTEVRGYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCATGGAGGGGCGCATTCAGTACTTCGGCGCC	CASMEGRIQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	7	10	0	9	1	3	26	36	43	37	46														CASMEGRIQYF+TCRBV06-07+TCRBJ02-04	TCRBV06-07*01	TCRBD02-01*02	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTGGGGCCTGGAGCGGGGAGTGGAGGAGACCCAGTACTTCGGGCCA	CASSWGLERGVEETQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	51	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	6	3	5	9	7	26	39	55	48	62														CASSWGLERGVEETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGACTCGGGATGGGATAGAGTCCGGTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	2.810085083131684E-4		58	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-05	01	0	0	8	0	0	15	23	-1	44	40	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAACGGGACAGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	23	3.590664272890485E-4		34	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	4	6	2	0	26	36	-1	38	46														X+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCATCAACCAGGGCTACGAGCAGTACTTCGGGCCG	CASINQGYEQYF	In	VDJ	2	43	6.712981031925689E-4	7.923054245283019E-4	36	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	3	3	5	0	26	36	-1	41	46														CASINQGYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCAGGGTTAAGGACCGGGGAGCTGTTTTTTGGAGAA	CASSPGLRTGELFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	5	1	6	19	31	37	32	43														CASSPGLRTGELFF+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTGAGTGGACTAGCGGGACAAGAGACCCAGTACTTCGGGCCA	CASSLSGLAGQETQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	48	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	1	3	2	4	0	19	33	-1	37	49														CASSLSGLAGQETQYF+TCRBV07-07+TCRBJ02-05	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGAAGCCGCTGTTGCAGATACGCAGTATTTTGGCCCA	CASSLEAAVADTQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	45	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	6	7	4	1	8	19	35	39	36	47						01,02								CASSLEAAVADTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCAGCCATGTATCGCTGTGCTAGCAGCCAAGATACCCTAGCGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDTLAGNTGELFF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	51	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	4	1	9	0	19	31	-1	40	48						01,02								CASSQDTLAGNTGELFF+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCAGCCATGTATCGCTGTGCTAGCAGCCCGCTAGCGGGAGAGACAGATACGCAGTATTTTGGCCCA	CASSPLAGETDTQYF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	45	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	4	2	3	3	2	19	31	44	34	46														CASSPLAGETDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCCAGCGGGAATGAGTAATGAGCAGTTCTTCGGGCCA	CASSPAGMSNEQFF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	42	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	3	7	2	6	19	31	40	33	46														CASSPAGMSNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTACAGGGGTCCTCCTACGAGCAGTACTTCGGGCCG	CASSLQGSSYEQYF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	0	0	2	19	-1	40	34	42														CASSLQGSSYEQYF+TCRBV07-07+TCRBJ02-07	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTCAATGGTTATAGCGCCCTATGGCTACACCTTCGGTTCG	CASSSMVIAPYGYTF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	45	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	5	6	4	9	2	19	32	46	41	48						01,02								CASSSMVIAPYGYTF+TCRBV07-07+TCRBJ01-02	TCRBV07-07*01	TCRBD02-01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGAATCTACCGGGACGGCGGGGCCAACGTCCTGACTTTCGGGGCC	CASRIYRDGGANVLTF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	48	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-06	01	6	0	7	4	8	3	19	30	43	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRIYRDGGANVLTF+TCRBV07-07+TCRBJ02-06	TCRBV07-07*01		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTGGTTGGGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLVGGSGANVLTF	In	VDJ	3	45	7.025212707829209E-4	8.291568396226415E-4	48	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-06	01	3	6	1	0	4	0	19	33	-1	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGGSGANVLTF+TCRBV07-07+TCRBJ02-06	TCRBV07-07*01		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAAATTATCCAAGAGACCCAGTACTTCGGGCCA	CASSQIIQETQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	39	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	5	9	1	2	1	29	44	48	46	49			01,02			01,02								CASSQIIQETQYF+TCRBV16-01+TCRBJ02-05	TCRBV16-01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCACCCCGAGGAGGGGGCCGGTGAAAAACTGTTTTTTGGCAGT	CASSHPEEGAGEKLFF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	48	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	5	0	7	8	3	29	43	58	51	61			01,02											CASSHPEEGAGEKLFF+TCRBV16-01+TCRBJ01-04	TCRBV16-01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCATGAAGGGTAGGTTCAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	42	6.556865193973929E-4		49	TCRBV16	TCRBV16-01					TCRBJ02	TCRBJ02-04	01	5	5	3	0	4	7	29	41	49	45	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV16-01+TCRBJ02-04	TCRBV16-01		TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAAGAGGTTTTTGGGCAGTTCTTCGGGCCA	CASSQEVFGQFF	In	VDJ	3	55	8.586371087346812E-4	0.0010134139150943396	36	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	11	1	12	0	7	29	-1	48	44	55			01,02											CASSQEVFGQFF+TCRBV16-01+TCRBJ02-01	TCRBV16-01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCACGTTTGGTGGTCAGGAGACACAGCAGGTATTTCTGTGCCAGCACCAATCTAGCGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASTNLAGSYNEQFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV21	TCRBV21-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	4	3	1	1	0	36	50	-1	51	60														CASTNLAGSYNEQFF+TCRBV21-01+TCRBJ02-01	TCRBV21-01*01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAACGGGACACAGATACGCAGTATTTTGGCCCA	CASSERDTDTQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	8	3	2	0	0	23	-1	-1	38	43		TCRBV06-01,TCRBV06-08												CASSERDTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAAGTCTGGGGTAGGGGCCTACTATGGCTACACCTTCGGTTCG	CASKSGVGAYYGYTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	5	2	3	10	3	26	36	51	46	54		TCRBV06-08,TCRBV06-09												CASKSGVGAYYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGGGCGGGAGCCCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	6	9.366950277105613E-5		43	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	2	2	2	3	18	32	41	34	44		TCRBV11-01,TCRBV11-03												X+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCTCAGGAGCAAACTATGGCTACACCTTCGGTTCG	CASSSGANYGYTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	TCRBV07	unresolved					TCRBJ01	TCRBJ01-02	01	4	4	4	2	0	4	22	-1	39	35	43		TCRBV07-02,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGANYGYTF+TCRBV07-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTCCGGGAGGTCCAATGAGCAGTTCTTCGGGCCA	CASSSGRSNEQFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	1	6	0	2	22	-1	43	36	45		TCRBV07-01,TCRBV07-04												CASSSGRSNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTTGCCGGGGCCTTCAGTCAGTTYTTCGGGCCA	CASSFAGAFSQFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	TCRBV07	unresolved					TCRBJ02	unresolved		4	7	0	19	5	13	22	35	45	40	58		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05						CASSFAGAFSQFF+TCRBV07-X+TCRBJ02-X	unresolved		unresolved	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCAACAACCCAGGGAACTGAAGCTTTCTTTGGACAA	CATTQGTEAFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	33	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	4	3	5	7	1	28	33	45	40	46		TCRBV06-04,TCRBV06-07												CATTQGTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACGACAGGGGGTACGAGCAGTACTTCGGGCCG	CASSYDRGYEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	1	4	0	0	23	-1	-1	38	47		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYDRGYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCGAGCGGGCTAGCGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSYSSGLAGSYEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	1	7	0	23	40	-1	47	56		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYSSGLAGSYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCCAGATGGGCGCTTCCTACGAGCAGTACTTCGGGCCG	CASSQMGASYEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	8	0	1	5	3	19	31	40	36	43		TCRBV07-05,TCRBV07-07												CASSQMGASYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTAGTATTGGGGTCCCTAAACTATGGCTACACCTTCGGTTCG	CASSLVLGSLNYGYTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	48	TCRBV05	unresolved					TCRBJ01	TCRBJ01-02	01	2	6	2	2	6	6	19	33	43	39	49		TCRBV05-04,TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVLGSLNYGYTF+TCRBV05-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGRGGACTYSGCYGTGTATCTCTGTGCCAGCAGCCCTGGACTAGCAGGTGAGCAGTTCTTCGGGCCA	CASSPGLAGEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	7	9	3	3	22	34	45	37	48		TCRBV07-01,TCRBV07-08				01,02								CASSPGLAGEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCCGGACCTCTACAACTAGCGGGAGGGATGAGCAGTTCTTCGGGCCA	CASSRTSTTSGRDEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	51	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	3	0	8	12	0	22	34	-1	46	59		TCRBV07-01,TCRBV07-02												CASSRTSTTSGRDEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTTCAGGGCGGGGAATGAAAAACTGTTTTTTGGCAGT	CASSFRAGNEKLFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	7	3	5	6	0	28	40	-1	46	52		TCRBV06-04,TCRBV06-08												CASSFRAGNEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTACCCGGGACAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYPGQGNTGELFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	0	3	1	2	0	24	39	-1	41	50		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSYPGQGNTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGAACAGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSEQGTGELFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	3	4	0	0	23	-1	-1	38	43		TCRBV06-01,TCRBV06-04,TCRBV06-08												CASSEQGTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCGACTTGGATGGTGGCCTATGGCTACACCTTCGGTTCG	CASSPTWMVAYGYTF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	2	10	4	3	11	26	37	44	40	55		TCRBV06-07,TCRBV06-08				01,02								CASSPTWMVAYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTAGAATGAGGGACAGGGGATCATAGGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	10	1.5611583795176022E-4		55	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	2	4	7	7	18	31	48	38	55		TCRBV07-06,TCRBV07-07												X+TCRBV07-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGAGATGAGAGACCCAGTACTTCGGGCCA	CASSESR*ETQYF	Stop	VDJ	1	10	1.5611583795176022E-4		39	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	11	2	4	0	3	23	-1	43	40	46		TCRBV10-01,TCRBV10-02												CASSESR*ETQYF+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCCATAGACTAGAAACCGCCTACAATGAGCAGTTCTTCGGGCCA	CASSHRLETAYNEQFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	8	2	4	6	19	31	41	35	47		TCRBV07-02,TCRBV07-07				01,02								CASSHRLETAYNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAACCTACTAGAAGACAACACAGATACGCAGTATTTTGGCCCA	CASNLLEDNTDTQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	3	8	2	4	7	28	38	47	42	54		TCRBV06-04,TCRBV06-07				01,02								CASNLLEDNTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCCCCGGACAGGGGGAGACCCAGTACTTCGGGCCA	CASSPGQGETQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	2	5	3	0	18	30	-1	33	42		TCRBV07-02,TCRBV07-08												CASSPGQGETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCTCGGGTTTCGAGGGCACTGAAGCTTTCTTTGGACAA	CASSSGFEGTEAFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	0	4	8	0	19	32	-1	40	45		TCRBV07-02,TCRBV07-07												CASSSGFEGTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACATTTTGGTCGGAGCAGATACGCAGTATTTTGGCCCA	CASSYILVGADTQYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	2	4	12	0	28	40	-1	52	56		TCRBV06-04,TCRBV06-08												CASSYILVGADTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGACCGGGGGAAGACAGAGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	2.341737569276403E-4		53	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	2	3	10	26	43	52	46	62		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASGACTCGGCCCTGTATCTCTGTGCCAGCAGCTTTCACAGTAAAGAGACCCAGTACTTCGGGCCA	CASSFHSKETQYF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	39	TCRBV05	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	5	3	2	2	20	34	40	36	42		TCRBV05-04,TCRBV05-08												CASSFHSKETQYF+TCRBV05-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCTGCTCGACAGGGGGCCTACTGAAGCTTTCTTTGGACAA	CASSLLDRGPTEAFF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	5	6	2	22	34	50	40	52		TCRBV07-01,TCRBV07-04												CASSLLDRGPTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGGGACTAGCGGGCCTACGAGCAGTACTTCGGGCCG	CARD*RAYEQYF	Stop	VDJ	1	18	2.810085083131684E-4		36	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	1	4	2	0	0	26	-1	-1	34	45		TCRBV10-01,TCRBV10-02				01,02								CARD*RAYEQYF+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTCGGGACTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRDSNTGELFF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	10	0	1	0	26	38	-1	39	45		TCRBV06-08,TCRBV06-09				01,02								CASSRDSNTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGRGGACTYSGCYGTGTATCTCTGTGCCAGCAGTCCGAGCCGGGACAACCCGAACACTGAAGCTTTCTTTGGACAA	CASSPSRDNPNTEAFF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	48	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	6	1	8	4	20	31	45	39	49		TCRBV07-01,TCRBV07-08												CASSPSRDNPNTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAGGACAAGATGATGGCTACACCTTCGGTTCG	CASSLGQDDGYTF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	6	6	2	5	22	35	42	37	47		TCRBV07-01,TCRBV07-04												CASSLGQDDGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCGACAACCGGGGCCTTAATGAAAAACTGTTTTTTGGCAGT	CASSDNRGLNEKLFF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	45	TCRBV07	unresolved					TCRBJ01	TCRBJ01-04	01	4	7	0	4	7	2	19	31	43	38	45		TCRBV07-02,TCRBV07-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDNRGLNEKLFF+TCRBV07-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGAAGGGCAAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSEGQDTGELFF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	42	TCRBV06	unresolved		unresolved			TCRBJ02	TCRBJ02-02	01	3	5	3	3	0	4	28	-1	46	42	50		TCRBV06-01,TCRBV06-04		TCRBD01,TCRBD02										CASSEGQDTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	unresolved	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGAGAGTCGGGAGGCTTACAATGAGCAGTTCTTCGGGCCA	CASSESREAYNEQFF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	8	1	4	4	2	28	42	53	46	55		TCRBV06-04,TCRBV06-08												CASSESREAYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGGACTAGCGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	23	3.590664272890485E-4		37	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	2	6	4	0	0	23	-1	-1	36	44		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCTTAGCAAGGGAACATACTGAAGCTTTCTTTGGACAA	CASSLAREHTEAFF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	42	TCRBV07	unresolved					TCRBJ01	TCRBJ01-01	01	0	0	8	5	2	4	19	36	42	38	46		TCRBV07-02,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAREHTEAFF+TCRBV07-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCATTTCACGCGAGGGACAGGGTGAGGTCGGGGAGCTGTTTTTTGGAGAA	CAISREGQGEVGELFF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	3	7	10	6	28	35	54	45	60		TCRBV06-04,TCRBV06-08												CAISREGQGEVGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTGGGGTCTAGGGACTAGCGGGGCACAAGAGACCCAGTACTTCGGGCCA	CASSWGLGTSGAQETQYF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	54	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	0	3	2	8	2	24	37	58	45	60		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSWGLGTSGAQETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASGACTCSGCYGTGTATCTCTGTGCCAGCAGCTTGGCCCGGGCCACGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLARATGTGELFF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	48	TCRBV07	unresolved					TCRBJ02	TCRBJ02-02	01	2	8	0	4	5	6	19	33	42	38	48		TCRBV07-05,TCRBV07-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLARATGTGELFF+TCRBV07-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCGTTCAAGGGCAGGGCTTTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	3.746780110842245E-4		53	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	4	9	4	28	45	59	54	63		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAATCGGTCAGGGGAAGAGACCCAGTACTTCGGGCCA	CASNRSGEETQYF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	4	2	3	6	0	26	36	-1	42	48		TCRBV10-01,TCRBV10-02												CASNRSGEETQYF+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCCCGGGACTCAGGGGGGAAGCTTTCTTTGGACAA	CASSPGLRGEAFF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	8	8	0	22	34	-1	42	49		TCRBV07-01,TCRBV07-02												CASSPGLRGEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCCCGCTTAGGGGTTAAAGCTTTCTTTGGACAA	CASSPRLGVKAFF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	2	9	9	3	23	34	48	43	51		TCRBV06-07,TCRBV06-08												CASSPRLGVKAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYGGCYRTGTATCKCTGTGCCAGCAGCTTAGCGCAGGAGGGGACAACTGGCTACACCTTCGGTTCG	CASSLAQEGTTGYTF	In	VDJ	2	30	4.683475138552806E-4	5.527712264150943E-4	45	TCRBV07	unresolved					TCRBJ01	TCRBJ01-02	01	0	0	6	7	7	2	22	39	52	46	54		TCRBV07-01,TCRBV07-06		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAQEGTTGYTF+TCRBV07-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTAGAGGACAGGGGCTTCGAAAACTGTTTTTTGGCAGT		Out	VDJ	2	32	4.995706814456326E-4		43	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	2	10	4	5	28	40	53	44	58		TCRBV06-04,TCRBV06-07												X+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGTGAGCAGTACGGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVSSTGSYNEQFF	In	VDJ	2	34	5.307938490359847E-4	6.264740566037736E-4	48	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	4	1	9	1	26	39	52	48	53		TCRBV10-01,TCRBV10-02				01,02								CASSVSSTGSYNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGGGGAGGGGCTTTCACTGAGCAGTTCTTCGGGCCA	CASRGGAFTEQFF	In	VDJ	2	36	5.620170166263368E-4	6.633254716981132E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	0	9	0	8	26	-1	44	37	52		TCRBV06-07,TCRBV06-08												CASRGGAFTEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCCCTCAGGGACCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	40	6.244633518070409E-4		38	TCRBV07	unresolved					TCRBJ01	TCRBJ01-05	01	5	0	7	7	6	0	22	34	-1	40	45		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTCACGGCTACGAGCAGTACTTCGGGCCG	CASSHGYEQYF	In	VDJ	2	43	6.712981031925689E-4	7.923054245283019E-4	33	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	5	3	2	0	26	38	-1	40	43		TCRBV06-04,TCRBV06-07				01,02								CASSHGYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTTTTGGGACCAATCACAGATACGCAGTATTTTGGCCCA	CASSFLGPITDTQYF	In	VDJ	2	44	6.869096869877449E-4	8.107311320754717E-4	45	TCRBV07	unresolved					TCRBJ02	TCRBJ02-03	01	3	0	7	2	3	4	18	32	40	35	44		TCRBV07-06,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFLGPITDTQYF+TCRBV07-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTCATCGGGATACGCAGTATTTTGGCCCA	CASSHRDTQYF	In	VDJ	2	44	6.869096869877449E-4	8.107311320754717E-4	33	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	8	5	6	3	0	28	40	-1	43	46		TCRBV06-04,TCRBV06-07				01,02								CASSHRDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCGGCCCACAGGACCCCTTTTACTATGGCTACACCTTCGGTTCG	CASSGPQDPFYYGYTF	In	VDJ	3	46	7.18132854578097E-4	8.475825471698113E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	4	3	6	9	26	37	48	43	57		TCRBV06-07,TCRBV06-08												CASSGPQDPFYYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTAGCGGAGGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAEGGSYNEQFF	In	VDJ	3	46	7.18132854578097E-4	8.475825471698113E-4	48	TCRBV07	unresolved					TCRBJ02	TCRBJ02-01	01	0	5	1	0	2	1	18	35	43	37	44		TCRBV07-06,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAEGGSYNEQFF+TCRBV07-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCATTGGTGGCGAGCCCTACAATGAGCAGTTCTTCGGGCCA	CASIGGEPYNEQFF	In	VDJ	3	46	7.18132854578097E-4	8.475825471698113E-4	42	TCRBV07	unresolved					TCRBJ02	TCRBJ02-01	01	7	9	0	2	5	4	19	29	37	34	41		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIGGEPYNEQFF+TCRBV07-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAATCGTGACGGGTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	58	9.054718601202092E-4		41	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	8	4	3	7	1	26	36	47	43	48		TCRBV10-01,TCRBV10-02				01,02								X+TCRBV10-X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGGAAGGGCTCGGGGACTATGGCTACACCTTCGGTTCG	CASSLEGLGDYGYTF	In	VDJ	4	65	0.0010147529466864413	0.0011976709905660377	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	3	3	9	0	18	32	-1	41	46		TCRBV11-01,TCRBV11-03												CASSLEGLGDYGYTF+TCRBV11-X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGACGCCAGGGCCTGAGGGCTTTCTTTGGACAA	CASRRQGLRAFF	In	VDJ	4	68	0.0010615876980719695	0.0012529481132075471	36	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	11	4	7	23	34	43	38	50		TCRBV06-07,TCRBV06-08												CASRRQGLRAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCGAAGACAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASEDRSSYEQYF	In	VDJ	8	149	0.002326125985481227	0.002745430424528302	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	2	4	0	3	2	18	27	36	30	38		TCRBV07-01,TCRBV07-02												CASEDRSSYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTAATAGCGGGAGCTGAAGAGCAGTACTTCGGGCCG	CASSLIAGAEEQYF	In	VDJ	24	433	0.006759815783311217	0.007978331367924528	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	5	2	7	1	5	22	37	47	38	52		TCRBV07-01,TCRBV07-04												CASSLIAGAEEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGTTTGATGGGGCCCCAGCATTTTGGTGAT	YASSLMGPQHF	In	VDJ	3	61	9.523066115057373E-4	0.0011239681603773585	33	TCRBV26	TCRBV26-01	01				TCRBJ01	TCRBJ01-05	01	4	0	9	9	4	0	27	40	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									YASSLMGPQHF+TCRBV26-01+TCRBJ01-05	TCRBV26-01*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAAGACTCGGCCCTGTATCTCTGTGCTAGCAGCTCTACATGGACTGATACGCAGTATTTTGGCCCA	CASSSTWTDTQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	39	TCRBV04	TCRBV04-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	10	6	7	0	21	33	-1	40	45						01,02								CASSSTWTDTQYF+TCRBV04-02+TCRBJ02-03	TCRBV04-02*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ACTCGGCCSTGTATCTCTGTGCCAGCAGCCAAGAAAACCGCCGGGACTAGCGGGGAAGGGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	8	1.2489267036140816E-4		64	TCRBV04	TCRBV04-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	0	3	4	8	7	17	34	55	42	62														X+TCRBV04-02+TCRBJ02-02	TCRBV04-02*01	TCRBD02-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCTCGCGGGGCCAGCTCCTTTAATGAAAAACTGTTTTTTGGCAGT	CASSPRGASSFNEKLFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	51	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	7	3	4	4	10	18	30	40	34	50														CASSPRGASSFNEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD02-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAAAAACAGGGGCGAGGAGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLKTGARSSNQPQHF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	54	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	2	0	3	7	18	33	43	36	50														CASSLKTGARSSNQPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGAGTGGAGGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLEWRSSGANVLTF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	51	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	1	10	1	0	3	2	18	34	42	37	44														CASSLEWRSSGANVLTF+TCRBV07-06+TCRBJ02-06	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGAAAGGCCAGGGAAGGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	11	1.7172742174693622E-4		43	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	3	4	6	5	18	29	40	35	45														X+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGGCAGGGGGCCTACGAGCAATACTTCGGGCCG	CASSLGQGAYEQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	0	13	2	10	18	34	44	36	54														CASSLGQGAYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGATGGGGGGAGCGGGAGAGATACGCAGTATTTTGGCCCA	CASSLDGGSGRDTQYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	6	2	5	10	0	18	32	-1	42	50														CASSLDGGSGRDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCATTGTTTCGGGGGTCGGGTGAAAAACTGTTTTTTGGCAGT	CASSPLFRGSGEKLFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	2	7	9	5	18	30	45	39	50														CASSPLFRGSGEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD02-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTCCCTCAGGGTCCGAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	16	2.497853407228163E-4		50	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	3	1	4	5	18	32	41	36	46														X+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCTAGCAGCCCGAGGACAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPRTGTGELFF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	4	4	4	0	18	30	-1	34	41														CASSPRTGTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCACCCGGACTGGAGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSTRTGASTDTQYF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	48	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	10	0	4	6	18	30	39	34	45						01,02								CASSTRTGASTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTCCAGCGGGAGGGGTGGAATGAGCAGTTCTTCGGGCCA	CASSFQREGWNEQFF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	6	0	7	2	4	18	32	44	34	48														CASSFQREGWNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTATTCCGACTAGCGGAAAGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLFRLAERSSYNEQFF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	57	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	5	0	4	7	18	33	46	37	53						01,02								CASSLFRLAERSSYNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTGGGAGGGCCGCAATCAGCCCCAGCATTTTGGTGAT	CASSWEGRNQPQHF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	9	0	2	0	2	18	-1	38	31	40														CASSWEGRNQPQHF+TCRBV07-06+TCRBJ01-05	TCRBV07-06*01	TCRBD02-01*02	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGGACGCTACAGCAACATGAACACTGAAGCTTTCTTTGGACAA	CASSGRYSNMNTEAFF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	48	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-01	01	5	1	7	0	0	12	18	-1	34	30	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGRYSNMNTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCAGAGAGGCAAGGACAGTTAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQRGKDS*NTGELFF	Stop	VDJ	2	30	4.683475138552806E-4		54	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	5	1	11	3	18	30	47	41	50														CASSQRGKDS*NTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGTACCTTCGGACTAGCTCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	5	7.805791897588011E-5		47	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	1	7	2	10	2	19	27	45	37	47						01,02								X+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGAGACAGGGGGCTATGAGCAGTTTTTCGGGCCA	CASSLETGGYEQFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02			0	2	0	19	1	12	19	35	46	36	58								TCRBJ02-01,TCRBJ02-05						CASSLETGGYEQFF+TCRBV07-05+TCRBJ02-X	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCTGTGTATCTCTGTGCCAGAACCCTTTCACAGGGGGCGATGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	8	1.2489267036140816E-4		53	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	0	0	7	4	19	29	45	36	49														X+TCRBV07-05+TCRBJ01-04	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCCCGGGAGGCGCTATTGAGGTACAATGAGCAGTTCTTCGGGCCA	CASSPREALLRYNEQFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	51	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	1	4	3	11	19	31	41	34	52														CASSPREALLRYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCGGACCTCGGGAACACTGAAGCTTTCTTTGGACAA	CASSSDLGNTEAFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV07	TCRBV07-05	01				TCRBJ01	TCRBJ01-01	01	3	1	7	1	1	5	19	32	37	33	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSDLGNTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTTAGAGGGACTGGCACTGAAGCTTTCTTTGGACAA	CASSFRGTGTEAFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	0	10	4	4	2	19	33	43	37	45						01,02								CASSFRGTGTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCACCGGACTAGCGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSTGLAVYNEQFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	5	3	3	1	19	31	44	34	45						01,02								CASSTGLAVYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGTCCTCGTGGGGGGGACTGAGCAGTTCTTCGGGCCA	CASSLVLVGGTEQFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	9	0	9	9	2	19	33	49	42	51														CASSLVLVGGTEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCCGGTGACAGGGAGAGACACTGAAGCTTTCTTTGGACAA	CASSPVTGRDTEAFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	3	5	4	19	31	43	36	47														CASSPVTGRDTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCGAGGACTAGTGCTGTTCACAATGAGCAGTTCTTCGGGCCA	CASSSRTSAVHNEQFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	8	5	3	8	19	32	42	35	50						01,02								CASSSRTSAVHNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCATTTCGGGACAGGGCTGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	2.1856217313246428E-4		43	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	6	6	3	19	31	46	37	49														X+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTACYTGGGTCCTACACTGAAGCTTTCTTTGGACAA	CASSLXGSYTEAFF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	42	TCRBV07	TCRBV07-05	01				TCRBJ01	TCRBJ01-01	01	1	0	9	3	3	4	19	34	40	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLXGSYTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGGTCAGGACAGGGAAATTACAATGAGCAGTTCTTCGGGCCA	CASRSGQGNYNEQFF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	1	3	4	7	4	19	27	42	34	46														CASRSGQGNYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAAGACTCGGCCCTGTATCTCTGCGCCAGCAGCCGAATAGCGGTTGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSRIAVGGNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV04	TCRBV04-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	5	6	3	7	21	34	43	37	50						01,02							Vb 7.2	CASSRIAVGGNEQFF+TCRBV04-03+TCRBJ02-01	TCRBV04-03*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGGACTCGGCCCTGTATCTCTGTGCCAGCAGCCCAGGGGCCCCCACTGAAGCTTTCTTTGGACAA	CASSPGAPTEAFF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	39	TCRBV05	TCRBV05-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	2	4	1	4	20	32	39	33	43														CASSPGAPTEAFF+TCRBV05-08+TCRBJ01-01	TCRBV05-08*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAAGTCCAGGAGGTGTAGAGACCCAGTACTTCGGGCCA	CASSLSPGGVETQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	10	1	4	8	3	22	35	48	43	51														CASSLSPGGVETQYF+TCRBV07-01+TCRBJ02-05	TCRBV07-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCACCCCCAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASTPSGSTDTQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	6	4	0	5	0	22	32	-1	37	43						01,02								CASTPSGSTDTQYF+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTCCCGGGACAGGGACATTTACCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSFPGQGHLPTNEKLFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	57	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	3	0	4	8	22	35	48	39	56														CASSFPGQGHLPTNEKLFF+TCRBV07-01+TCRBJ01-04	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCAAGGAGACAGCTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGDSFSGANVLTF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	51	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	5	0	6	3	22	34	45	40	48														CASSQGDSFSGANVLTF+TCRBV07-01+TCRBJ02-06	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTATCGGGCGGGGACAATGAGCAGTTCTTCGGGCCA	CASSLSGGDNEQFF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	42	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	3	5	6	0	22	35	-1	41	47														CASSLSGGDNEQFF+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCCGCGGGACTAGTGCAGATACGCAGTATTTTGGCCCA	CASRGTSADTQYF	In	VDJ	2	42	6.556865193973929E-4	7.738797169811321E-4	39	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	0	8	4	3	2	22	31	42	34	44						01,02								CASRGTSADTQYF+TCRBV07-01+TCRBJ02-03	TCRBV07-01*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGCCAGCAGCATAAAGACCGGGACTAGCGGATACTGAGGACCTTTGGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIKTGTSGY*GPLGSYNEQFF	Stop	VDJ	3	51	7.961907735539771E-4		72	TCRBV07	TCRBV07-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	0	5	1	5	19	-1	14	30	19	49						01,02								CASSIKTGTSGY*GPLGSYNEQFF+TCRBV07-03+TCRBJ02-01	TCRBV07-03*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCGTGACAGGGGGCCAGCCCCAGCATTTTGGTGAT	CASSVTGGQPQHF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	39	TCRBV07	TCRBV07-08		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	0	7	2	0	20	32	-1	34	44			01,02											CASSVTGGQPQHF+TCRBV07-08+TCRBJ01-05	TCRBV07-08	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTTAAAGACTAGCGGGAGAGGGGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	10	1.5611583795176022E-4		49	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	2	2	6	2	5	20	35	49	37	54			01,02											X+TCRBV07-08+TCRBJ02-03	TCRBV07-08	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCGACAGCGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSDSDSNQPQHF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	5	0	1	3	23	34	40	35	43													Vb 12	CASSDSDSNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCTTGCGACCCACGCGAAGGGAGGTTGGTTACGCAGTATTTTGGCCCA		Out	VDJ	1	6	9.366950277105613E-5		53	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	1	8	18	5	23	34	58	52	63													Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGTGCGGGAGGTGGTACCGGGGAGCTGTTTTTTGGAGAA	CASSGAGGGTGELFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	7	1	5	2	4	23	36	46	38	50													Vb 12	CASSGAGGGTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAGGCCGGGATATGGCTACACCTTCGGTTCG	CASSERPGYGYTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	8	3	5	4	0	23	38	-1	42	47													Vb 12	CASSERPGYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGTAGGTTAGCGGACATGTACGAGCAGTACTTCGGGCCG	CASSGRLADMYEQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	5	4	6	5	23	36	48	42	53						01,02							Vb 12	CASSGRLADMYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTGGCGGGAGAGCTCCGAGCAGTACTTCGGGCCG	CASSWRESSEQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	2	6	2	5	23	35	44	37	49													Vb 12	CASSWRESSEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATGGACAGGGGGCTTCCTACGAGCAGTACTTCGGGCCG	CASSDGQGASYEQYF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	0	1	1	1	23	37	49	38	50													Vb 12	CASSDGQGASYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACGCGGGGTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASTRGATNEKLFF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	7	7	3	0	1	2	23	33	40	34	42													Vb 12	CASTRGATNEKLFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD02-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCCAGGGCTTTATGGCTACACCTTCGGTTCG	CASSPGLYGYTF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	5	1	3	23	35	41	36	44													Vb 12	CASSPGLYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCAGACAGGGCACACTGAAGCTTTCTTTGGACAA	CASQTGHTEAFF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	2	3	3	2	1	23	32	41	34	42													Vb 12	CASQTGHTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCTCCTCCGGGCGGGAGCTTACAATGAGCAGTTCTTCGGGCCA	CASSLLRAGAYNEQFF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	2	4	9	2	23	35	51	44	53													Vb 12	CASSLLRAGAYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCTCGCCACCCCGAAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	32	4.995706814456326E-4		43	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-05	01	0	2	8	8	10	0	23	40	-1	50	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGGCCAACTAGATACACCGGGGAGCTGTTTTTTGGAGAA	CASSEGPTRYTGELFF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	3	8	3	6	2	23	38	49	44	51						01,02							Vb 12	CASSEGPTRYTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCCGGGGTAAGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSESGVRSNQPQHF	In	VDJ	5	90	0.0014050425415658419	0.001658313679245283	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	8	3	1	0	5	23	-1	45	40	50													Vb 12	CASSESGVRSNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD02-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGAAGGGACGGGGACTACCAATGAGCAGTTCTTCGGGCCA	CAISEGTGTTNEQFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	9	6	7	1	24	38	52	45	53						01,02							Vb 12	CAISEGTGTTNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGCAAGACAGGGGTTGGTGAAAAACTGTTTTTTGGCAGT	CAISKTGVGEKLFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	2	7	3	4	24	35	46	38	50													Vb 12	CAISKTGVGEKLFF+TCRBV10-03+TCRBJ01-04	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTCCCGGACAGGGGGGGAACATTCAGTACTTCGGCGCC	CAISPGQGGNIQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	1	1	7	3	2	24	36	49	39	51													Vb 12	CAISPGQGGNIQYF+TCRBV10-03+TCRBJ02-04	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGCAAATCGGGGCAAGAGCAGTACTTCGGGCCG	CAISKSGQEQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	36	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-07	01	6	7	0	7	6	2	24	35	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISKSGQEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCGGGACAGCCGGGGTCGTGAACACTGAAGCTTTCTTTGGACAA	CAGTAGVVNTEAFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	0	5	0	0	9	24	-1	37	30	46													Vb 12	CAGTAGVVNTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCACCGAGCGGGGGGGGAACTATGGCTACACCTTCGGTTCG	CAITERGGNYGYTF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	6	0	2	3	1	24	34	47	37	48													Vb 12	CAITERGGNYGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD02-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATACGACTAGCAGGGGGTCGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	2.1856217313246428E-4		37	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-07	01	9	4	1	6	8	1	24	32	47	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCCGACCCCCGGATCAGCCCCAGCATTTTGGTGAT	CASRPPDQPQHF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	36	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-05	01	10	2	7	5	3	6	24	31	37	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASRPPDQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAGTCAGGTCAGGAGCAGTACTTCGGGCCG	CAISESGQEQYF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	36	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-07	01	0	4	5	7	4	0	23	40	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESGQEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAGTCCCAGGGGAGAGCGGGCAATCAGCCCCAGCATTTTGGTGAT	CAISESQGRAGNQPQHF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	51	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	2	1	7	23	40	47	41	54													Vb 12	CAISESQGRAGNQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGAGGGGGGGAACAGATACGCAGTATTTTGGCCCA	CAISESRGGTDTQYF	In	VDJ	2	32	4.995706814456326E-4	5.896226415094339E-4	45	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	9	0	3	2	1	23	40	49	42	50													Vb 12	CAISESRGGTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGAGAGGGGGCGCACATGAGCAGTTCTTCGGGCCA	CAISESRGGAHEQFF	In	VDJ	2	34	5.307938490359847E-4	6.264740566037736E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	0	8	3	4	23	40	50	43	54													Vb 12	CAISESRGGAHEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGGAGGGCATTACGAGCAGTACTTCGGGCCG	CAISESGGHYEQYF	In	VDJ	19	335	0.005229880571383967	0.006172612028301887	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	0	4	0	3	23	-1	47	40	50													Vb 12	CAISESGGHYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCTGCCTCGGACTAGCGATAACAAATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	5	7.805791897588011E-5		56	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	6	4	9	8	25	37	55	46	63			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGACCGTTTAACAGGGCGTTCGAATGGCTACACCTTCGGTTCG	CASRDRLTGRSNGYTF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	6	10	7	27	38	54	48	61			01,02										Vb 17	CASRDRLTGRSNGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGTGGGGACTAGCGGCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	5	7.805791897588011E-5		41	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	0	5	4	4	1	27	36	51	40	52			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTCACGCCCGAGGGGCCATGGCTACACCTTCGGTTCG	CASRPRGHGYTF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	11	5	2	6	9	2	27	33	47	42	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRPRGHGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACAAACCCCACGATTATGCGAGATACGCAGTATTTTGGCCCA	CATNPTIMRDTQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	7	6	5	16	0	27	34	-1	50	53			01,02			01,02							Vb 17	CATNPTIMRDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCTTTCTATCTCTGTGCCAGTAGTATAGATCCCCCTCATCGACTAGCGGTCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	6	9.366950277105613E-5		61	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	2	5	0	11	1	12	29	49	40	50			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TAGGAATTGGAGGGGACAGGGGGCCCGCGGGTGGAGCGGGAGACGGGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	6	9.366950277105613E-5		77	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	0	2	9	24	-1	3	24	12	48			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGATTAGCCGGAGTACCGGGGAGCTGTTTTTTGGAGAA	CASTISRSTGELFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	5	7	5	4	6	27	37	45	41	51			01,02			01,02							Vb 17	CASTISRSTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCGGGACGGTCCCTACGAGCAGTACTTCGGGCCG	CASRRDGPYEQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	7	3	2	0	5	27	-1	44	38	49			01,02										Vb 17	CASRRDGPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGAGGAGCGGTTTCCAAGAGACCCAGTACTTCGGGCCA	CASSLRSGFQETQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	6	5	1	6	3	27	39	50	45	53			01,02			01,02							Vb 17	CASSLRSGFQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCAGGGGCTCGGGGAACACTGAAGCTTTCTTTGGACAA	CASSSRGSGNTEAFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	1	2	6	27	39	47	41	53			01,02										Vb 17	CASSSRGSGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGCTTGGGGGATCCAACACTGAAGCTTTCTTTGGACAA	CASSWLGGSNTEAFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	6	1	2	6	4	27	39	50	45	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSWLGGSNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACCCCTAGCGGGGTGGAGACCCAGTACTTCGGGCCA	CASSITPSGVETQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	4	3	5	4	2	27	42	55	46	57			01,02										Vb 17	CASSITPSGVETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGGGGGATCGGTTATTCAGCCCCAGCATTTTGGTGAT	CASSPGGSVIQPQHF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	1	6	1	9	27	39	47	40	56			01,02										Vb 17	CASSPGGSVIQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTAGCGGGAGTTACAATGAGCAGTTCTTCGGGCCA	CASISGSYNEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	5	2	4	1	1	27	37	47	38	48			01,02										Vb 17	CASISGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGGGGGACAGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	9	1.405042541565842E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	3	4	0	27	40	-1	44	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCCGGTTCTTGGACAGCGAACACTGAAGCTTTCTTTGGACAA	CASSIPGSWTANTEAFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	5	1	11	1	27	41	58	52	59			01,02										Vb 17	CASSIPGSWTANTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCATCAGCAAGAGTGGAGACCCAGTACTTCGGGCCA	CASSSSARVETQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	5	4	5	5	4	8	27	39	46	43	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSSARVETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCAAATGGTCGGGGACAGTCTCCTACGAGCAGTACTTCGGGCCG	CASIKWSGTVSYEQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	5	0	11	1	27	37	55	48	56			01,02										Vb 17	CASIKWSGTVSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGAACGGGACTAGCGGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	1.5611583795176022E-4		40	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	0	4	5	3	0	27	35	-1	38	50			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGTAGGAACGGACATCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	1.5611583795176022E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	1	6	1	10	2	27	35	50	45	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAGAACAGGGGTAGACCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	1.5611583795176022E-4		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	2	2	4	5	27	38	49	42	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAATGGGGCAGGGTGAATCAGCCCCAGCATTTTGGTGAT	CASSKWGRVNQPQHF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	3	4	7	2	27	40	52	47	54			01,02										Vb 17	CASSKWGRVNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCGGGGACAGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTRGQYSNQPQHF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	5	0	4	2	27	40	51	44	53			01,02										Vb 17	CASSTRGQYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCAGGGGGCCCCCCGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	1.5611583795176022E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	6	2	6	27	39	49	41	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTTCTATCTCTGTGCCAGTAGTTTACAAAGGGGGACTAGCGGGTACGACTTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	1.5611583795176022E-4		62	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	4	1	9	8	10	22	43	31	51			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATACAGGACAGTCCTATCAGCCCCAGCATTTTGGTGAT	CASSIDTGQSYQPQHF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	5	5	4	4	27	44	54	48	58			01,02										Vb 17	CASSIDTGQSYQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGACCTCAAGGGCCTAACTATGGCTACACCTTCGGTTCG	CASSIGGPQGPNYGYTF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	1	0	7	0	1	9	27	43	49	44	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGPQGPNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAAGGTCACTGGGGCCAACGTCCTAACTTTCGGGGCC	CASSMKVTGANVLTF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	7	0	19	10	10	27	41	56	51	66			01,02										Vb 17	CASSMKVTGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTGGCTGGGGCCGAAGAGACCCAGTACTTCGGGCCA	CASSVAGAEETQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	7	0	3	6	2	27	39	50	45	52			01,02										Vb 17	CASSVAGAEETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCGCGGACTAGCGGGTAGGGCTTAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	1.8733900554211225E-4		50	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	4	5	4	8	27	38	53	42	61			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTAGGGACTAGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSIVGTRDYNEQFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	0	8	3	2	3	27	43	53	45	56			01,02			01,02							Vb 17	CASSIVGTRDYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAATACCGGGACAGGGCACAGATACGCAGTATTTTGGCCCA	CASSKIPGQGTDTQYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	4	1	7	0	27	40	-1	47	55			01,02										Vb 17	CASSKIPGQGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGGCTACAGGGCGGAACGGATTATGTAGTACTTCGGGCCG		Out	VDJ	1	14	2.1856217313246428E-4		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	3	3	11	3	15	27	35	44	38	59			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATGATGGCTTGACATACAATGAGCAGTTCTTCGGGCCA	CASNDGLTYNEQFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	2	6	4	10	0	27	37	-1	47	51			01,02										Vb 17	CASNDGLTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAAAGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	2.341737569276403E-4		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	2	0	2	0	27	42	-1	44	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATGGACAGGGCCAACGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	15	2.341737569276403E-4		50	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	2	1	6	27	44	53	45	59			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCGGCTAGCGGGAGCCATGAGCAGTTCTTCGGGCCA	CASSISASGSHEQFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	4	2	8	5	2	27	41	56	46	58			01,02										Vb 17	CASSISASGSHEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGATGGGGGGCGGGTTCTCTGAAGCTTTCTTTGGACAA	CASSMMGGGFSEAFF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	6	0	6	4	7	27	41	51	45	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMMGGGFSEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTGGGCAGGGAACACTGAAGCTTTCTTTGGACAA	CASSMWAGNTEAFF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	1	5	0	27	41	-1	46	50			01,02										Vb 17	CASSMWAGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAAATTCGGGACAGGGGACAGAGACCCAGTACTTCGGGCCA	CASSRNSGQGTETQYF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	2	4	7	2	27	40	57	47	59			01,02										Vb 17	CASSRNSGQGTETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGACAGGTCGCTTATGGCTACACCTTCGGTTCG	CASSRQVAYGYTF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	5	0	5	27	-1	46	40	51			01,02										Vb 17	CASSRQVAYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGAATCCGCCCCAGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIRIRPRDSNQPQHF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	0	12	1	27	41	58	53	59			01,02										Vb 17	CASSIRIRPRDSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTAGGGGTAGGTTCTGAAGCTTTCTTTGGACAA	CASSLGVGSEAFF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	0	9	6	0	6	27	-1	46	43	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLGVGSEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGTAGCGGGAGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSSSGRTYNEQFF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	1	2	1	1	27	40	51	41	52			01,02										Vb 17	CASSSSGRTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGCTGGGATGAGCAGTTCTTCGGGCCA	CASSIGGWDEQFF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	7	0	8	0	4	27	-1	48	43	52			01,02										Vb 17	CASSIGGWDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGACGGTACTACGAGCAGTACTTCGGGCCG	CASSIGRYYEQYF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	1	7	3	1	4	27	41	46	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGRYYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCGGGACTAGCGGCATCGCAGAGACCCAGTACTTCGGGCCA	CASSLGTSGIAETQYF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	5	4	3	6	27	39	53	42	59			01,02			01,02							Vb 17	CASSLGTSGIAETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGTCCTACGAGCAGTACTTCGGGCCG	CASSGSYEQYF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	0	9	1	0	0	27	-1	-1	39	42			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGGACAGGGGACTACGAGCAGTACTTCGGGCCG	CASRGTGDYEQYF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	3	1	1	27	38	49	39	50			01,02										Vb 17	CASRGTGDYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCGCGGGGGTTCTGACGCCGCCTACGAGCAGTACTTCGGGCCG	CASSIRGGSDAAYEQYF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	2	2	2	11	27	41	50	43	61			01,02										Vb 17	CASSIRGGSDAAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGGACAATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPGQSGANVLTF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	1	3	1	27	39	47	42	48			01,02										Vb 17	CASSPGQSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCCTGACAGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASPDRNTGELFF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	2	5	2	4	1	27	35	44	39	45			01,02										Vb 17	CASPDRNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGTAGGCAGGAAAAAAACATTCAGTACTTCGGCGCC	CASSISRQEKNIQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	4	4	4	6	2	27	42	52	48	54			01,02										Vb 17	CASSISRQEKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTCCAGGGGGCCGATCAGCCCCAGCATTTTGGTGAT	CASSIFQGADQPQHF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	0	5	4	2	27	41	53	45	55			01,02										Vb 17	CASSIFQGADQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGGGGCTCGCTCAGCCCCAGCATTTTGGTGAT	CASSIGGLAQPQHF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	1	6	0	5	27	-1	48	41	53			01,02										Vb 17	CASSIGGLAQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCTTGGGGGCCCAGCCAAAAACATTCAGTACTTCGGCGCC	CASSTLGGPAKNIQYF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	6	0	0	5	2	27	40	51	45	53			01,02										Vb 17	CASSTLGGPAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGACCCCAACAGCCTTGAAGCTTTCTTTGGACAA	CASSDPNSLEAFF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	7	7	3	27	39	50	46	53			01,02										Vb 17	CASSDPNSLEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAAAGGGGCTAGCGGGAGGGATGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	26	4.0590117867457656E-4		50	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	10	4	0	1	6	3	27	34	52	40	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCGGGACCTGAGACCCGGGGAGCTGTTTTTTGGAGAA	CATRDLRPGELFF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	10	0	7	6	3	7	27	34	42	37	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATRDLRPGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCCTTCGGGGCTCTCCCCGGCATACGCAGTATTTTGGCCCA	CASSPLRGSPRHTQYF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	6	7	0	7	8	10	27	38	51	46	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPLRGSPRHTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCCGGGATGGACAGCCCCAGCATTTTGGTGAT	CASSPRDGQPQHF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	8	3	7	3	4	27	39	47	42	51			01,02										Vb 17	CASSPRDGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGACGGACAGGGGGCGACTATGGCTACACCTTCGGTTCG	CASSGRTGGDYGYTF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	0	3	4	1	27	39	54	43	55			01,02										Vb 17	CASSGRTGGDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCACTCACTGGAGGGTTCCACAGATACGCAGTATTTTGGCCCA	CASHSLEGSTDTQYF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	10	0	2	9	3	27	35	50	44	53			01,02										Vb 17	CASHSLEGSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAAAGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSKKTGNTEAFF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	4	1	4	0	27	40	-1	44	50			01,02										Vb 17	CASSKKTGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATACTAGCGGGGGCATACGAGCAGTACTTCGGGCCG	CASSILAGAYEQYF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	4	0	2	27	-1	52	42	54			01,02										Vb 17	CASSILAGAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAGGGGGTGAGACCCAGTACTTCGGGCCA	CASSKGGETQYF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	5	1	5	1	1	27	40	47	41	48			01,02										Vb 17	CASSKGGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATGGGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSIWGGNQPQHF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	9	1	2	1	0	27	42	-1	43	49			01,02										Vb 17	CASSIWGGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCCAGGGGCGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	29	4.527359300601046E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	2	2	2	2	27	42	50	44	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAAGGGACAGTTGCCCATACTGAAGCTTTCTTTGGACAA	CASSEGTVAHTEAFF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	5	3	8	27	39	49	42	57			01,02										Vb 17	CASSEGTVAHTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTACGGCGGGGGCGGGAGGTCTAATGAGCAGTTCTTCGGGCCA	CASSYGGGGRSNEQFF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	1	7	10	3	27	39	57	49	60			01,02										Vb 17	CASSYGGGGRSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGGGACAGGGGACGAAAAACTGTTTTTTGGCAGT	CASSTGTGDEKLFF	In	VDJ	2	31	4.8395909765045663E-4	5.711969339622641E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	2	8	2	2	27	40	52	42	54			01,02										Vb 17	CASSTGTGDEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGAGTACAGTGAAGCTTTCTTTGGACAA	CASSIEYSEAFF	In	VDJ	2	32	4.995706814456326E-4	5.896226415094339E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	5	7	5	0	27	41	-1	46	50			01,02										Vb 17	CASSIEYSEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACTCATCCTCAGCCTACGAGCAGTACTTCGGGCCG	CASSIDSSSAYEQYF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	5	2	8	0	27	44	-1	52	55			01,02										Vb 17	CASSIDSSSAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACAGAGTTATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRTELYSNQPQHF	In	VDJ	2	36	5.620170166263368E-4	6.633254716981132E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	5	0	0	7	27	-1	43	38	50			01,02										Vb 17	CASRTELYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGATACACAGCGGGAGGGTCCCGGGAGCAGTTCTTCGGGCCA	CASRYTAGGSREQFF	In	VDJ	2	38	5.932401842166888E-4	7.001768867924528E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	0	10	6	6	27	38	54	44	60			01,02										Vb 17	CASRYTAGGSREQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGATGGCGGGGGGTCGGATGAGCAGTTCTTCGGGCCA	CASRDGGGSDEQFF	In	VDJ	2	38	5.932401842166888E-4	7.001768867924528E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	1	8	5	4	27	38	51	43	55			01,02										Vb 17	CASRDGGGSDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCAGACAGATTCCACGATCAATCAGCCCCAGCATTTTGGTGAT	CASQTDSTINQPQHF	In	VDJ	2	39	6.088517680118648E-4	7.186025943396226E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	2	5	3	3	10	27	35	43	38	53			01,02										Vb 17	CASQTDSTINQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCTGCCACGTCAGGTGGCTACACCTTCGGTTCG	CASSISATSGGYTF	In	VDJ	2	40	6.244633518070409E-4	7.370283018867925E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	4	7	10	0	27	42	-1	52	56			01,02										Vb 17	CASSISATSGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTTGGACAGGGGCAGGGCGGGGAGCTGTTTTTTGGAGAA	CASSLGQGQGGELFF	In	VDJ	2	40	6.244633518070409E-4	7.370283018867925E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	2	7	3	5	27	39	51	42	56			01,02										Vb 17	CASSLGQGQGGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCACCCGGAGTGAGCAGTACTTCGGGCCG	CASSLTRSEQYF	In	VDJ	2	41	6.400749356022168E-4	7.554540094339623E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	2	7	7	1	27	39	50	46	51			01,02										Vb 17	CASSLTRSEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTCAAAGGGACAAACTAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSKGQTSSGANVLTF	In	VDJ	2	43	6.712981031925689E-4	7.923054245283019E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	9	0	6	0	6	6	27	35	47	41	53			01,02										Vb 17	CASSKGQTSSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACTCCGGATAGCGGGAGTTTACGAGCAGTACTTCGGGCCG	CASRLRIAGVYEQYF	In	VDJ	2	43	6.712981031925689E-4	7.923054245283019E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	5	2	4	8	2	27	38	55	46	57			01,02										Vb 17	CASRLRIAGVYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCACAGTTAATGAAAAACTGTTTTTTGGCAGT	CASSITVNEKLFF	In	VDJ	2	43	6.712981031925689E-4	7.923054245283019E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	5	4	1	1	27	41	46	42	47			01,02										Vb 17	CASSITVNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAATAGTTCTAGCGGGGGGACCCAGTACTTCGGGCCA	CANSSSGGTQYF	In	VDJ	3	45	7.025212707829209E-4	8.291568396226415E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	4	2	7	1	0	27	39	-1	40	50			01,02										Vb 17	CANSSSGGTQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGATTTCGGGGGTTAGGTACGAGCAGTACTTCGGGCCG	CASSMRISGVRYEQYF	In	VDJ	3	45	7.025212707829209E-4	8.291568396226415E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	2	4	8	5	27	41	55	49	60			01,02										Vb 17	CASSMRISGVRYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAGAGTTAGGGGAGGGACAGATACGCAGTATTTTGGCCCA	CATRVRGGTDTQYF	In	VDJ	3	46	7.18132854578097E-4	8.475825471698113E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	10	9	0	3	10	0	27	34	-1	44	51			01,02										Vb 17	CATRVRGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGGAGGCGCTACAATGAGCAGTTCTTCGGGCCA	CASSGRRYNEQFF	In	VDJ	3	48	7.49356022168449E-4	8.84433962264151E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	1	3	0	2	27	-1	45	38	47			01,02										Vb 17	CASSGRRYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGAAACGGAGCCGAGCAGTACTTCGGGCCG	CASSGNGAEQYF	In	VDJ	3	49	7.649676059636251E-4	9.028596698113208E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	10	2	6	7	1	27	38	49	45	50			01,02										Vb 17	CASSGNGAEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGCTAGCGAACAGGGGCCGTTTGAACACTGAAGCTTTCTTTGGACAA	CASSKLANRGRLNTEAFF	In	VDJ	3	49	7.649676059636251E-4	9.028596698113208E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	0	9	5	27	40	56	49	61			01,02										Vb 17	CASSKLANRGRLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATATTTTTTGGGAGGGGGAATAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	57	8.898602763250332E-4		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	0	5	5	5	27	41	53	46	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGCCACAGATTTACTATGGCTACACCTTCGGTTCG		Out	VDJ	3	57	8.898602763250332E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	5	3	5	4	27	41	50	46	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACCAGGGCCTCGATGAGCAGTTCTTCGGGCCA	CASSIDQGLDEQFF	In	VDJ	3	61	9.523066115057373E-4	0.0011239681603773585	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	8	1	5	27	44	50	45	55			01,02										Vb 17	CASSIDQGLDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGTCAGTAGCCCGGGAGGCGGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	62	9.679181953009133E-4		49	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	1	0	2	7	27	38	47	40	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGCTAGCGGGAGGCACTATAAGCACAGATACGCAGTATTTTGGCCCA	CASSIGLAGGTISTDTQYF	In	VDJ	4	63	9.835297790960892E-4	0.001160819575471698	57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	4	1	0	4	7	24	38	53	42	60			01,02										Vb 17	CASSIGLAGGTISTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGGTGGTTTCGGCCGGTACAATGAGCAGTTCTTCGGGCCA	CASSIEGGFGRYNEQFF	In	VDJ	4	64	9.991413628912653E-4	0.0011792452830188679	51	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	0	0	9	4	0	13	27	-1	47	44	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEGGFGRYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTTTTCGGGGGTAGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	4	65	0.0010147529466864413		41	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	8	2	5	6	4	27	37	49	43	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGACTAGCGACTCATATATTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIRLATHILNTGELFF	In	VDJ	4	68	0.0010615876980719695	0.0012529481132075471	57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	2	6	1	1	11	24	39	48	40	59			01,02			01,02							Vb 17	CASSIRLATHILNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCGGTACGGGCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSIGGTGSSYEQYF	In	VDJ	4	72	0.0011240340332526735	0.0013266509433962263	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	1	8	0	0	7	2	27	43	54	50	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGTGSSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGGGGGGGCTTTACAATGAGCAGTTCTTCGGGCCA	CASSRGGLYNEQFF	In	VDJ	4	72	0.0011240340332526735	0.0013266509433962263	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	4	0	4	27	-1	47	39	51			01,02										Vb 17	CASSRGGLYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGGACAGGGGATAGGGAGACCCAGTACTTCGGGCCA	CASSGTGDRETQYF	In	VDJ	4	73	0.0011396456170478496	0.0013450766509433961	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	2	5	1	5	27	38	49	39	54			01,02										Vb 17	CASSGTGDRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATGCTGGGACCAGCCCTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	79	0.0012333151198189057		50	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	0	0	7	3	4	8	27	44	53	48	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCACAGCGGGACGGCTACACCTTCGGTTCG	CASSPQRDGYTF	In	VDJ	4	79	0.0012333151198189057	0.001455630896226415	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	6	3	8	4	1	27	39	50	43	51			01,02										Vb 17	CASSPQRDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGAACTTAGGGCACCCGTAGACTATGGCTACACCTTCGGTTCG	CASRELRAPVDYGYTF	In	VDJ	5	87	0.0013582077901803137	0.0016030365566037737	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	6	5	3	3	7	9	27	38	49	45	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRELRAPVDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGCACCGCCCTTACAATGAGCAGTTCTTCGGGCCA	CASKHRPYNEQFF	In	VDJ	5	94	0.0014674888767465459	0.0017320165094339623	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	6	7	4	0	8	27	-1	40	37	48			01,02			01,02							Vb 17	CASKHRPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCGGCGGGAGATAGTCTATGAGCAGTTCTTCGGGCCA		Out	VDJ	5	95	0.001483100460541722		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	2	8	4	7	27	39	50	43	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGAAGACAGGTCCCATGAAGCTTTCTTTGGACAA	CASSEDRSHEAFF	In	VDJ	6	100	0.001561158379517602	0.0018425707547169812	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	7	4	5	27	38	48	42	53			01,02										Vb 17	CASSEDRSHEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCTATCTCTGTGCCAGTACTCAGCACCTTCGACAGGCAGAGTTGTGGTAGGCCAAAAACATTCAGTACTTCGGCGCC	CASTQHLRQAELW*AKNIQYF	Stop	VDJ	7	127	0.0019826711419873547		63	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	2	4	1	12	14	8	18	36	30	50			01,02										Vb 17	CASTQHLRQAELW*AKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCCCTATTTTCGGGACCGAGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	9	164	0.0025602997424088673		43	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	8	0	7	7	10	4	27	36	51	46	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCAACAGGGCAGCCACTACTCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	10	172	0.0026851924127702757		50	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	3	0	2	13	27	36	44	38	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCTGCCACGTCGGGTGGCTACACCTTCGGTTCG	CASSISATSGGYTF	In	VDJ	10	175	0.0027320271641558037	0.003224498820754717	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	8	4	7	10	0	27	42	-1	52	56			01,02			01,02							Vb 17	CASSISATSGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGGAACGGAGCCGAGCAGTACTTCGGGCCG	CASSGNGAEQYF	In	VDJ	10	177	0.002763250331746156	0.0032613502358490565	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	3	6	0	7	27	-1	43	38	50			01,02										Vb 17	CASSGNGAEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCTCGGGAGACTGACACTGAAGCTTTCTTTGGACAA	CASSSRETDTEAFF	In	VDJ	12	204	0.0031847630942159083	0.0037588443396226415	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	2	3	3	4	27	39	48	42	52			01,02										Vb 17	CASSSRETDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGACGACGCCGGGGGGATGCGGTCAGATACGCAGTATTTTGGCCCA	CASDDAGGMRSDTQYF	In	VDJ	13	228	0.0035594411053001328	0.004201061320754717	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	8	1	4	8	7	27	36	51	44	58			01,02										Vb 17	CASDDAGGMRSDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAACACAGGACAGGTTTAGTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	22	382	0.0059636250097572395		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	1	4	0	5	5	27	34	46	39	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCTCGCTCCGGGACAGGGGAGACATTCAGTACTTCGGCGCC	CASSLRDRGDIQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	8	0	2	8	7	2	23	32	49	39	51													Vb 11	CASSLRDRGDIQYF+TCRBV25-01+TCRBJ02-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGAGAGGGTGGCACTGAAGCTTTCTTTGGACAA	CASREGGTEAFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	36	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	11	0	4	1	3	23	34	40	35	43													Vb 11	CASREGGTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCGACTCCGGGACTAGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	7	1.0928108656623214E-4		47	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	8	4	7	2	23	34	49	41	51						01,02							Vb 11	X+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCGCCGGGGCACAGCCCCAGCATTTTGGTGAT	CASSAGAQPQHF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	36	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-05	01	6	7	0	7	4	1	23	34	43	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSAGAQPQHF+TCRBV25-01+TCRBJ01-05	TCRBV25-01*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCTCCGGGACCAACACTGAAGCTTTCTTTGGACAA	CASSSGTNTEAFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	39	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	6	0	7	2	4	1	23	34	43	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSSGTNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCCTCAGGGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSASGGSNQPQHF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	1	0	3	0	23	36	-1	39	46													Vb 11	CASSASGGSNQPQHF+TCRBV25-01+TCRBJ01-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATCTCCGGCAGCAGCTTTCTTTGGACAA	CASSESPAAAFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	36	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	1	4	5	10	6	1	23	39	48	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSESPAAAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGGATAACGAGATTCTGGTACGAGCAGTACTTCGGGCCG	CASSGITRFWYEQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-07	01	4	1	8	4	0	14	23	-1	39	36	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSGITRFWYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCCGCGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSRGGYNEQFF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	2	3	2	0	23	34	-1	36	43													Vb 11	CASSRGGYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTAACAGGGGGGGGTTACAATGAGCAGTTCTTCGGGCCA	CASSVTGGGYNEQFF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	1	4	2	4	23	36	46	38	50													Vb 11	CASSVTGGGYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGATTTAGGCAATATCAATGAGCAGTTCTTCGGGCCA	CASSDLGNINEQFF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	42	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-01	01	3	5	4	6	3	6	23	37	43	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSDLGNINEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCTCTACTGACAGAAAAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	32	4.995706814456326E-4		47	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	1	7	4	23	35	47	42	51													Vb 11	X+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCGCCCGGGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASARGGYNEQFF	In	VDJ	2	37	5.776286004215128E-4	6.81751179245283E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	8	0	4	3	1	23	32	43	35	44													Vb 11	CASARGGYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCACTTAGCGGGAGTGGCAGAGACCCAGTACTTCGGGCCA	CASSHLAGVAETQYF	In	VDJ	2	44	6.869096869877449E-4	8.107311320754717E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	5	2	4	4	4	23	35	48	39	52													Vb 11	CASSHLAGVAETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAAGTGCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSESASGANVLTF	In	VDJ	3	57	8.898602763250332E-4	0.0010502653301886792	45	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-06	01	2	5	5	0	0	3	23	-1	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSESASGANVLTF+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTTGGGACAGAACACTGAAGCTTTCTTTGGACAA	CASSLGQNTEAFF	In	VDJ	9	154	0.002404183904457107	0.0028375589622641507	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	1	2	0	23	35	-1	37	43													Vb 11	CASSLGQNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGACTACCATGAAGCGAGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	10	1.5611583795176022E-4		49	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	3	9	4	0	18	25	-1	40	36	58						01,02								X+TCRBV22-01+TCRBJ01-02	TCRBV22-01*01	TCRBD02-01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGTCACCTCCCGGTCAGGGACAATGAGCAGTTCTTCGGGCCA	CASSHLPVRDNEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	5	12	0	23	34	-1	46	51													Vb 7.1	CASSHLPVRDNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATGACAGATCGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQDDRSSSYEQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	5	0	1	6	23	40	46	41	52													Vb 7.1	CASSQDDRSSSYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAAACGGGCCGCAATCAGCCCCAGCATTTTGGTGAT	CASSQETGRNQPQHF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-05	01	0	8	0	2	3	1	23	40	47	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQETGRNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGCCAGGGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSQGQGGGTDTQYF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	48	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-03	01	1	4	1	1	2	3	23	39	48	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQGQGGGTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCGTCGGGGAGGGTCGGGGAGCTGTTTTTTGGAGAA	CASSPSGRVGELFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	9	0	7	5	1	23	36	48	41	49													Vb 7.1	CASSPSGRVGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCGTCAGGGGGTTAATGAAAAACTGTTTTTTGGCAGT	CASSRQGVNEKLFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	1	4	2	1	23	36	45	38	46													Vb 7.1	CASSRQGVNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAACAGGCCGGAGGTGAAAAACTGTTTTTTGGCAGT	CASSQEQAGGEKLFF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	45	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-04	01	0	3	4	7	0	7	23	-1	45	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQEQAGGEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01		TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAATATCATTCGTTGAGACCCAGTACTTCGGGCCA	CASSQISFVETQYF	In	VDJ	2	31	4.8395909765045663E-4	5.711969339622641E-4	42	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-05	01	2	4	6	5	4	6	23	38	44	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQISFVETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTCGTTGGGGCCGGGGGCTACACCTTCGGTTCG	CASSLVGAGGYTF	In	VDJ	2	31	4.8395909765045663E-4	5.711969339622641E-4	39	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	7	0	8	5	4	23	36	46	41	50													Vb 7.1	CASSLVGAGGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAATTCCAAGGGACTAGCGGGAGGGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSQFQGTSGRGDTGELFF	In	VDJ	2	42	6.556865193973929E-4	7.738797169811321E-4	60	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	0	0	3	6	3	21	36	58	42	61													Vb 7.1	CASSQFQGTSGRGDTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCTTCGATCGGGGGTCACTAATGAAAAACTGTTTTTTGGCAGT	CASSQDLRSGVTNEKLFF	In	VDJ	3	50	7.80579189758801E-4	9.212853773584906E-4	54	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	8	2	2	8	2	23	40	54	48	56													Vb 7.1	CASSQDLRSGVTNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD02-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGTCTACAGGGGCTCACTAATGAAAAACTGTTTTTTGGCAGT	CASSLQGLTNEKLFF	In	VDJ	3	55	8.586371087346812E-4	0.0010134139150943396	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	2	2	3	3	23	34	44	37	47													Vb 7.1	CASSLQGLTNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTCCTAGCGGGTAAGGATACGCAGTATTTTGGCCCA	CASSQVLAGKDTQYF	In	VDJ	4	66	0.0010303645304816174	0.0012160966981132075	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	4	6	2	4	23	39	49	41	53						01,02							Vb 7.1	CASSQVLAGKDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTTACACCGACAGGGGGGGCGAAAAACTGTTTTTTGGCAGT	CASSYTDRGGEKLFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV06	TCRBV06-09	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	1	8	4	3	26	40	53	44	56													Vb 13.1	CASSYTDRGGEKLFF+TCRBV06-09+TCRBJ01-04	TCRBV06-09*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGCACCGACGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSTDGSSYNEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV06	TCRBV06-09	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	2	0	6	0	26	37	-1	43	49													Vb 13.1	CASSTDGSSYNEQFF+TCRBV06-09+TCRBJ02-01	TCRBV06-09*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGACTAGGACAGGGGAGCACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRLGQGSTGANVLTF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	51	TCRBV06	TCRBV06-09	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	1	2	2	4	4	26	37	50	41	54													Vb 13.1	CASRLGQGSTGANVLTF+TCRBV06-09+TCRBJ02-06	TCRBV06-09*01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGCCACGGGCAGGCCGATCAGCCCCAGCATTTTGGTGAT	CASSHGQADQPQHF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	42	TCRBV06	TCRBV06-09	01				TCRBJ01	TCRBJ01-05	01	6	4	4	5	7	3	26	37	48	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 13.1	CASSHGQADQPQHF+TCRBV06-09+TCRBJ01-05	TCRBV06-09*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCATCAGCTGGGGGGGCCCCTACGAGCAGTACTTCGGGCCG	CAISWGGPYEQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	39	TCRBV06	TCRBV06-09	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	9	0	2	2	2	26	37	46	39	48													Vb 13.1	CAISWGGPYEQYF+TCRBV06-09+TCRBJ02-07	TCRBV06-09*01	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGGAACTAGCGGGCAGTTCTTCGGGCCA	CASSGTSGQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	33	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	5	12	2	0	26	39	-1	41	49			01,02			01,02							Vb 12	CASSGTSGQFF+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGCCCCTCAGGGACTCCCTACGAGCAGTACTTCGGGCCG	CASSPSGTPYEQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	2	7	1	26	37	50	44	51			01,02			01,02							Vb 12	CASSPSGTPYEQYF+TCRBV10-01+TCRBJ02-07	TCRBV10-01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTCGGTCAGGGGAAGAGACCCAGTACTTTGGGCCA	CASSRSGEETQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	39	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02			5	4	2	22	4	17	26	38	48	42	65			01,02					TCRBJ02-01,TCRBJ02-05					Vb 12	CASSRSGEETQYF+TCRBV10-01+TCRBJ02-X	TCRBV10-01	TCRBD01-01*01	TCRBJ02	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAACGGGACAGAAGCTTTCTTTGGACAA		Out	VDJ	1	7	1.0928108656623214E-4		34	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	8	2	0	26	40	-1	42	48			01,02										Vb 12	X+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGTAGCCATAACTAAGTTCTACACCTTCGGTTCG		Out	VDJ	1	7	1.0928108656623214E-4		34	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	9	3	9	10	8	4	26	34	46	42	50			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ01-02	TCRBV10-01	TCRBD02-01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGGATTCTTCCCCCGACACTGAAGCTTTCTTTGGACAA	CASSEDSSPDTEAFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV10	TCRBV10-01					TCRBJ01	TCRBJ01-01	01	2	2	8	3	0	11	26	-1	43	41	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEDSSPDTEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGACCTGGTACGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	13	2.0295058933728828E-4		41	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	5	3	7	0	26	40	-1	47	50			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGTTTAAGCGGGATTCTATAAGATACGCAGTATTTTGGCCCA	CASLSGIL*DTQYF	Stop	VDJ	1	23	3.590664272890485E-4		42	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	6	3	5	4	7	26	34	45	38	52			01,02										Vb 12	CASLSGIL*DTQYF+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCCCTGGAGAGTCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	25	3.902895948794005E-4		50	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	2	0	3	5	26	43	50	46	55			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	54	8.430255249395051E-4		41	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	8	2	0	0	0	26	-1	-1	39	45			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGAGTCTAGCGTCTAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	7	131	0.002045117477168059		44	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	9	4	6	0	3	5	26	34	43	37	48			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCCGCCTAAAGGGACTAGCGGGAGGGCCTCCGGGGAGCTGTTTTTTGGAGAA	CASSPPKGTSGRASGELFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	57	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	0	0	6	9	3	22	34	59	43	62														CASSPPKGTSGRASGELFF+TCRBV12-01+TCRBJ02-02	TCRBV12-01*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGTAGCCCTAGCGGGAGATACACCGGGGAGCTGTTTTTTGGAGAA	CASSPSGRYTGELFF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	45	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	4	2	3	1	2	22	34	45	35	47														CASSPSGRYTGELFF+TCRBV12-01+TCRBJ02-02	TCRBV12-01*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCCTCAGGGTAGCGGGAGGCTCCAGGGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	5	7.805791897588011E-5		64	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	5	1	0	8	8	17	33	51	41	59														X+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGACAGCGTCTGAGATTGGCTACACCTTCGGTTCG	CATSRGTASEIGYTF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	5	7	0	10	18	-1	40	34	50														CATSRGTASEIGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAAGCTACAGGGAGGACACTGAAGCTTTCTTTGGACAA	CATSRSYREDTEAFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	2	3	3	3	4	3	18	33	43	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRSYREDTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAAGTGCTAGCGGTCACAGATACGCAGTATTTTGGCCCA	CATSREVLAVTDTQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	5	2	4	1	18	35	46	39	47						01,02								CATSREVLAVTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGCTTGGCGGGAGGATATAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSGLAGGYSSYNEQFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	54	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	7	1	0	6	6	18	30	44	36	50														CATSGLAGGYSSYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACGACTGGGGCTTCCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	15	2.341737569276403E-4		53	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	7	0	2	5	3	18	35	45	40	48														X+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGAGGGGCAGGACTCTCCTACGAGCAGTACTTCGGGCCG	CATSRDRGAGLSYEQYF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	51	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	0	5	2	0	3	7	18	35	43	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRGAGLSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACTCGGGACAGGGCACAGATACGCAGTATTTTGGCCCA	CATSRDSGQGTDTQYF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	4	1	3	0	18	35	-1	38	46														CATSRDSGQGTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGCAGGACAGGGCTAAATGAGCAGTTCTTCGGGCCA	CATSRGRTGLNEQFF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	3	7	3	3	18	34	45	37	48														CATSRGRTGLNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCGCGGGACATTTCGTGAAAAACTGTTTTTTGGCAGT	CATSRGTFREKLFF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	5	0	6	7	3	5	18	30	39	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGTFREKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGGGGGGAGTGGTACGAGCAGTACTTCGGGCCG	CATSRDRGEWYEQYF	In	VDJ	2	30	4.683475138552806E-4	5.527712264150943E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-07	01	0	5	1	4	1	6	18	35	42	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRGEWYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGCGACTAGCGGGAGCCCGTACGAGCAGTACTTCGGGCCG	CATSRATSGSPYEQYF	In	VDJ	2	34	5.307938490359847E-4	6.264740566037736E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	2	2	4	3	4	18	32	47	35	51														CATSRATSGSPYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGGTCCCGGGACAGGGGACTCAATGAGCAGTTCTTCGGGCCA	CATRSRDRGLNEQFF	In	VDJ	2	37	5.776286004215128E-4	6.81751179245283E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	2	6	5	3	18	29	44	34	47														CATRSRDRGLNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCGTCAACTAGCGAACTACGAGCAGTACTTCGGGCCG	CATSRQLANYEQYF	In	VDJ	2	39	6.088517680118648E-4	7.186025943396226E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	6	3	5	2	18	30	42	35	44						01,02								CATSRQLANYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGATCTAGCGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CATSRGSSGGYNEQFF	In	VDJ	2	40	6.244633518070409E-4	7.370283018867925E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	4	2	3	3	0	18	34	-1	37	47														CATSRGSSGGYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGGGACCGGGACAGGGCCCCGGGGAGCAGTTCTTCGGGCCA	CATSREGPGQGPGEQFF	In	VDJ	3	45	7.025212707829209E-4	8.291568396226415E-4	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	10	6	7	18	35	50	41	57														CATSREGPGQGPGEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGTGCCGGGCTCCAATCCCCCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	51	7.961907735539771E-4		55	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	1	8	0	5	5	13	18	34	43	39	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTTGACTCCACAGATACGCAGTATTTTGGCCCA	CATSRVDSTDTQYF	In	VDJ	3	57	8.898602763250332E-4	0.0010502653301886792	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	2	10	2	2	1	18	34	40	36	41						01,02								CATSRVDSTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGGGCCCCTACACTGAAGCTTTCTTTGGACAA	CATSREGPYTEAFF	In	VDJ	4	73	0.0011396456170478496	0.0013450766509433961	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	8	0	3	0	4	18	-1	39	35	43														CATSREGPYTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCATCAGCTGTCAACTAGCGAACTACGAGCAGTACTTCGGGCCG	CAISCQLANYEQYF	In	VDJ	4	73	0.0011396456170478496	0.0013450766509433961	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	3	6	3	5	2	18	30	42	35	44						01,02								CAISCQLANYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGAGCGGGAGAGCGGATGAACAGTTCTTCGGGCCA	CATSRSGRADEQFF	In	VDJ	4	74	0.0011552572008430256	0.001363502358490566	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	6	2	13	1	10	18	32	41	33	51														CATSRSGRADEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTGCGTCCGGGGTCCAACCCTACGAGCAGTACTTCGGGCCG	CATSSASGVQPYEQYF	In	VDJ	4	75	0.0011708687846382015	0.0013819280660377358	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	3	2	6	6	18	32	43	38	49														CATSSASGVQPYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTGCGTTCGGGGTCCAATCCTACGAGCAGTACTTCGGGCCG	CATSSAFGVQSYEQYF	In	VDJ	4	77	0.0012020919522285536	0.0014187794811320754	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	3	1	6	5	18	32	43	38	48														CATSSAFGVQSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGTTACTAGCGGGAGGGCCCCCGGGGAGCTGTTTTTTGGAGAA	CATSVTSGRAPGELFF	In	VDJ	5	81	0.0012645382874092576	0.0014924823113207548	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	3	0	6	3	3	18	30	46	33	49														CATSVTSGRAPGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCCACTAAAGAGACTAGCGGTTACGAGCAGTACTTCGGGCCG	CATSPTKETSGYEQYF	In	VDJ	7	123	0.0019202248068066505	0.002266362028301887	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	5	4	11	1	18	30	50	41	51						01,02								CATSPTKETSGYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTACCACCAGCAGAGAGGAGCGGGCTAACTACGAGCAGTACTTCGGGCCG	CTTSREERANYEQYF	In	VDJ	7	125	0.0019514479743970026	0.0023032134433962266	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	6	4	3	2	4	18	35	43	37	47						01,02								CTTSREERANYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCGGACTACTCGAACAATGAGCAGTTCTTCGGGCCA	CATSRADYSNNEQFF	In	VDJ	7	131	0.002045117477168059	0.0024137676886792454	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	9	5	1	5	18	34	41	35	46						01,02								CATSRADYSNNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTTACCAGGCGGGTTGATACGCAGTATTTTGGCCCA	CATSRVTRRVDTQYF	In	VDJ	55	965	0.01506517836234486	0.017780807783018868	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	7	4	6	7	2	18	34	46	41	48						01,02								CATSRVTRRVDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ACGACTCGGCCCTGTATCTCTGTGCCAGCAGCCCGCCGGTGAGAGGGGGGACTGAAGCTTTCTTTGGACAA	CASSPPVRGGTEAFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV05	TCRBV05-04	01				TCRBJ01	TCRBJ01-01	01	4	5	1	5	11	1	20	32	49	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPVRGGTEAFF+TCRBV05-04+TCRBJ01-01	TCRBV05-04*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCGGTCCTTCTCCGGTGAGCAGTACTTCGGGCCG	CASSRSFSGEQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	5	7	0	12	18	-1	33	30	45						01,02								CASSRSFSGEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGGTTGGGTCGGGAGCAGTACTTCGGGCCG	CASSLGLGREQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-07	01	1	0	9	7	4	4	18	34	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLGREQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGTCACAGGGTGGCGGGGAGAGACCCAGTACTTCGGGCCA	CASSLVTGWRGETQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	48	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-05	01	1	3	3	4	2	8	18	34	42	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVTGWRGETQYF+TCRBV07-02+TCRBJ02-05	TCRBV07-02*01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGCGGGACAGATTCAGTACGAGCAGTACTTCGGGCCG	CASSLAGQIQYEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	5	4	0	6	18	-1	42	35	48														CASSLAGQIQYEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTGGCTCCCGGGTCACTCCTACGAGCAGTACTTCGGGCCG	CASSWLPGHSYEQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	45	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	4	0	6	3	18	31	41	37	44						01,02								CASSWLPGHSYEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCGGGACAGCAATCAGCCCCAGCATTTTGGTGAT	CASSRDSNQPQHF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-05	01	5	0	7	1	1	0	18	30	-1	31	36				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDSNQPQHF+TCRBV07-02+TCRBJ01-05	TCRBV07-02*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGTTCAGAACACTGAAGCTTTCTTTGGACAA	CASSLVQNTEAFF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	6	1	2	0	18	34	-1	36	38														CASSLVQNTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGGCTGGGACAGGGTCCAAACATTCAGTACTTCGGCGCC	CASRLGQGPNIQYF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	42	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	0	3	6	3	3	18	29	41	32	44														CASRLGQGPNIQYF+TCRBV07-02+TCRBJ02-04	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATCTCTGTGCCAGCACCACCCCCAAAATGGATACGCAGTATTTTGGCCCA	CASTTPKMDTQYF	In	VDJ	2	44	6.869096869877449E-4	8.107311320754717E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-03	01	7	3	7	6	2	10	18	28	32	30	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTTPKMDTQYF+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGGATCCCCTGGACGGATAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	6	9.366950277105613E-5		49	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	3	1	7	3	9	5	18	32	45	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGCCAGCATCACAGATACGCAGTATTTTGGCCCA	CASSLGASITDTQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	6	0	2	0	6	18	-1	38	32	44														CASSLGASITDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGGGACTAGCGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASRGTSGDTGELFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	3	1	0	18	29	-1	30	43														CASRGTSGDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCKGCCGTGTATSTCTGTGCCAGCAGCCCCCACCCACAGGAGATGAACACTGAAGCTTTCTTTGGACAA	CASSPHPQEMNTEAFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	0	8	3	19	31	44	39	47														CASSPHPQEMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTACAGGGTGCCCTTGGAGAGCCCCAGCATTTTGGTGAT	CASSVQGALGEPQHF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	8	2	11	18	30	38	32	49														CASSVQGALGEPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCCGGATTCCGGAAACACCATATATTTTGGAGAG	CASSLDPDSGNTIYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	0	1	8	4	3	4	18	35	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDPDSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCGGGACTAGCGGGACTGAGTACTTCGGGCCG	CASSLAGTSGTEYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	0	3	11	4	3	18	32	49	36	52														CASSLAGTSGTEYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTCCCTCATAGCCCTCACAGATACGCAGTATTTTGGCCCA	CASSSLIALTDTQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	7	2	6	3	18	31	41	37	44						01,02								CASSSLIALTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTARTCGGAGGGACAGGAAGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	8	1.2489267036140816E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	4	5	5	5	18	34	47	39	52														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCCAGACAGGGGACTACCAAAACATTCAGTACTTCGGCGCC	CASSLAQTGDYQNIQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	2	2	5	6	6	18	32	46	38	52														CASSLAQTGDYQNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACCCAAGGGGCGATTACAATGAGCAGTTCTTCGGGCCA	CASNPRGDYNEQFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	5	2	4	5	4	18	28	38	33	42														CASNPRGDYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGGGGCCTAGCGGGAGATACGCAGTATTTTGGCCCA	CASSPGGLAGDTQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	4	5	9	0	18	30	-1	39	47						01,02								CASSPGGLAGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGGACAGCCAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSRGQPSSYEQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	0	2	5	18	30	39	32	44														CASSRGQPSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCATCAGACAGGGGGGTACACTGAAGCTTTCTTTGGACAA	CASSHQTGGYTEAFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	3	5	2	18	30	44	35	46														CASSHQTGGYTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCACTTCCGGGACAGGGGGCGGCTACACCTTCGGTTCG	CASSSTSGTGGGYTF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	0	8	8	0	18	31	-1	39	51														CASSSTSGTGGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTCGGGGACTATTAAGGGAGGGTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	10	1.5611583795176022E-4		56	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	9	1	5	12	18	31	43	36	55						01,02								X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGACAGACAATGCGCTCCTACGAGCAGTACTTCGGGCCG	CASSRQTMRSYEQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	0	1	8	18	30	36	31	44														CASSRQTMRSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTCTAGCGGGGGAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	11	1.7172742174693622E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	4	2	7	2	1	18	34	46	36	47														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCTTACCACTAGCGGGAGGGCCGACAGATACGCAGTATTTTGGCCCA	CASSLPLAGGPTDTQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	3	0	3	2	3	18	33	48	35	51														CASSLPLAGGPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGATTGACTAGTGGGAGTGGCTACGAGCAGTACTTCGGGCCG	CASRLTSGSGYEQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	8	3	3	9	18	29	38	32	47						01,02								CASRLTSGSGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAAGGACAGGGGGCTCAGGAGACCCAGTACTTCGGGCCA	CASSQGQGAQETQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	0	5	3	4	18	30	44	33	48														CASSQGQGAQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGGGAGAATTCTCAAGAGACCCAGTACTTCGGGCCA	CASSPRENSQETQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	8	2	2	3	6	18	30	39	33	45														CASSPRENSQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCTACTAGCGGGAACGGGAAGCTGTTTTTTGGAGAA	CASSLATSGNGKLFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	3	3	12	4	6	18	32	46	36	52														CASSLATSGNGKLFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATSTCTGTGCCAGCCACACCGAATCACAGGGACGTCGGGGCTACACCTTCGGTTCG	CASHTESQGRRGYTF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	3	3	8	11	7	18	27	44	38	51														CASHTESQGRRGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAGGGGGGTTGAAAGACCTATGGCTACACCTTCGGTTCG	CASS*GG*KTYGYTF	Stop	VDJ	1	13	2.0295058933728828E-4		45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	4	5	1	4	0	10	18	-1	37	31	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASS*GG*KTYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTTTCGGGAGAGCTACGAGCAGTACTTCGGGCCG	CASSSFRESYEQYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	2	3	5	2	18	31	42	36	44														CASSSFRESYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTGGCGGCCCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	2.0295058933728828E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	7	5	2	3	3	18	33	40	36	43						01,02								X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTTCAGCGTGAACACTGAAGCTTTCTTTGGACAA	CASSLFSVNTEAFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	6	6	0	4	0	18	32	-1	36	40						01,02								CASSLFSVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAAGGTTCTACTTGGCCTTCACTGGCCTTACGAGCAGTACTTCGGGCCG	CASSPKVLLGLHWPYEQYF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	57	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	5	4	4	4	23	18	30	37	34	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPKVLLGLHWPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGGGTAAAACTATGGCTACACCTTCGGTTCG	CASSLGG*NYGYTF	Stop	VDJ	1	15	2.341737569276403E-4		42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	1	0	9	2	2	3	18	34	39	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGG*NYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGCCTCGTCCTACGAGCAGTACTTCGGGCCG	CASSLGASSYEQYF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	8	0	1	0	4	18	-1	38	34	42														CASSLGASSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGTCAGCAGCTTTGCCGGGACAGGGAAGGGCTACACCTTCGGTTCG	CVSSFAGTGKGYTF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	8	4	3	18	32	45	36	48														CVSSFAGTGKGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGCGGACTAGCGGGAGAATCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	19	2.966200921083444E-4		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	2	6	5	3	18	30	48	35	51														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGACAGGATTTCCTCTGGAAACACCATATATTTTGGAGAG	CASSFDRISSGNTIYF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	2	4	0	1	5	18	32	39	33	44														CASSFDRISSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGCTAGGGGGGTATAATGAGCAGTTCTTCGGGCCA	CASSQLGGYNEQFF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	5	1	7	5	4	18	30	41	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQLGGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTGACGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSVTTSTDTQYF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	10	0	5	0	18	30	-1	35	39						01,02								CASSVTTSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCGGGACAGGATTAATCTACGAGCAGTACTTCGGGCCG	CASSTGTGLIYEQYF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	3	3	6	18	30	41	33	47														CASSTGTGLIYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGTAGCGGAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	24	3.746780110842245E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	5	1	3	1	18	30	39	33	40						01,02								X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTTCGGCCTTTCATGGGGAAAAACTGTTTTTTGGCAGT	CASSSSAFHGEKLFF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	4	0	9	8	14	0	18	31	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSAFHGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGACCGGGACAGACTTAGCCGGGGAGCTATTTTTTGGAGAA	CASSSTGTDLAGELFF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	5	17	5	17	18	31	43	36	60														CASSSTGTDLAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGATCACTAGCGGTCCATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	27	4.2151276246975256E-4		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	3	5	3	4	5	18	31	43	35	48						01,02								X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTATCCATGACAGGGGCGGAAGAGCAGTACTTCGGGCCG	CASSLSMTGAEEQYF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	2	7	5	5	18	33	46	38	51														CASSLSMTGAEEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCTTAACGGTCACATCCTACAATGAGCAGTTCTTCGGGCCA	CASSLALTVTSYNEQFF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	3	3	6	1	13	0	18	32	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLALTVTSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATCGGACTAGCGGGATGGGGCGAGCAGTACTTCGGGCCG	CASIGLAGWGEQYF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	1	3	6	2	5	18	28	42	30	47														CASIGLAGWGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGTCTGGGACACTAAACGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	30	4.683475138552806E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	3	8	8	18	30	44	38	52														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACCGGGACTAGCCTCTCAGGAGAGCAGTTCTTCGGGCCA	CASSLGTGTSLSGEQFF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	0	7	10	5	9	18	34	48	39	57						01,02								CASSLGTGTSLSGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCTAGCGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSSLAGPYEQYF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	4	2	2	2	18	31	41	33	43						01,02								CASSSLAGPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCAGTTCAGCGCAGGCCAATGAGCAGTTCTTCGGGCCA	CASSFSSAQANEQFF	In	VDJ	2	37	5.776286004215128E-4	6.81751179245283E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	3	4	4	6	10	1	18	32	46	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSSAQANEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCATCGCTCAACGGCTTAGTGGAAGAGACCCAGTACTTCGGGCCA	CASSPSLNGLVEETQYF	In	VDJ	2	38	5.932401842166888E-4	7.001768867924528E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	9	0	3	12	7	18	30	45	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSLNGLVEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGTAATGACGGACATTCTGGGGCTACACCTTCGGTTCG		Out	VDJ	2	43	6.712981031925689E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	6	8	12	6	18	30	47	42	53														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAATTCGTGTGCGGGAGTCGGATCGCGAGCAGTACTTCGGGCCG		Out	VDJ	2	44	6.869096869877449E-4		53	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	2	6	8	8	18	35	50	43	58														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGNSGANVLTF	In	VDJ	3	48	7.49356022168449E-4	8.84433962264151E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	3	0	8	0	0	2	18	-1	36	32	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGNSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCGGCGGGAGGGGAACAGACCCAGTACTTCGGGCCA	CASSPSAGGEQTQYF	In	VDJ	3	49	7.649676059636251E-4	9.028596698113208E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	7	0	6	6	4	18	30	45	36	49														CASSPSAGGEQTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGGGTGGGCTACTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	49	7.649676059636251E-4		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	10	0	3	0	9	18	-1	38	32	47														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCTCGGGGACTACTCAGGGGACGAGCAGTTCTTCGGGCCA	CASTLGDYSGDEQFF	In	VDJ	3	51	7.961907735539771E-4	9.397110849056604E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	9	10	6	10	18	28	41	34	51						01,02								CASTLGDYSGDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGGGAGTGAGGGGGAGACCCAGTACTTCGGGCCA	CASSLGGSEGETQYF	In	VDJ	3	52	8.118023573491531E-4	9.581367924528302E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	1	5	2	5	9	0	18	34	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGSEGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCGAACCCGGACTAGCGGAAAATGAGCAGTTCTTCGGGCCA	CASTEPGLAENEQFF	In	VDJ	3	53	8.274139411443291E-4	9.765625E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	1	5	7	8	2	18	28	46	36	48						01,02								CASTEPGLAENEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAATGGAAGGGCCTGGGAGACCCAGTACTTCGGGCCA	CASSLNGRAWETQYF	In	VDJ	3	55	8.586371087346812E-4	0.0010134139150943396	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	2	5	3	5	6	5	18	33	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNGRAWETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCCGGGACAGGGGGCTGGGACCACGAGCAGTACTTCGGGCCG	CASSPSGTGGWDHEQYF	In	VDJ	3	58	9.054718601202092E-4	0.001068691037735849	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	0	5	6	7	18	30	48	36	55														CASSPSGTGGWDHEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTCGGGATAATAGGTGAAGCTTTCTTTGGACAA	CASSLLGIIGEAFF	In	VDJ	4	63	9.835297790960892E-4	0.001160819575471698	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	8	3	7	2	7	18	33	40	35	47														CASSLLGIIGEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGCAACAGGGGTATAGATGAAAAACTGTTTTTTGGCAGT	CASSSNRGIDEKLFF	In	VDJ	4	65	0.0010147529466864413	0.0011976709905660377	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	2	6	4	5	18	30	41	34	46														CASSSNRGIDEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAAAAAAGGGAGGCGAAGAAAGTATGGGTGCTCGGCTACACCTTCGGTTCG	CASSLEKREAKKVWVLGYTF	In	VDJ	4	65	0.0010147529466864413	0.0011976709905660377	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	1	8	8	20	18	32	46	40	66														CASSLEKREAKKVWVLGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACAAACGTTGGGTTAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSTNVGLSSYEQYF	In	VDJ	4	71	0.0011084224494574974	0.0013082252358490565	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	0	9	0	9	5	18	30	42	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTNVGLSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCACCTTACAGGGGGCGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSTLQGASSYEQYF	In	VDJ	4	76	0.0011864803684333775	0.0014003537735849056	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	0	0	7	3	18	31	47	38	50														CASSSTLQGASSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCGATTGACAGGGGGAAACACTGAAGCTTTCTTTGGACAA	CASSSRLTGGNTEAFF	In	VDJ	5	85	0.0013269846225899618	0.001566185141509434	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	1	2	7	1	18	31	47	38	48														CASSSRLTGGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCCGACGGGCGCCGATAGCACAGATACGCAGTATTTTGGCCCA	CASSLPTGADSTDTQYF	In	VDJ	6	105	0.001639216298493482	0.0019346992924528302	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	3	8	0	0	6	6	18	32	42	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPTGADSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATACAGGGTAGCGATGAGCAGTTCTTCGGGCCA	CASSLIQGSDEQFF	In	VDJ	6	108	0.0016860510498790103	0.0019899764150943396	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	3	8	2	5	18	33	41	35	46														CASSLIQGSDEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAATTTCGGGGACAGGGACACTGAAGCTTTCTTTGGACAA	CASSLNFGDRDTEAFF	In	VDJ	7	118	0.0018421668878307704	0.0021742334905660377	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	3	7	0	18	33	-1	40	49														CASSLNFGDRDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGACCAGGGGACTGGAAACACCATATATTTTGGAGAG	CASSFDQGTGNTIYF	In	VDJ	7	126	0.0019670595581921784	0.002321639150943396	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	4	2	2	4	1	18	32	42	36	43														CASSFDQGTGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATGGCTAGCGTAGATCAGCAGTACTTCGGGCCG	CASSLMASVDQQYF	In	VDJ	7	131	0.002045117477168059	0.0024137676886792454	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	6	8	4	6	18	33	43	37	49						01,02								CASSLMASVDQQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACCACTGGACGGTACAGATACGCAGTATTTTGGCCCA	CASRPLDGTDTQYF	In	VDJ	10	169	0.0026383576613847473	0.003113944575471698	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	6	1	7	3	6	3	18	29	39	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPLDGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTAGGGACAGGTGCGGGGAGCAGCTGATACGCAGTATTTTGGCCCA		Out	VDJ	10	179	0.0027944734993365075		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	4	6	2	14	18	29	39	31	53														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGCGCCATAAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	11	190	0.002966200921083444		47	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	9	0	0	2	8	18	30	35	32	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAACGAGCCGACAGAAACTACGAGCAGTACTTCGGGCCG	CASSQRADRNYEQYF	In	VDJ	12	220	0.0034345484349387247	0.0040536556603773585	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	3	9	3	18	30	44	39	47														CASSQRADRNYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGTCCCGCTTTAGCCAGGGACTACGAGCAGTACTTCGGGCCG	CASSLRPALARDYEQYF	In	VDJ	14	248	0.003871672781203653	0.004569575471698113	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	3	14	1	18	33	52	47	53														CASSLRPALARDYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAGCGGGACACACCGGGGAGCTGTTTTTTGGAGAA	CASSLVAGHTGELFF	In	VDJ	16	277	0.004324408711263758	0.005103920990566038	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	5	3	3	0	1	18	-1	42	34	43														CASSLVAGHTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLSGDTGELFF	In	VDJ	18	325	0.005073764733432207	0.0059883549528301884	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	2	3	1	0	18	33	-1	34	40														CASSLSGDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTGGGGACAGGGGGCACCGCGGATGGCTACACCTTCGGTTCG	CASSLGTGGTADGYTF	In	VDJ	19	332	0.005183045819998439	0.006117334905660378	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	0	6	3	7	18	30	45	33	52														CASSLGTGGTADGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGAAGATCCGGGACGGCAGGAGAGACCCAGTACTTCGGGCCA	CASGRSGTAGETQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-05	01	6	0	7	4	7	6	26	37	49	44	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGRSGTAGETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCGAAGGACGACGGACGCCGCTCCTACGAGCAGTACTTCGGGCCG	CASGLAKDDGRRSYEQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	54	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	1	1	7	0	4	11	26	42	50	46	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLAKDDGRRSYEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACCCAGCCATCACACTGAAGCTTTCTTTGGACAA	CASGLVPSHHTEAFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-01	01	0	4	5	3	3	5	26	43	49	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLVPSHHTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCGGAGGGGACAGGGTGGGCAATGAGCAGTTCTTCGGGCCA	CASTGGDRVGNEQFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	0	3	6	11	4	26	31	51	42	55														CASTGGDRVGNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCCGGGGACAGGGCGGAGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	10	1.5611583795176022E-4		44	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	6	4	6	26	38	51	42	57														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCAGGGGTAGCGGATACAATGAGCAGTTCTTCGGGCCA	CASGRGSGYNEQFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	6	4	2	4	0	7	26	-1	43	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGRGSGYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCTTTCCTGCCGGAGAGCTTTCTTTGGACAA		Out	VDJ	1	18	2.810085083131684E-4		35	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	10	2	10	11	0	26	36	-1	47	51														X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCCCATAGCAAGGAGCTCTCCACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	3.2784325969869644E-4		52	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	5	7	3	4	13	26	41	49	45	62						01,02								X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCCGGGACAGGGGCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	4.0590117867457656E-4		41	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	5	2	2	26	39	51	41	53														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTACATAATAGTAGCGGGGAGGCCGATACGCAGTATTTTGGCCCA		Out	VDJ	2	29	4.527359300601046E-4		49	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	3	6	9	5	26	38	55	47	60														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCGAAAGACGACGGACGCCGCTCCTACGAGCAGTACTTCGGGCCG	CASGLAKDDGRRSYEQYF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	54	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	1	1	7	0	11	4	26	42	57	53	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLAKDDGRRSYEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTAACTCCCGACGGTATTGGCGTCCCCCTACAATGAGCAGTTCTTCGGGCCA	CASG*LPTVLASPYNEQFF	Stop	VDJ	2	29	4.527359300601046E-4		57	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	4	2	7	2	7	14	24	37	47	44	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASG*LPTVLASPYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGAACCCTGGGGCAGTGTACCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	34	5.307938490359847E-4		52	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	7	0	2	6	9	26	41	52	47	61														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGGCGAAATGAGCAGTTCTTCGGGCCA	CASGLGRNEQFF	In	VDJ	3	61	9.523066115057373E-4	0.0011239681603773585	36	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	1	9	0	7	0	2	26	-1	45	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLGRNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGTCATAGCGGGTCATTCAATGAGCAGTTCTTCGGGCCA	CASGLGHSGSFNEQFF	In	VDJ	5	84	0.0013113730387947858	0.0015477594339622642	48	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	4	6	4	5	26	42	53	46	58						01,02								CASGLGHSGSFNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTTTTGTGCTAGTGGCTCGCCCGACAGGGACCAGCTTTAGCGGAATACGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	7	131	0.002045117477168059		64	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	1	7	19	4	15	29	22	48														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACCCAAGAACTAGCGAATTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	5	7.805791897588011E-5		43	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	3	6	4	7	4	20	30	44	37	48						01,02								X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCATCCTAGGACTAGCGGGGCACCTACAATGAGCAGTTCTTCGGGCCA	CASSQSS*D*RGTYNEQFF	Stop	VDJ	1	5	7.805791897588011E-5		57	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	1	3	2	6	2	20	37	55	43	57														CASSQSS*D*RGTYNEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCCCGATCCGGGACAGGAACGGCGGCCAAAAACATTCAGTACTTCGGCGCC	CASSQSRSGTGTAAKNIQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	60	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	0	4	1	7	7	20	37	52	44	59														CASSQSRSGTGTAAKNIQYF+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGTTCGCTGACACCCGAAACTTTAACTATGGCTACACCTTCGGTTCG	CASSQSFADTRNFNYGYTF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	57	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	6	1	7	10	20	37	48	44	58														CASSQSFADTRNFNYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCTGCGCCAGCAGTCAAACCCTTTGACAGGGATATTAGCCTTAGGGCTACAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	1.8733900554211225E-4		68	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	3	1	7	20	2	17	31	24	51														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGACACGGCACTGTATCTCTGCGCCATATGGGACAGGGGGCGAGTAGAGGTTTGAGAGACCCAGTACTTCGGGCCA	CAIWDRGRVEV*ETQYF	Stop	VDJ	1	16	2.497853407228163E-4		51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	0	0	4	3	13	20	27	42	30	55														CAIWDRGRVEV*ETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGACACGGCACTGTATCTCTGCGCCAGCGGATTGACAGGGAAACTGATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	2.6539692451799237E-4		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	2	3	4	5	7	20	29	41	34	48														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAAGCCCGGGAGTGACCTACGAGCAGTACTTCGGGCCG	CASSQSPGVTYEQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	2	2	4	3	20	35	45	39	48														CASSQSPGVTYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCTTAAGGGGATCTATGGCTACACCTTCGGTTCG	CASSLKGIYGYTF	In	VDJ	2	44	6.869096869877449E-4	8.107311320754717E-4	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	5	2	4	3	2	20	33	41	36	43														CASSLKGIYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACCGGACAGGGTGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	3	51	7.961907735539771E-4		41	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	3	9	2	3	20	35	45	37	48														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACGCTCCCCGGGACAGGGTCCGACGAGCAGTACTTCGGGCCG	CASTLPGTGSDEQYF	In	VDJ	6	102	0.0015923815471079541	0.0018794221698113208	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	3	5	8	4	20	30	47	38	51														CASTLPGTGSDEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGGCATGGGCATAGGGTGGGATACGCAGTATTTTGGCCCA	CASSQGMGIGWDTQYF	In	VDJ	11	201	0.0031379283428303803	0.003703567216981132	48	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-03	01	2	5	3	6	11	3	20	35	50	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGMGIGWDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTAAAGCCCCTTAATGAGCAGTTCTTCGGGCCA	CASSLKPLNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	9	7	1	9	26	37	41	38	50		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSLKPLNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCCGGGACTAGCGGTCAAACCGGGGAGCTGTTTTTTGGAGAA	CASSAGTSGQTGELFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	5	5	4	4	26	37	52	41	56		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSAGTSGQTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCGGGAGGGGATGGGGCTGAAGCTTTCTTTGGACAA	CASSAGGDGAEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	7	0	6	1	7	26	37	47	38	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSAGGDGAEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGAGGGGGTGACTGAAGCTTTCTTTGGACAA	CASSVEGVTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	1	5	5	2	26	37	48	42	50		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVEGVTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTATCAATGAGCAGTTCTTCGGGCCA	CASSFINEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	33	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	9	6	0	1	26	-1	42	40	43		TCRBV12-03,TCRBV12-04				01,02								CASSFINEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAAAAGAAGACAGCCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASKRRQPSSYNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	2	5	0	6	5	24	34	45	40	50	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASKRRQPSSYNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCGGGGACAGGGCGCCGATACGCAGTATTTTGGCCCA	CASTRGQGADTQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	3	6	4	4	26	36	49	40	53		TCRBV03-01,TCRBV03-02												CASTRGQGADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGGGGGACTGGTACCGGGGAGCTGTTTTTTGGAGAA	CASSQEGGTGTGELFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV03						TCRBJ02	TCRBJ02-02	01	0	5	1	5	0	7	26	-1	49	43	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGGTGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATAGGGCGACGGGGGATACGCAGTATTTTGGCCCA	CASSHRATGDTQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	3	6	8	0	26	40	-1	48	53		TCRBV03-01,TCRBV03-02												CASSHRATGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATCAGGGGGACGGCAACTATGGCTACACCTTCGGTTCG	CASSHQGDGNYGYTF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	1	2	1	5	26	40	48	41	53		TCRBV03-01,TCRBV03-02												CASSHQGDGNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTATCCTGGGGGACACTGAAGCTTTCTTTGGACAA	CASSILGDTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	6	6	1	3	6	0	26	37	-1	43	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSILGDTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCTAGCAGCCTTTTATGGCCCAGATCGGACACTGAAGCTTTCTTTGGACAA	CASSLLWPRSDTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	4	5	3	10	5	26	39	52	49	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLWPRSDTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAGGGAAAGCAATCAGCCCCAGCATTTTGGTGAT	CSARESNQPQHF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	36	TCRBV20						TCRBJ01	TCRBJ01-05	01	6	0	8	1	2	1	26	34	40	36	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARESNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGACTCAAATGGGCACAGATACGCAGTATTTTGGCCCA	CSARTQMGTDTQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	10	1	2	7	26	34	41	36	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTQMGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGAGGGGACTCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSARRRGLPNTGELFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	0	10	0	5	2	26	38	49	43	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRRGLPNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCAACGGGAGACACAGATACGCAGTATTTTGGCCCA	CSARPTGDTDTQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	8	2	2	4	1	26	38	48	42	49		TCRBV20-01,TCRBV20-or09_02												CSARPTGDTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACGTGGGAACTCCTACAATGAGCAGTTCTTCGGGCCA	CSARERGNSYNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	0	8	0	4	1	26	40	48	44	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARERGNSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCATGGCGGAACTACAATGAGCAGTTCTTCGGGCCA	CSARSWRNYNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	7	5	3	5	2	26	38	47	43	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSWRNYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCGGGACTAGCGGACACAGATACGCAGTATTTTGGCCCA	CSARPGLADTDTQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	5	2	3	1	26	37	51	40	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARPGLADTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCAAGCCATAGCAGATGAGCAGTTCTTCGGGCCA	CSAPQAIADEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	7	8	10	2	26	35	49	45	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPQAIADEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGAGGGGGGGAGAGAACACTGAAGCTTTCTTTGGACAA	CSAPRGGENTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	1	4	3	26	35	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSAPRGGENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCTACGCCACTAGCGGGAGGATCGAATGAGCAGTTCTTCGGGCCA	CSAATPLAGGSNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	3	1	7	8	4	26	35	55	43	59		TCRBV20-01,TCRBV20-or09_02												CSAATPLAGGSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGCGCGGGGACACTGAAGCTTTCTTTGGACAA	CSASRGDTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	3	3	4	0	26	35	-1	39	45		TCRBV20-01,TCRBV20-or09_02												CSASRGDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACCAGGACAGGGCCCGACTCTGGAAACACCATATATTTTGGAGAG	CASTRTGPDSGNTIYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	1	3	0	3	5	22	32	43	35	48		TCRBV12-03,TCRBV12-04												CASTRTGPDSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCCAGGGGGGGGAGGGCCATCGCAGTTCTTCGGGCCA	CASSPGGGGPSQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	5	4	1	12	1	12	22	34	42	35	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGGGGPSQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCCTCAGTCCGGGACAGGGACCTACGAGCAGTACTTCGGGCCG	CASSPQSGTGTYEQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	2	9	1	22	34	52	43	53		TCRBV12-03,TCRBV12-04												CASSPQSGTGTYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGACGGGGCCGCGGGAGGCACAGATACGCAGTATTTTGGCCCA	CASSDGAAGGTDTQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	2	1	9	0	22	34	-1	43	50		TCRBV12-03,TCRBV12-04												CASSDGAAGGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCGGTGGACAGGGGGCTTTTGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	5	7.805791897588011E-5		52	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	0	5	6	6	24	38	55	44	61		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTTAGCGGGAGGGCCCTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	5	7.805791897588011E-5		52	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	5	0	2	1	4	24	41	53	42	57		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGAAGGGGGAGCTCCAACGAGCAGTACTTCGGGCCG	CATGRGSSNEQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	5	1	5	3	7	24	33	42	36	49		TCRBV24-01,TCRBV24-or09_02												CATGRGSSNEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCGGGGCCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLSGASSYNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48							TCRBJ02	TCRBJ02-01	01	6	7	0	0	6	3	24	36	47	42	50	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGASSYNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCACCAGGACCCGAGGGGAGACCCAGTACTTCGGGCCA	CASSFTRTRGETQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	11	0	5	13	0	24	36	-1	49	54		TCRBV24-01,TCRBV24-or09_02												CASSFTRTRGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCTACGGGGGTTACACTGAAGCTTTCTTTGGACAA	CASYGGYTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	36	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	11	8	2	3	4	2	24	31	41	35	43		TCRBV24-01,TCRBV24-or09_02												CASYGGYTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGGCTAGCGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSQEASGPYNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	4	2	2	1	18	35	45	37	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQEASGPYNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGCAAGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTAAAACTAGCGGTAACAATGAGCAGTTCTTCGGGCCA	CASSKTSGNNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	5	5	3	2	39	51	62	54	64	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01				01,02								CASSKTSGNNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCAACTAGCGGGAGCCCCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQLAGAPGANVLTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	51	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	3	2	4	2	5	26	38	51	40	56		TCRBV12-03,TCRBV12-04												CASSQLAGAPGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD02-01*02	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCATCCAAAGTCCCGGCGGGGGCTACACCTTCGGTTCG	CAIQSPGGGYTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	12	7	4	8	14	0	26	31	-1	45	50	TCRBV09,TCRBV12					01,02								CAIQSPGGGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCCAATTATGATGGGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	6	9.366950277105613E-5		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	8	0	2	12	0	24	31	-1	43	47	TCRBV06,TCRBV10													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGGCAGGGCTTACGTGGCTACACCTTCGGTTCG	CASSQEGQGLRGYTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	7	4	6	26	43	52	47	58		TCRBV03-01,TCRBV03-02												CASSQEGQGLRGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACCCAGTGTCCCGGCGAAATGAGCAGTTCTTCGGGCCA	CASSQDPVSRRNEQFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	48	TCRBV03						TCRBJ02	TCRBJ02-01	01	0	4	5	7	2	11	26	43	48	45	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDPVSRRNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACAAGACAGGGTCTATGGCTACACCTTCGGTTCG	CASSPQDRVYGYTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	4	5	1	26	39	51	44	52		TCRBV03-01,TCRBV03-02												CASSPQDRVYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGGACTCGGCCSTGTATSTCTGTGCCAGCAGCCAAGCCGGGACGGCCGAGGAGCTGTTTTTTGGAGAA	CASSQAGTAEELFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	4	0	7	10	6	6	20	32	43	38	49	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAGTAEELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAATGACAGGCCCCCCTATGGCTACACCTTCGGTTCG	CSANDRPPYGYTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	4	4	4	5	26	34	44	38	49		TCRBV20-01,TCRBV20-or09_02												CSANDRPPYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATYTGGAGGGKCGCGGGGGGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	6	9.366950277105613E-5		50	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	7	0	5	11	1	26	40	60	51	61		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTCCCGGGCTCAACACCGGGGAGCTGTTTTTTGGAGAA	CSARVPGLNTGELFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV20						TCRBJ02	TCRBJ02-02	01	1	8	0	2	5	2	26	39	48	44	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVPGLNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTATCTAGCGGGAGATTGGGGGACCCAGTACTTCGGGCCA	CSASYLAGDWGTQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	4	2	7	4	7	26	37	51	41	58		TCRBV20-01,TCRBV20-or09_02												CSASYLAGDWGTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGGGAAGGGCCGGCACAGATACGCAGTATTTTGGCCCA	CSASWGRAGTDTQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	0	8	1	3	7	26	37	44	40	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASWGRAGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAACGGGGGAATCATGAACACTGAAGCTTTCTTTGGACAA	CASNGGIMNTEAFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	2	0	1	5	22	32	39	33	44	TCRBV09,TCRBV12													CASNGGIMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCCCGGGGGGAACCTACGAGCAGTACTTCGGGCCG	CASSPGGTYEQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	1	2	2	2	22	33	42	35	44	TCRBV09,TCRBV12													CASSPGGTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGAACTAGCGGGAGGATTGGGTGAGCAGTTCTTCGGGCCA	CASSELAGGLGEQFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	3	1	9	3	6	22	33	48	36	54		TCRBV12-03,TCRBV12-04												CASSELAGGLGEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGCAGCGGGGGGACACTGAAGCTTTCTTTGGACAA	CASRQRGDTEAFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	6	1	3	2	0	22	33	-1	35	44	TCRBV02,TCRBV12													CASRQRGDTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
SRGGGACTCAGCTGTGTAYYTCTGTGCCAGCAGGCGGGAGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASRREDSYNEQFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	7	1	0	0	1	22	-1	41	33	42	TCRBV07,TCRBV12													CASRREDSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCWSSSASWCAKCTGTGTACTTSTGTGCCAGCAGTGAAAGGGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSERGTGELFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	5	2	5	3	1	22	34	42	37	43	TCRBV06,TCRBV12													CASSERGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGACAGTCGAGGGCCCGAGCAGTACTTCGGGCCG	CASSDSRGPEQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	5	2	5	6	0	9	22	-1	39	34	48	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSRGPEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTACCTCACGGGAGAACAGATACGCAGTATTTTGGCCCA	CASSLPHGRTDTQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	8	2	3	5	1	22	37	48	42	49		TCRBV12-03,TCRBV12-04												CASSLPHGRTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGGCACAGCCAGAGTCTCCTCTGGAAACACCATATATTTTGGAGAG	CGTARVSSGNTIYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	13	3	5	0	2	10	22	26	32	28	42		TCRBV12-03,TCRBV12-04												CGTARVSSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
MSCWMCCAGACAKCTSTKTACTTCTGTGCCAGCAGTTTAGCCGGGAGCAATGAGCAGTTCTTCGGGCCA	CASSLAGSNEQFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	2	6	5	0	24	36	-1	41	47	TCRBV06,TCRBV24													CASSLAGSNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGTTTTTGACAGGGAGACAGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	6	9.366950277105613E-5		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	0	4	6	24	36	47	40	53	TCRBV24,TCRBV28													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCTACCAGCGGATCCGAAATGGGGGAGCAGTACTTCGGGCCG	CATSGSEMGEQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	TCRBV24						TCRBJ02	TCRBJ02-07	01	7	6	2	7	12	0	24	35	-1	47	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSGSEMGEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCACAGGGGTAGGGGAAGAGACCCAGTACTTCGGGCCA	CATTGVGEETQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	3	2	3	2	6	23	30	39	32	45	TCRBV06,TCRBV10													CATTGVGEETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCATCGAATCGGGGACAGTGCAAGATATGCAGTATTTTGGCCCA	CAIESGTVQDMQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	0	5	11	8	10	26	33	48	41	58	TCRBV06,TCRBV10													CAIESGTVQDMQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ACGACTCGGCCSTGTATCTCTGTGCCAGCAGCTCCACAATCTGGTATGGCTACACCTTCGGTTCG	CASSSTIWYGYTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	6	5	2	6	18	31	36	33	42	TCRBV05,TCRBV07													CASSSTIWYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGAAGCCGAACTGACAGGGGGGGTGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	6	9.366950277105613E-5		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	1	4	6	5	18	30	45	36	50	TCRBV05,TCRBV07,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCGGACTAGCGGGAGAAAATCCCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGLAGENPNTGELFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	1	2	2	2	8	18	31	46	33	54	TCRBV07,TCRBV11													CASSSGLAGENPNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCTTCCTAGCGGGAGCAACGAGCAGTACTTCGGGCCA		Out	VDJ	1	6	9.366950277105613E-5		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	4	2	11	5	7	18	31	46	36	53	TCRBV07,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGCGCCATTCAGGGTCGCTCTGGAAACACCATATATTTTGGAGAG	CASAIQGRSGNTIYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	4	3	0	6	3	18	27	38	33	41	TCRBV07,TCRBV11													CASAIQGRSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGGCGGACCCGGGAGGGGGGCGGAAGAGACCCAGTACTTCGGGCCA	CASSQGGPGRGAEETQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	8	0	3	8	6	20	35	51	43	57	TCRBV04,TCRBV23													CASSQGGPGRGAEETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GCCACGTTTGGTGCATCCTGAAGACGCAGCTTCTACATCTGCAGTGCTCCCCCGGGGGGTCAGAACACTGAAGCTTTCTTTGGACAA	CSAPPGGQNTEAFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	1	1	4	3	39	48	59	52	62		TCRBV20-01,TCRBV20-or09_02												CSAPPGGQNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCCACTAGCGGGAGAGGGAGAGCAGTTCTTCGGGCCA	CASSPLAGEGEQFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	3	2	10	2	5	19	31	44	33	49	TCRBV07,TCRBV11													CASSPLAGEGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCCAAGACAGGACTACCTTAACAGATACGCAGTATTTTGGCCCA	CASSQDRTTLTDTQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	48	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	5	2	4	3	3	9	19	31	40	34	49	TCRBV03,TCRBV07,TCRBV11			TCRBD01,TCRBD02										CASSQDRTTLTDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCACGCTAGCGGGAGGTCTCGAGCAGTACTTCGGGCCG	CASSTLAGGLEQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	4	1	6	3	3	19	31	45	34	48	TCRBV05,TCRBV07													CASSTLAGGLEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCCAAGTCTCAGGGGCTGAGCCCCAGCATTTTGGTGAT	CASSQVSGAEPQHF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	2	8	7	3	19	31	44	38	47	TCRBV05,TCRBV07													CASSQVSGAEPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCCGAGATACAGGGTTCTATGGCTACACCTTCGGTTCG	CASSRDTGFYGYTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	4	6	2	19	31	43	37	45	TCRBV05,TCRBV07													CASSRDTGFYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTAGAGATAGGGGGCTATGAGCAGTTCTTTGGGCCA	CASSLEIGGYEQFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02			2	5	0	22	6	15	19	33	46	39	61	TCRBV05,TCRBV11							TCRBJ02-01,TCRBJ02-05						CASSLEIGGYEQFF+X+TCRBJ02-X	unresolved	TCRBD01-01*01	TCRBJ02	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GARGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTGTGGGACGTTCGGGACGAGCAGTACTTCGGGCCG	CASSLWDVRDEQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	1	0	7	5	1	7	19	34	40	35	47	TCRBV04,TCRBV05			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWDVRDEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
SGACTCGGCYSTGTATCTCTGTGCCAGCAGCGCAAAGACACCCGGCACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	6	9.366950277105613E-5		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	6	2	5	7	19	31	40	36	47	TCRBV05,TCRBV07													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCSTGTATCTCTGTGCCAGCAGCTTGGTAGGGGCGTCCTATGGCTACACCTTCGGTTCG	CASSLVGASYGYTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	4	1	4	19	35	41	36	45	TCRBV05,TCRBV07													CASSLVGASYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTKTGTATYTCTGTGCCAGCAGCCCTCGGGACTAGCGGGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	6	9.366950277105613E-5		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	4	3	4	0	22	34	-1	38	50	TCRBV07,TCRBV09					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTKTGTATYTCTGTGCCAGCAGCTCCGATATAGACAGTCTTCAGTACTTCGGGCCG	CASSSDIDSLQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	5	10	8	4	22	35	48	43	52	TCRBV07,TCRBV09													CASSSDIDSLQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYGGCYRTGTATCTCTGTGCCAGCAGCTTACTAGCGGGAGAACCCGGGGAGCTGTTTTTTGGAGAA	CASSLLAGEPGELFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	3	2	6	1	3	22	35	47	36	50	TCRBV07,TCRBV11													CASSLLAGEPGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTTAGTTCCGGGACAGACTTCAATGAGCAGTTCTTCGGGCCA	CASSVSSGTDFNEQFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	6	9	4	24	36	52	45	56	TCRBV09,TCRBV21													CASSVSSGTDFNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCTACTAGCGGGAGGTGAAAGAAACGTGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	6	9.366950277105613E-5		59	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	3	1	1	4	12	22	33	49	37	61		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGRGACWCRGCWYTGTATYTCTGYGCCAGCAGCCCTCAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPQNTGELFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	unresolved						TCRBJ02	TCRBJ02-02	01	4	4	6	1	3	0	23	35	-1	38	40	TCRBV09,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCTGGACGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSWTGNQPQHF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	8	3	4	4	0	23	35	-1	39	44	TCRBV02,TCRBV09													CASSWTGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGWACCCWSKSASWCAKCTGTGTAYTTYTGTGCCATCAGTGAGCCCGGGACAGGGAGCAATGAGCAGTTCTTCGGGCCA	CAISEPGTGSNEQFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	6	4	2	28	42	55	46	57	TCRBV06,TCRBV12													CAISEPGTGSNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTCTGCGCCAGCAGTGAGTCGTTAGTGGCAGGGAGACCCTTTTGGAGGGAAAAGAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSESLVAGRPFWREKSSGANVLTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	78	TCRBV10			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	0	10	0	0	23	7	3	20	49	43	56		TCRBV10-01,TCRBV10-02												CASSESLVAGRPFWREKSSGANVLTF+TCRBV10-X+TCRBJ02-06	TCRBV10	TCRBD02-01*02	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAAGAGGTCTAGCGGGAGGTGATACGCAGTATTTTGGCCCA	CASSVRGLAGGDTQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	4	1	6	10	1	26	37	58	47	59		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVRGLAGGDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGACAAGACGGGAATAATGAAAAACTGTTTTTTGGCAGT	CASRQDGNNEKLFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	8	3	4	0	1	26	-1	48	43	49		TCRBV03-01,TCRBV03-02												CASRQDGNNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGGCTTCCGGGGAGCAGTACTTCGGGCCG	CASSQDRASGEQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	42	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	8	0	7	2	7	26	43	49	45	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRASGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATCGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQSPNTGELFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	42	TCRBV03						TCRBJ02	TCRBJ02-02	01	2	10	0	0	2	0	26	41	-1	43	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSPNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCTAACCGGGACTGAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	7	1.0928108656623214E-4		40	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	9	0	10	0	6	3	26	31	43	37	46		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCGGAATCAGTCCCAGCATTTTGGTGAT	CSARDRNQSQHF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	36	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	1	8	11	2	6	26	40	45	42	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDRNQSQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAACTGATGGGGGAAAATCAGCCCCAGCATTTTGGTGAT	CSARDQLMGENQPQHF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	48	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	6	1	4	9	2	26	40	54	49	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDQLMGENQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAGGGGGGTAAGCAATCAGCCCCAGCATTTTGGTGAT	CSARRGVSNQPQHF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	42	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	5	1	1	1	3	26	37	44	38	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRGVSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGACTAGCCATAATCAGCCCCAGCATTTTGGTGAT	CSAQTSHNQPQHF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	2	7	4	2	3	26	35	44	37	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSAQTSHNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCGTCTAGAGACTGAGCAGTTCTTTGGGCCA	CSAPRLETEQFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02			5	2	10	22	11	12	26	35	50	46	62		TCRBV20-01,TCRBV20-or09_02				01,02		TCRBJ02-01,TCRBJ02-05						CSAPRLETEQFF+TCRBV20-X+TCRBJ02-X	TCRBV20	TCRBD02-01	TCRBJ02	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTGATAGAGGACAGAACCACTGAAGCTTTCTTTGGACAA	CSALIEDRTTEAFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	4	8	3	26	35	49	43	52		TCRBV20-01,TCRBV20-or09_02												CSALIEDRTTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGAGGAGCGGCAGCCCCAGCATTTTGGTGAT	CATSEEERQPQHF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	6	5	7	5	0	24	38	-1	43	48		TCRBV24-01,TCRBV24-or09_02				01,02								CATSEEERQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCAGCAGGGACAGACTCTACTAACTATGGCTACACCTTCGGTTCG	CASSSAGTDSTNYGYTF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	0	6	6	24	36	49	42	55		TCRBV24-01,TCRBV24-or09_02												CASSSAGTDSTNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCATTAGGACTAGCGGGAGTGCGGGCTCAACCGGGGAGCTGTTTTTTGGAGAA	CAIRTSGSAGSTGELFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	51				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	10	1	2	5	3	10	30	37	53	40	63	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CAIRTSGSAGSTGELFF+X+TCRBJ02-02		TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGCCCCACAACTTCCTTAGCTAACTATGGCTACACCTTCGGTTCG	CASSQEGPTTSLANYGYTF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	57	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	3	6	0	7	10	24	41	51	48	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGPTTSLANYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCGCAACCCCGGACAGACCCTCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	7	1.0928108656623214E-4		46				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	1	5	4	9	6	18	27	42	36	48	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												X+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCGGTGGGCAAGCGCGGAATGAGCAGTTCTTCGGGCCA	CASSGGQARNEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	6	8	0	7	4	8	26	37	45	41	53		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGGQARNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSYNEQFF	In	VJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	33	TCRBV12						TCRBJ02	TCRBJ02-01	01	5	0	0	1	0	0	26	-1	-1	-1	38		TCRBV12-03,TCRBV12-04												CASSSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGTCGTAGCGGGACCACAGATACGCAGTATTTTGGCCCA	CASSRSGTTDTQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	3	2	2	1	24	36	46	38	47	TCRBV06,TCRBV10													CASSRSGTTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTCGACAGACCCTATGGCTACACCTTCGGTTCG	CASSQFDRPYGYTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	5	4	3	3	26	41	49	44	52		TCRBV03-01,TCRBV03-02												CASSQFDRPYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGTTCAGGACAGGTCTACGAGCAGTACTTCGGGCCG	CASSQGSGQVYEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	4	3	7	1	26	40	54	47	55		TCRBV03-01,TCRBV03-02												CASSQGSGQVYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCGGGGGGTGAGGGAGGCTACACCTTCGGTTCG	CASSPPGGEGGYTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	1	8	3	7	26	39	49	42	56		TCRBV03-01,TCRBV03-02												CASSPPGGEGGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCGTTCGACGGATCCTGGAAACACCATATATTTTGGAGAG	CASSPRSTDPGNTIYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	48	TCRBV03						TCRBJ01	TCRBJ01-03	01	4	1	8	2	10	2	26	39	52	49	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRSTDPGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCCTGCTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	8	1.2489267036140816E-4		41	TCRBV03						TCRBJ01	TCRBJ01-03	01	6	10	0	0	5	1	26	37	44	42	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGTTGACCCCCAGGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	8	1.2489267036140816E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	5	8	0	26	37	-1	45	50	TCRBV03,TCRBV12													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGGGCGGAAAAACTGTTTTTTGGCAGT	CSAREGAEKLFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	2	8	0	2	26	-1	45	40	47		TCRBV20-01,TCRBV20-or09_02												CSAREGAEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATGGAACCCGAGCAGTTCTTCGGGCCA	CSARDMEPEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	1	8	10	3	4	26	40	46	43	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDMEPEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAGGGACCCTAGCTCCTACGAGCAGTACTTCGGGCCG	CSARRDPSSYEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	0	7	0	2	5	26	37	44	39	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRDPSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCATTGAAGCGGACCCCACAGATACGCAGTATTTTGGCCCA	CSAPIEADPTDTQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	5	2	8	4	26	35	48	43	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPIEADPTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGCAGCCAGGGAACCTACGAGCAGTACTTCGGGCCG	CSGSQGTYEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	3	2	5	2	26	33	43	38	45		TCRBV20-01,TCRBV20-or09_02												CSGSQGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCGCCTGAGGTTGCCGGGACAACGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	8	1.2489267036140816E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	6	5	13	3	25	34	53	47	56	TCRBV24,TCRBV28													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCCCGGGACTAGCGAACACAGATACGCAGTATTTTGGCCCA	CASSPGLANTDTQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	6	2	3	2	22	33	46	36	48	TCRBV09,TCRBV12					01,02								CASSPGLANTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCGCCTTACAGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSALQGLNTEAFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	0	6	1	22	33	46	39	47		TCRBV12-03,TCRBV12-04												CASSALQGLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
SRGGGACTYRGCTGTGTAYYTCTGTGCCAGCAGGGACAGGGGGCTACCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	8	1.2489267036140816E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	0	5	0	4	22	-1	44	33	48	TCRBV07,TCRBV12													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGGCGACAGTAACTATGGCTACACCTTCGGTTCG	CASSGDSNYGYTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	5	1	3	0	22	34	-1	37	42	TCRBV09,TCRBV12													CASSGDSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCACCCAGGACAGGGAGGGCACTGAAGCTTTCTTTGGACAA	CATQDREGTEAFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	1	3	4	4	4	23	30	42	34	46	TCRBV24,TCRBV27													CATQDREGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCCTCAGGGGGCGCCGGGACTATGGCTACACCTTCGGTTCG	CASSLRGRRDYGYTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	0	3	3	6	23	34	45	37	51	TCRBV24,TCRBV27													CASSLRGRRDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCATGCGAGGGTTTGGTGAGCAGTTCTTCGGGCCA	CASMRGFGEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	36	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	11	0	9	6	5	24	31	42	37	47		TCRBV24-01,TCRBV24-or09_02												CASMRGFGEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCATGGCAGAGTAGGGGAGGTCGGGTTATATGAGCAGTTCTTCGGGCCA	CSARDHGRVGEVGLYEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	57	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	9	1	8	14	9	24	38	58	52	67		TCRBV20-01,TCRBV20-or09_02												CSARDHGRVGEVGLYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCWSKSASWCWKCTGTKTACTTCTGTGCCAGCAGAAGGACAGGGGCAGACTATGGCTACACCTTCGGTTCG	CASRRTGADYGYTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	3	2	3	26	37	48	39	51	TCRBV06,TCRBV12													CASRRTGADYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAAGACTCGGCCMTGTATCKCTGTGCCAGCAGGAGCAGGCAGGGTTATGGGGAGCTGTTTTTTGGAGAA	CASRSRQGYGELFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	3	8	7	4	21	32	44	39	48	TCRBV04,TCRBV07													CASRSRQGYGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCTAGGACAGGGGGCCGTCACACTGAAGCTTTCTTTGGACAA	CASSPRTGGRHTEAFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	0	3	4	4	18	30	45	34	49	TCRBV07,TCRBV11													CASSPRTGGRHTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGCGTCGGGGCGTAAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	8	1.2489267036140816E-4		47							TCRBJ02	TCRBJ02-03	01	0	7	0	3	3	4	18	35	43	38	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03			TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCCCGAGGACTAGCGGGAGAGAGACCCAGTACTTCGGGCCA	CASSPRTSGRETQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	1	2	4	4	0	18	30	-1	34	47	TCRBV05,TCRBV11													CASSPRTSGRETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTAGGGGGCAGTTCAAACTATGGCTACACCTTCGGTTCG	CASSLGGSSNYGYTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	7	0	2	0	6	18	-1	39	34	45	TCRBV07,TCRBV11													CASSLGGSSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTCAGCGACACAGGTGCGAGGGGCTACACCTTCGGTTCG	CASSFSDTGARGYTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	4	8	7	7	18	32	44	39	51	TCRBV07,TCRBV11													CASSFSDTGARGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCCGAGTAAGGACACCTACGAGCAGTACTTCGGGCCG	CASSPSKDTYEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	2	8	0	19	31	-1	39	44	TCRBV07,TCRBV11													CASSPSKDTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASGACTCRGCCMTGTATCKCTGTGCCAGCAGCTTGCTAGCGGACCACAATGAGCAGTTCTTCGGGCCA	CASSLLADHNEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	5	5	1	3	19	33	41	34	44	TCRBV05,TCRBV07					01,02								CASSLLADHNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCCCCGCCGGGGGGACTAGCAGAGAGACCCAGTACTTCGGGCCA	CASSPAGGTSRETQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	7	4	9	2	19	31	49	40	51	TCRBV07,TCRBV11					01,02								CASSPAGGTSRETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTGGAGGGCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLEGSSYEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	3	10	0	0	0	3	19	-1	39	33	42	TCRBV05,TCRBV11			TCRBD01,TCRBD02										CASSLEGSSYEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCGGACTAGCGGGAGGAGGTACGCAGTATTTTGGCCCA	CASSGLAGGGTQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	1	1	8	0	3	19	-1	45	31	48	TCRBV05,TCRBV07													CASSGLAGGGTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCTACCGGGACAGGGGACGAAAAACTGTTTTTTGGCAGT	CASSSTGTGDEKLFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	2	8	5	2	19	32	47	37	49		TCRBV05-06,TCRBV05-07												CASSSTGTGDEKLFF+TCRBV05-X+TCRBJ01-04	TCRBV05	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTCCGCGGGACTAGCGGGATACGGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	8	1.2489267036140816E-4		53	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	0	3	7	4	7	19	33	50	37	57		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
SGACTCGGCYSTSTATCTCTGTGCTAGCAGCTTAGGGGCCAGCCAAGAGACCCAGTACTTCGGGCCA	CASSLGASQETQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	5	2	1	0	4	19	-1	38	33	42	TCRBV05,TCRBV07													CASSLGASQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCMTGTATCTCTGTGCAAGTCGCAAAATAGGGGCCGGCGCAATCCACGAGCAGTACTTCGGGCCG	CASRKIGAGAIHEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	5	5	12	19	31	41	36	53	TCRBV11,TCRBV12													CASRKIGAGAIHEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYGGCYGTGTATSTCTGTGCTAGCAGCTTATCTAGCGGGAGCCAAGAGACCCAGTACTTCGGGCCA	CASSLSSGSQETQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	4	2	1	3	0	22	35	-1	38	48	TCRBV07,TCRBV11													CASSLSSGSQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCACCGGGACTAGCGGGAGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSAPGLAGAGANVLTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	0	2	2	5	0	24	36	-1	41	55	TCRBV09,TCRBV21													CASSAPGLAGAGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCCCTCCCAAACATCTGTGTACTTCTGTGCCAGCAGGGTAGGCCAGGGGTTAGGGGATACGCAGTATTTTGGCCCA	CASRVGQGLGDTQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	6	7	6	25	36	49	43	55		TCRBV06-02,TCRBV06-03												CASRVGQGLGDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TMSCTCCCARACATCTGTGTACTTCTGTGCCAGCAGTTCAGGGTGGAGGACCTACGAGCAGTACTTCGGGCCG	CASSSGWRTYEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	42	TCRBV06						TCRBJ02	TCRBJ02-07	01	4	4	3	2	0	7	25	-1	43	38	50		TCRBV06-02,TCRBV06-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGWRTYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGCTACTGAGAGAGACGGAGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	9	1.405042541565842E-4		53	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	5	7	1	2	17	26	37	43	39	60		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								X+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGAGAGGCGAGGAGACCCAGTACTTCGGGCCA	CASRRGEETQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	36	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	11	1	5	2	4	26	37	43	39	47		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRRGEETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCTACCAGGGACAGGGGCTCTACGAGCAGTACTTCGGGCCG	CASSYQGQGLYEQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	2	3	2	2	24	39	51	41	53		TCRBV06-05,TCRBV06-06												CASSYQGQGLYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAATTGGGAGTGGCTACACCTTCGGTTCG	CASSQIGSGYTF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	9	2	7	3	0	26	41	-1	44	49		TCRBV03-01,TCRBV03-02												CASSQIGSGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACGGCCCAATGAGCAGTTCTTCGGGCCA	CASSQGRPNEQFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	39	TCRBV03						TCRBJ02	TCRBJ02-01	01	1	2	7	6	0	4	26	-1	45	42	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGRPNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACCGGACAGTGAAGCTTTCTTTGGACAA	CASSPPDSEAFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	7	4	0	26	39	-1	43	49		TCRBV03-01,TCRBV03-02												CASSPPDSEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGGGGGGGATTGAAGCTTTCTTTGGACAA	CASSLGGIEAFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	36	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	9	0	7	1	2	26	39	47	40	49		TCRBV03-01,TCRBV03-02												CASSLGGIEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAAGGGTGCAGGGTGGAGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLRVQGGAGANVLTF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	3	2	9	5	26	38	52	47	57		TCRBV03-01,TCRBV03-02												CASSLRVQGGAGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAAAAGGGTGTCAGCCCACTTTCTGAAGCTTTCTTTGGACAA	CSAKKGVSPLSEAFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	5	3	6	5	14	26	34	43	39	57		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKKGVSPLSEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGACCATTAAAGGGCCATATCAGCCCCAACATTTTGGTGAT	CSAPTIKGPYQPQHF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	6	5	3	16	12	15	26	34	50	46	65		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPTIKGPYQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGACCACAGGGGTTGGGCCAGATACGCAGTATTTTGGCCCA	CSATTGVGPDTQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	2	4	4	6	26	34	45	38	51		TCRBV20-01,TCRBV20-or09_02												CSATTGVGPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCTAGCGGGAGTAGTAGAGCAGTTCTTCGGGCCA	CSARALAGVVEQFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	4	2	10	2	5	26	39	51	41	56		TCRBV20-01,TCRBV20-or09_02												CSARALAGVVEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCCGTCCGAGCTAAGGGCTTCGGGCCG		Out	VDJ	1	9	1.405042541565842E-4		34	TCRBV20						TCRBJ02	TCRBJ02-07	01	1	5	3	15	13	0	26	39	-1	52	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCCGGGACAGGGGACACTGAAGCTTTCTTTGGACAA	CSARAGTGDTEAFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	2	3	4	0	26	37	-1	41	51		TCRBV20-01,TCRBV20-or09_02												CSARAGTGDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGTGGTGGCGGGAGAGGATGAGCAGTTCTTCGGGCCA	CSARVVAGEDEQFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	8	7	3	26	37	51	44	54		TCRBV20-01,TCRBV20-or09_02												CSARVVAGEDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGAGGGGGGGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	9	1.405042541565842E-4		41	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	1	4	2	26	35	46	39	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTTGGGATAAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSALGIRNTGELFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV20						TCRBJ02	TCRBJ02-02	01	5	0	8	1	3	4	26	35	42	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALGIRNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCACCCGGGACTAGTAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	9	1.405042541565842E-4		43	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	8	3	6	2	26	35	49	41	51		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGGGACGTATGGCTACACCTTCGGTTCG	CATSEGTYGYTF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	36	TCRBV24						TCRBJ01	TCRBJ01-02	01	4	0	7	5	1	1	24	38	44	39	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSEGTYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGATAGCGGGATCGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSGIAGSNTGELFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	5	3	0	3	1	24	37	48	40	49		TCRBV24-01,TCRBV24-or09_02												CATSGIAGSNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGGGGGTGATCTGGAAACACCATATATTTTGGAGAG	CATRG*SGNTIYF	Stop	VDJ	1	9	1.405042541565842E-4		39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	9	8	2	1	0	3	24	-1	39	33	42		TCRBV24-01,TCRBV24-or09_02												CATRG*SGNTIYF+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD02-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTATAGCGGGAGGAGCAGTAGAGACCCAGTACTTCGGGCCA	CASSFIAGGAVETQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	5	1	4	4	6	24	36	50	40	56		TCRBV24-01,TCRBV24-or09_02												CASSFIAGGAVETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCGACTAGCGGGAAACCAGGAGACCCAGTACTTCGGGCCA	CASRLAGNQETQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	11	2	3	5	3	6	24	31	45	34	51		TCRBV24-01,TCRBV24-or09_02												CASRLAGNQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACAAGCTACAACCCGTGGCTACGAGCAGTACTTCGGGCCG	CASSEQATTRGYEQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	48	TCRBV06						TCRBJ02	TCRBJ02-07	01	2	3	6	3	6	8	23	38	47	44	55		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEQATTRGYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACGGCCGCGCGGGTAGTAAGAAGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	9	1.405042541565842E-4		58	TCRBV06			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	7	4	0	7	10	23	38	50	45	60		TCRBV06-01,TCRBV06-08				01,02								X+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCATGACGGGGTAGGAGAGGTCGGGTTATATGAGCAGTTCTTCGGGCCA	CSARDHDGVGEVGLYEQFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	57	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	3	8	6	18	24	38	49	44	67		TCRBV20-01,TCRBV20-or09_02												CSARDHDGVGEVGLYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACAGGGGGGACTATGGCTACACCTTCGGTTCG	CASSQDRGDYGYTF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	1	3	0	1	18	-1	42	35	43	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDRGDYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCAAGGCATCACAGGGGACTATGGCTACACCTTCGGTTCG	CASSQGITGDYGYTF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	2	3	9	0	19	31	-1	40	47		TCRBV05-06,TCRBV05-07												CASSQGITGDYGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTCATCCGGGATCTAGATACGCAGTATTTTGGCCCA	CASSFIRDLDTQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	8	3	5	4	3	19	33	42	37	45		TCRBV05-06,TCRBV05-07												CASSFIRDLDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCAGAGCGGGAGACAGGGAACAGATACACAATATTTTGGCCCA		Out	VDJ	1	10	1.5611583795176022E-4		47	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	2	15	3	19	26	37	48	40	67		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCGACAGGGGTACAGCGAGCAGTACTTCGGGCCG	CASSQGRQGYSEQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	2	6	3	5	26	42	53	45	58		TCRBV03-01,TCRBV03-02												CASSQGRQGYSEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCAAGTGGCGGCCGAGCAGTACTTCGGGCCG	CASSQVAAEQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	7	5	6	2	1	26	42	48	44	49	TCRBV03,TCRBV12					01,02								CASSQVAAEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCGCTGCATCCATTTACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	10	1.5611583795176022E-4		55	TCRBV03						TCRBJ02	TCRBJ02-06	01	5	3	6	5	15	5	26	38	56	53	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-06	TCRBV03		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGKGACTCWGCYRTGTATYKCTGTGCCAGCAGCTTAAAGGGGGACACTCAGCGCTATGGCTACACCTTCGGTTCG	CASSLKGDTQRYGYTF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	6	4	7	7	26	38	51	45	58	TCRBV03,TCRBV07													CASSLKGDTQRYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTATTCTCCGAGGGGGCGAGCACAGATACGCAGTATTTTGGCCCA	CASSLFSEGASTDTQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	0	0	10	1	26	38	55	48	56	TCRBV03,TCRBV11													CASSLFSEGASTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGGGGACTCRGCCMTGTATCKCTGTGCCAGCAGCCCTGGACTAGCGGGAGCCTACGAGCAGTACTTCGGGCCG	CASSPGLAGAYEQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	1	2	2	5	0	22	32	-1	37	50	TCRBV05,TCRBV07													CASSPGLAGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGGCCGTGCTCGGGACTAGCGTCCCGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	10	1.5611583795176022E-4		53	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	6	5	13	7	26	34	57	47	64		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCTCACCCGGACAGAGAGAACACTGAAGCTTTCTTTGGACAA	CSASHPDRENTEAFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	1	9	3	26	34	49	43	52		TCRBV20-01,TCRBV20-or09_02												CSASHPDRENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATGAACAGGGGGAGACCCAGTACTTCGGGCCA	CSANEQGETQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	2	5	4	0	26	36	-1	40	47		TCRBV20-01,TCRBV20-or09_02												CSANEQGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGACGGGGACAATGAACACTGAAGCTTTCTTTGGACAA	CSARATGTMNTEAFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	6	0	5	1	26	39	50	44	51		TCRBV20-01,TCRBV20-or09_02												CSARATGTMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCTCGGGGGCTCTAACATTGAAGCTTTCTTTGGACAA	CSASLGGSNIEAFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	6	0	7	4	8	26	37	47	41	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASLGGSNIEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGATAGCGGGAGTGACATTCAGTATTTCGGCGCC	CSASDSGSDIQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	3	5	2	19	3	13	26	37	49	40	62		TCRBV20-01,TCRBV20-or09_02												CSASDSGSDIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTTAGTCAGGGGCGTTTGGGGTATCAGCCCCAGCATTTTGGTGAT	CSASFSQGRLGYQPQHF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	5	7	10	26	37	50	44	60		TCRBV20-01,TCRBV20-or09_02												CSASFSQGRLGYQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCGGGACTAGCGGCTACAATGAGCAGTTCTTCGGGCCA	CSAAGTSGYNEQFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	3	3	0	26	35	-1	38	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAAGTSGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCTACTTGGGGTTCGGAAGAGACCCAGTACTTCGGGCCA	CSAATWGSEETQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	6	2	3	7	5	26	35	46	42	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAATWGSEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCGCCAGGACAGGGAACACAGATACGCAGTATTTTGGCCCA	CASARTGNTDTQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	1	3	2	4	2	22	31	43	35	45		TCRBV12-03,TCRBV12-04												CASARTGNTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCTAGCCAGGGACTAGCGGGAGCCCCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASQGLAGAPGTGELFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	51	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	0	2	4	2	7	22	31	47	33	54		TCRBV12-03,TCRBV12-04												CASQGLAGAPGTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTGGTTATTCAGGGTGATTAGCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	10	1.5611583795176022E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	3	4	7	8	23	37	49	44	57	TCRBV24,TCRBV27													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTATCGAATAACGAGACAGAACACTGAAGCTTTCTTTGGACAA	CASSYRITRQNTEAFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	6	1	13	0	24	36	-1	49	53	TCRBV24,TCRBV27													CASSYRITRQNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAAGAGCGGGGTGAAAGCTACGAGCAGTACTTCGGGCCG	CASSQERGESYEQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	7	3	3	0	6	18	-1	41	35	47	TCRBV04,TCRBV07,TCRBV11													CASSQERGESYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGCCGAACCTCCGGGACTAGCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRRTSGTSGNTGELFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	57	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	5	1	12	0	18	30	-1	42	53	TCRBV07,TCRBV11					01,02								CASSRRTSGTSGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGAAGGGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CASSLEGTGNEKLFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	3	5	1	0	18	35	-1	36	45	TCRBV05,TCRBV11													CASSLEGTGNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTGGACTAGCGGGGGATTTATGCAGTTCTTCGGGCCA		Out	VDJ	1	10	1.5611583795176022E-4		44	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	1	2	12	1	6	18	32	46	33	52	TCRBV05,TCRBV11													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCCAGGTCCTGGGGGGGACAGGGGGTCTCTATGGCTACACCTTCGGTTCG	CASQVLGGTGGLYGYTF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	1	4	12	3	18	27	50	39	53	TCRBV05,TCRBV11													CASQVLGGTGGLYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTAGGAGGGACCCAGGATACGCAGTATTTTGGCCCA	CASSLGGTQDTQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	2	10	0	6	1	6	19	33	40	34	46	TCRBV05,TCRBV07			TCRBD01,TCRBD02										CASSLGGTQDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGCTAGCGGGATTAAGACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	1.5611583795176022E-4		52	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	3	2	3	6	19	33	45	36	51	TCRBV05,TCRBV11													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTAGAGGCCAGGGGGCATGAGCAGTTCTTCGGGCCA	CASSLEARGHEQFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	0	8	3	0	19	36	-1	39	47	TCRBV05,TCRBV11													CASSLEARGHEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTCCAGGGACTAGCGGGGGAGACCCAGTACTTCGGGCCA	CASSFQGLAGETQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	0	3	5	3	0	22	36	-1	39	52	TCRBV07,TCRBV11													CASSFQGLAGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTATCTAGCGGGCTCTCCTACGAGCAGTACTTCGGGCCG	CASSLSSGLSYEQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	4	0	3	2	22	35	46	38	48	TCRBV07,TCRBV11					01,02								CASSLSSGLSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTYRGCTKTGTATYTCTGTGCCAGCAGCTTTGGGCGGGGGCACGAGCAGTACTTCGGGCCG	CASSFGRGHEQYF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	7	2	5	4	1	22	35	46	39	47	TCRBV07,TCRBV09													CASSFGRGHEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAAAGGGACGGCCGTCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASKGTAVPNTGELFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	48	unresolved						TCRBJ02	TCRBJ02-02	01	7	0	7	0	2	8	23	33	40	35	48	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKGTAVPNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGAGGAGGGGGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASRRRGTGNTEAFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	4	1	7	0	26	37	-1	44	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRRRGTGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGAGCGGGAGAGGAGAAATGAGCAGTTCTTCGGGCCA	CASRERERRNEQFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	6	2	7	2	6	26	37	47	39	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRERERRNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCACGACAGACCCTAGGCGCAGATACGCAGTATTTTGGCCCA	CASSPRQTLGADTQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	5	4	4	10	26	38	47	42	57		TCRBV12-03,TCRBV12-04												CASSPRQTLGADTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACAGGGGTACGAGCAGTACTTCGGGCCG	CASSLQGYEQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	4	0	0	26	-1	-1	41	47		TCRBV12-03,TCRBV12-04												CASSLQGYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGAGGGTGGCAGGTGAAGCTTTCTTTGGACAA	CASSQRVAGEAFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	11	0	7	0	7	23	-1	42	37	49	TCRBV01,TCRBV04													CASSQRVAGEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCCACTAGCGGGATCGCACAGATACGCAGTATTTTGGCCCA	CASSH*RDRTDTQYF	Stop	VDJ	1	11	1.7172742174693622E-4		45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	3	3	1	2	2	24	35	47	37	49	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSH*RDRTDTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGTGGGACAGGGGAGCTTTCTTTGGACAA	CASSQEWDRGAFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	2	10	2	0	26	43	-1	45	55		TCRBV03-01,TCRBV03-02												CASSQEWDRGAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGGGACTAGCGGGAGGGCCGGTAACATTCAGTACTTCGGCGCC	CASSQGGTSGRAGNIQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	54	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	0	0	7	2	5	26	42	60	44	65		TCRBV03-01,TCRBV03-02												CASSQGGTSGRAGNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01*02	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCTCTTAGGGACGCTCTTACTATGGCTACACCTTCGGTTCG	CSS*GRSYYGYTF	Stop	VDJ	1	11	1.7172742174693622E-4		39	TCRBV20						TCRBJ01	TCRBJ01-02	01	9	0	7	3	6	6	26	31	42	37	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSS*GRSYYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACAGGGACCTATGGCTACACCTTCGGTTCG	CSARTGTYGYTF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	3	4	0	2	26	-1	44	38	46		TCRBV20-01,TCRBV20-or09_02												CSARTGTYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCGTCCCCGGGACAGGGGGCCACTGAAGCTTTCTTTGGACAA	CSASPSPGQGATEAFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	0	4	9	0	26	37	-1	46	58		TCRBV20-01,TCRBV20-or09_02												CSASPSPGQGATEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGACAGGGGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSASRQGSNTGELFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	2	2	0	2	1	26	37	47	39	48		TCRBV20-01,TCRBV20-or09_02												CSASRQGSNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGGACAGGGCAACGAGCAGTACTTCGGGCCG	CSAPGQGNEQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	5	2	2	26	35	46	37	48		TCRBV20-01,TCRBV20-or09_02												CSAPGQGNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAACTAGGGGGCGAAACTGAAGCTTTCTTTGGACAA	CASSELGGETEAFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	0	5	5	3	22	34	46	39	49		TCRBV12-03,TCRBV12-04												CASSELGGETEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAAGGGGCGGGCTGATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	11	1.7172742174693622E-4		40	TCRBV24						TCRBJ02	TCRBJ02-07	01	8	5	2	3	0	9	24	-1	39	34	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAATGATCGTCGGACCCAATCGAACTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	11	1.7172742174693622E-4		52	TCRBV24						TCRBJ01	TCRBJ01-02	01	3	1	7	0	4	9	24	39	47	43	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCGCCACACAGAGAATAACTATGGCTACACCTTCGGTTCG	CASSRHTENNYGYTF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	5	1	7	4	24	35	46	42	50		TCRBV24-01,TCRBV24-or09_02												CASSRHTENNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTGGCCGGAATGCAAACCTACAATGAGCAGTTCTTCGGGCCA	CASSLAGMQTYNEQFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	48							TCRBJ02	TCRBJ02-01	01	0	1	8	2	2	7	18	34	39	36	46	TCRBV05,TCRBV07	TCRBV05-08,TCRBV07-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGMQTYNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTACCAGCAGCTTAGCGGGAGACGCAGATACGCAGTATTTTGGCCCA	CTSSLAGDADTQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	9	2	4	0	3	18	-1	40	35	43	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CTSSLAGDADTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGATACGAGACAGGGAGGCTACAATGAGCAGTTCTTCGGGCCA	CASSDTRQGGYNEQFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	3	3	5	3	24	38	50	43	53	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03												CASSDTRQGGYNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGGGCCGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSQRAGSSYEQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	2	0	5	0	26	41	-1	46	52		TCRBV03-01,TCRBV03-02												CASSQRAGSSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGTCCGGGAGGGGAAATGAAAAACTGTTTTTTGGCAGT	CASSQGSGRGNEKLFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	1	8	0	5	4	2	26	42	54	46	56		TCRBV03-01,TCRBV03-02												CASSQGSGRGNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGACTAGCGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSRTSGGTDTQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	1	1	3	0	0	26	-1	-1	39	53		TCRBV03-01,TCRBV03-02												CASSRTSGGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAACTAGCAGCTTCGGGTTAGGGGGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	1.8733900554211225E-4		50	TCRBV20						TCRBJ02	TCRBJ02-07	01	2	5	1	6	19	0	26	38	-1	57	63		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCARTAGGATACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	1.8733900554211225E-4		34	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	1	8	5	6	1	26	35	44	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTGAAGGGAGCGGCGGGGGAGCAGTACTTCGGGCCG	CSVKGAAGEQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	7	3	7	11	0	26	33	-1	44	50		TCRBV20-01,TCRBV20-or09_02												CSVKGAAGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCCCGACGGGCCCTATGGCTACACCTTCGGTTCG	CASSPDGPYGYTF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	39	TCRBV12						TCRBJ01	TCRBJ01-02	01	6	8	0	4	7	1	22	33	44	40	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPDGPYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
SRGGGACTCAGCTGTGTAYYTCTGTGCCAGCAGCGTAGCGATGAGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSVAMRANTEAFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	5	6	1	2	8	22	33	40	35	48	TCRBV07,TCRBV12					unresolved								CASSVAMRANTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATTCTCGGGACTTTCGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLFSGLSSNQPQHF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	0	10	1	4	4	23	39	49	43	53	TCRBV24,TCRBV27					01,02								CASSLFSGLSSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTCATTTCGCCGGGACTAGCGGGAGTCGAGCAGTTCTTCGGGCCA	CASSFISPGLAGVEQFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	0	2	10	9	2	23	37	60	46	62	TCRBV24,TCRBV27													CASSFISPGLAGVEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCAGCGGGGGGCAGGGAGCGGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	12	1.8733900554211225E-4		43	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	9	6	1	5	1	10	24	33	43	34	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCAAAAGCCGGGACAGGCAAGAGACCCAGTACTTCGGGCCA	CASSKSRDRQETQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	4	2	7	0	18	30	-1	37	45	TCRBV03,TCRBV11													CASSKSRDRQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATAGCAGTCAAGAGACCCAGTACTTCGGGCCA	CASSQDSSQETQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	5	7	2	0	3	18	-1	39	35	42	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDSSQETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGCGACTAGTGATTTGAATGAGCAGTTCTTCGGGCCA	CASSLATSDLNEQFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	8	7	3	7	18	32	41	35	48	TCRBV07,TCRBV11					01,02								CASSLATSDLNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCGACTACGGTGGGGCAGGGCGGGGGAGCAGTACTTCGGGCCG	CASSRLRWGRAGEQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	3	7	18	0	19	31	-1	49	55	TCRBV07,TCRBV11													CASSRLRWGRAGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCCCACCAGGGATACTGGATACGCAGTATTTTGGCCCA	CASSPPGILDTQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	6	4	6	19	31	40	35	46	TCRBV07,TCRBV11													CASSPPGILDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTATCCGCGGGAGGGCCACAGGATGAGCAGTTCTTCGGGCCA	CASSLSAGGPQDEQFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	7	0	8	4	7	19	33	46	37	53	TCRBV05,TCRBV11													CASSLSAGGPQDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCAGCCTGGGGACAGGGGGTACCGCGGATGGCTACACTTTCGGTTCG	CASSLGTGGTADGYTF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	1	17	0	19	19	-1	45	35	64	TCRBV05,TCRBV07													CASSLGTGGTADGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCKGCCSTGTATCTCTGTGCCAGCAGCGGTAGCGGGAGGGTTGATACGCAGTATTTTGGCCCA	CASSGSGRVDTQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	0	6	2	2	19	31	44	33	46	TCRBV05,TCRBV11													CASSGSGRVDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCCCGGGGACTAGCGGGGAAAATGAGCAGTTCTTCGGGCCA	CASSPGTSGENEQFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	7	3	2	22	34	50	37	52	TCRBV07,TCRBV11													CASSPGTSGENEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGATCGGACAGGGCAAGAAACCCAGTACTTCGGGCCA	CASSDRTGQETQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	3	8	5	6	23	34	47	39	53	TCRBV02,TCRBV09													CASSDRTGQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCTCGCCCCCCGGGGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPPGGSNQPQHF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	8	2	1	8	1	23	32	46	40	47	TCRBV09,TCRBV21													CASSPPGGSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTGTACTTCTGTGCCAGCAGTGTCGGGGACGGCGAGACTTCTAGCGGGATTGGCAGGAAGACCCAGTACTTCGGGCCA	CASSVGDGETSSGIGRKTQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	63	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	4	3	6	18	9	10	23	50	41	59		TCRBV06-01,TCRBV06-04												CASSVGDGETSSGIGRKTQYF+TCRBV06-X+TCRBJ02-05	TCRBV06	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAATGGGGGTGGAAACACCATATATTTTGGAGAG	CASNGGGNTIYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	36	TCRBV03						TCRBJ01	TCRBJ01-03	01	7	6	1	3	2	0	26	36	-1	38	43		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNGGGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTACTAGCGGGAGGAGATGCAGATACGCAGTATTTTGGCCCA	CASSLLAGGDADTQYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	3	1	4	1	5	26	39	52	40	57		TCRBV03-01,TCRBV03-02												CASSLLAGGDADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAATAGCGGGATTGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	2.0295058933728828E-4		38	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	5	3	6	2	3	26	38	48	40	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAACGACAGGACCCCTATGGCTACACCTTCGGTTCG	CSAQRQDPYGYTF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	4	4	4	4	26	35	45	39	49		TCRBV20-01,TCRBV20-or09_02												CSAQRQDPYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTGGGACTAGTGGGAAATGAGCAGTTCTTCGGGCCA	CSALGLVGNEQFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	8	7	2	5	26	35	45	37	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSALGLVGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCWSKSASWCWKCTGTKTACTTCTGTGCCAGCAGTTCAAGCTAGCGGGAGGGCTACGAGCAGTACTTCGGGCCG	CASSSS*REGYEQYF	Stop	VDJ	1	13	2.0295058933728828E-4		45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	4	0	3	4	0	22	35	-1	39	51	TCRBV06,TCRBV12													CASSSS*REGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGAAGAGGGACCGGGAGCGGGTTCACAGATACGCAGTATTTTGGCCCA	CATSGRGTGSGFTDTQYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	54	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	4	2	14	2	24	37	57	51	59		TCRBV24-01,TCRBV24-or09_02				01,02								CATSGRGTGSGFTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGACTAGCGGGAGTGAAGGCGGGGAGCTGTTTTTTGGAGAA	CASSLTSGSEGGELFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	2	2	7	2	6	24	36	50	38	56		TCRBV24-01,TCRBV24-or09_02												CASSLTSGSEGGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTTACCTGCAGGGGGCTGGAACGGTTGACAGTCAGCCCCAGCATTTTGGTGAT	CASSYLQGAGTVDSQPQHF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	57	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	0	6	6	15	24	36	50	42	65		TCRBV06-04,TCRBV06-05,TCRBV06-06												CASSYLQGAGTVDSQPQHF+TCRBV06-X+TCRBJ01-05	TCRBV06	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCCTCCTGGACAAGCGACAATGAGCAGTTCTTCGGGCCA	CASSPSWTSDNEQFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	6	5	7	4	19	31	43	38	47		TCRBV05-06,TCRBV05-07												CASSPSWTSDNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCGGAACGGGATTTTCGGAGGAGACCCAGTACTTCGGGCCA	CASSGTGFSEETQYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	45	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	8	3	5	4	9	19	31	40	35	49		TCRBV05-06,TCRBV05-07												CASSGTGFSEETQYF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCCCCGGGTGGGAATGAGCAGTTCTTCGGGCCA	CASSDSPGGNEQFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	8	4	7	5	4	24	38	47	43	51	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-04,TCRBV06-05,TCRBV06-06,TCRBV10-03				01,02								CASSDSPGGNEQFF+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCCCAGCGGTAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	2.1856217313246428E-4		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	6	5	2	5	3	26	43	53	48	56		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGTCAGCAGCCTACAGGGGCCACCACGAGAGACCCAGTACTTCGGGCCA	CVSSLQGPPRETQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	2	4	1	8	26	39	47	40	55		TCRBV03-01,TCRBV03-02												CVSSLQGPPRETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACGACGACAGGGGGCTTCCAAGAGATCCAGTACTTCGGGCCA	CSATTTGGFQEIQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	0	10	6	11	26	34	50	40	61		TCRBV20-01,TCRBV20-or09_02												CSATTTGGFQEIQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTTTACAAAGACAGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	2.1856217313246428E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	4	2	9	0	26	34	-1	43	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAACAAACCCAAGCCTACAATGAGCAGTTCTTCGGGCCA	CSAKQTQAYNEQFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	6	2	1	8	26	36	40	37	48		TCRBV20-01,TCRBV20-or09_02												CSAKQTQAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGAGGGCCTACGAGCAGTACTTCGGGCCG	CSARDRRAYEQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	0	2	2	0	26	40	-1	42	48		TCRBV20-01,TCRBV20-or09_02												CSARDRRAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCAGGGGTTTATGGCTACACCTTCGGTTCG	CSASSGVYGYTF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	2	5	2	2	26	37	45	39	47		TCRBV20-01,TCRBV20-or09_02												CSASSGVYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGGCGGAAAGGGCTACACCGGGGAGCTGTTTTTTGGAGAA	CSAGGGKGYTGELFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	6	0	3	0	10	26	-1	41	35	51		TCRBV20-01,TCRBV20-or09_02												CSAGGGKGYTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGTAAGGGACTAGCGGCCTACGAGCAGTACTTCGGGCCG	CSGKGLAAYEQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	5	2	4	0	26	33	-1	37	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSGKGLAAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACGGCTAGCGGGAAAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	14	2.1856217313246428E-4		38	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	4	3	5	3	2	22	32	44	35	46		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGACAGATACGAGGGGAGACCCAGTACTTCGGGCCA	CASSLGQIRGETQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	5	5	3	9	24	36	45	39	54		TCRBV24-01,TCRBV24-or09_02												CASSLGQIRGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCAGATTAGCGGGAGGGCCGGGGATGAGCAGTTCTTCGGGCCA	CASSQISGRAGDEQFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	5	0	8	5	6	19	31	47	36	53	TCRBV07,TCRBV11													CASSQISGRAGDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCTTGGCGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSLAGANTEAFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	0	6	0	1	1	0	18	34	-1	35	41	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGANTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCTCCCATGGACAACAGGGGTACGAAGTACTTCGGGCCA		Out	VDJ	1	14	2.1856217313246428E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	2	12	10	5	18	31	48	41	53	TCRBV05,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGCTTAAATCCGGGACGGAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLNPGRNSGANVLTF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	54	unresolved						TCRBJ02	TCRBJ02-06	01	2	0	7	0	5	4	19	34	44	39	48	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNPGRNSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCGAACTTACTAGCGGGAGGGCCGAGCAGTACTTCGGGCCG	CASSELTSGRAEQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	45	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	3	0	6	6	1	19	31	50	37	51		TCRBV05-06,TCRBV05-07												CASSELTSGRAEQYF+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTCAGCCAGGGGAGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	2.1856217313246428E-4		47	unresolved						TCRBJ02	TCRBJ02-03	01	2	4	2	1	4	3	19	33	43	37	46	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTCCCTGCAGGGGGCGGGCAAGAGACCCAGTACTTCGGGCCA	CASSFPAGGGQETQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	0	2	5	3	19	33	46	38	49	TCRBV05,TCRBV11													CASSFPAGGGQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCCAAGGGGAAGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGEGSGANVLTF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	48	unresolved			unresolved			TCRBJ02	TCRBJ02-06	01	1	0	8	0	0	3	19	-1	39	35	42	TCRBV04,TCRBV05			TCRBD01,TCRBD02										CASSQGEGSGANVLTF+X+TCRBJ02-06	unresolved	unresolved	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGCAAGCCACGTTTGGTGGACTCGGCCGTGTATGKCTGTGCCAGCAGCTCATCCGGGACTAGCGACCACGAGCAGTACTTCGGGCCG	CASSSSGTSDHEQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	6	5	5	3	36	49	64	54	67	TCRBV07,TCRBV11					01,02								CASSSSGTSDHEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCGCCAGCGGGAGGACCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	14	2.1856217313246428E-4		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	6	1	1	3	3	22	34	46	37	49	TCRBV07,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCATCAGTGAGTCTGCGTGGGAGGGTGCAGATACGCAGTATTTTGGCCCA	CAISESAWEGADTQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	0	4	8	2	28	42	57	50	59	TCRBV06,TCRBV10													CAISESAWEGADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGCGGGTCAAGAGACCCAGTACTTCGGGCCA	CASSQAGQETQYF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	7	4	2	1	1	26	40	46	41	47		TCRBV03-01,TCRBV03-02				01,02								CASSQAGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCAGGGACAGGGGGGAAACACCATATATTTTGGAGAG	CASSQGQGGNTIYF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	2	4	0	0	26	-1	-1	40	50	TCRBV03,TCRBV12													CASSQGQGGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAGGGGCAGGGGAGATGGTACAATGAGCAGTTCTTCGGGCCA	CSARDEGQGRWYNEQFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	4	7	6	26	40	53	47	59		TCRBV20-01,TCRBV20-or09_02												CSARDEGQGRWYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAACCTCGGCGGAGTGACTATGGCTACACCTTCGGTTCG	CSAEPRRSDYGYTF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	7	5	3	8	4	26	35	47	43	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAEPRRSDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACGGGTCAGTTGAACACTGAAGCTTTCTTTGGACAA	CASTGQLNTEAFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	8	4	0	0	5	22	-1	36	32	41		TCRBV12-03,TCRBV12-04				01,02								CASTGQLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATTAGGCGGCGGGAGGGAAGACAATGAGCAGTTCTTCGGGCCA	CASSLLGGGREDNEQFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	7	0	5	6	3	23	39	54	45	57	TCRBV24,TCRBV27													CASSLLGGGREDNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCCGGTTCGGGCACAATGAGCAGTTCTTCGGGCCA	CATSDFRFGHNEQFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	45	TCRBV24						TCRBJ02	TCRBJ02-01	01	1	8	0	5	7	0	24	41	-1	48	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDFRFGHNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCCAGGGAAAGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	15	2.341737569276403E-4		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	4	3	4	3	3	24	36	44	39	47		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASGACTCGGCCMTGTATCTCTGTGCCAGCAGCAACCGGGACAGGGTCAATGAGCAGTTCTTCGGGCCA	CASSNRDRVNEQFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	6	4	1	19	31	44	35	45	TCRBV05,TCRBV11													CASSNRDRVNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAAACGGCATGAACACTGAAGCTTTCTTTGGACAA	CASSLNGMNTEAFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	42	TCRBV05						TCRBJ01	TCRBJ01-01	01	2	9	0	0	4	1	19	33	40	37	41		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNGMNTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCGAACAGGGTGGCAGGACACTGAAGCTTTCTTTGGACAA	CASRTGWQDTEAFF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	3	3	3	5	7	24	31	42	36	49	TCRBV06,TCRBV10													CASRTGWQDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCTTAGGGCAGCCCGGGGCTACACCTTCGGTTCG	CASSQDLRAARGYTF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	45	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	5	3	8	4	8	26	43	51	47	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLRAARGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATCAGACAGCCTAGCACAGATACGCAGTATTTTGGCCCA	CSAIRQPSTDTQYF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	5	0	5	3	26	34	44	39	47		TCRBV20-01,TCRBV20-or09_02												CSAIRQPSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCATTAGACACTGCGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	16	2.497853407228163E-4		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	2	6	4	6	6	26	39	49	45	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGTTGGCGGGAGGAACCAAGAGACCCAGTACTTCGGGCCA	CSASVGGRNQETQYF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	7	1	0	5	1	26	37	50	42	51		TCRBV20-01,TCRBV20-or09_02												CSASVGGRNQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTGGACGGGGAGGACTGAAGCTTTCTTTGGACAA	CSARWTGRTEAFF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	1	5	7	0	26	37	-1	44	50		TCRBV20-01,TCRBV20-or09_02												CSARWTGRTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACCGGACAGGGTGAGGGAGAGCAGYACTTCGGGCCG	CASTGQGEGEQXF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	3	7	2	7	22	32	42	34	49		TCRBV12-03,TCRBV12-04												CASTGQGEGEQXF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGATTTTAACGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	2.497853407228163E-4		37	TCRBV24						TCRBJ02	TCRBJ02-07	01	4	2	8	6	0	8	24	-1	40	38	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCCGGACAGGGACGGGAGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	16	2.497853407228163E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	1	3	6	4	7	24	35	47	39	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCAACAGGGGGCGGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	16	2.497853407228163E-4		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	0	7	2	3	24	36	47	38	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCCTGATAGCGGGAGGGCAGTATACGCAGTATTTTGGCCCA	CASSLIAGGQYTQYF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	0	7	4	4	18	30	45	34	49	TCRBV11,TCRBV23													CASSLIAGGQYTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCGACAGGGGGCGAGCTATGGCTACACCTTCGGTTCG	CASSRQGASYGYTF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	0	4	1	3	19	31	42	32	45		TCRBV05-06,TCRBV05-07												CASSRQGASYGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCAAGAACCCTAGCGTATGAGCAGTTCTTCGGGCCA	CASSPRTLAYEQFF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	6	8	10	1	26	37	53	47	54		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSPRTLAYEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGTGGAGCAAGCAGGGACACAGATACGCAGTATTTTGGCCCA	CASGASRDTDTQYF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	4	3	2	10	1	24	31	46	41	47	TCRBV06,TCRBV10													CASGASRDTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCAGGCACCTAGGCACTACGAGCAGTACTTCGGGCCG	CASSPQAPRHYEQYF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	45	TCRBV03						TCRBJ02	TCRBJ02-07	01	4	4	4	3	2	10	26	39	45	41	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQAPRHYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGGACAGTTCTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPGTVLSNQPQHF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	5	0	2	4	26	39	48	41	52		TCRBV03-01,TCRBV03-02												CASSPGTVLSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGACAGGAAGTGATGAAAAACTGTTTTTTGGCAGT	CSAQTGSDEKLFF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	4	6	3	5	26	34	43	37	48		TCRBV20-01,TCRBV20-or09_02												CSAQTGSDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCGGGGGCTCAGCATGAAAAACTGTTTTTTGGCAGT	CSARDSGAQHEKLFF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	45	TCRBV20						TCRBJ01	TCRBJ01-04	01	0	6	0	6	3	5	26	40	49	43	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDSGAQHEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCATTTAGCGGGAGAGGCAGATACGCAGTATTTTGGCCCA	CSAHLAGEADTQYF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	2	4	4	3	26	35	48	39	51		TCRBV20-01,TCRBV20-or09_02												CSAHLAGEADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTGGAGGGGGGAACCGACAATCAGCCCCAGCATTTTGGTGAT	CSALEGGTDNQPQHF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	5	5	1	3	4	7	26	35	45	39	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALEGGTDNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTTGTCTGGGATAGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	17	2.6539692451799237E-4		44	TCRBV12						TCRBJ01	TCRBJ01-05	01	3	0	8	4	5	3	22	36	45	41	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATATGGACAGGGCCCAGTACTTCGGGCCG	CATSDMDRAQYF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	10	2	2	24	39	49	41	51		TCRBV24-01,TCRBV24-or09_02												CATSDMDRAQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCTCCGGACTAGCGGGAGATCTCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGLAGDLPNTGELFF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	1	2	0	3	6	24	36	52	39	58	TCRBV03,TCRBV12													CASSSGLAGDLPNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCACTCGGCAGGAGGCGATCAACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	2.6539692451799237E-4		49	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	12	10	1	0	9	9	18	23	37	32	46	TCRBV07,TCRBV12													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGTCCTCAGCCCGTCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPQPVSSYNEQFF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	48							TCRBJ02	TCRBJ02-01	01	6	4	5	0	4	8	18	29	36	33	44	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQPVSSYNEQFF+X+TCRBJ02-01			TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTCGAAGACGGGACAACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	2.6539692451799237E-4		47	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	6	0	7	1	19	33	46	40	47		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCAAGACTCTACATACGCAGTATTTTGGCCCA	CASSKTLHTQYF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	36				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	10	7	3	4	24	35	42	38	46	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03				01,02								CASSKTLHTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGAGGGAACTATGGCTACACCTTCGGTTCG	CASSQGGGNYGYTF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	9	0	2	1	0	26	42	-1	43	50		TCRBV03-01,TCRBV03-02												CASSQGGGNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGGCCCGGGACGGTAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	2.810085083131684E-4		49	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	0	7	2	7	3	26	42	54	49	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGAGGGGACCTCCTAATGAAAAACTGTTTTTTGGCAGT	CASSLRGPPNEKLFF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	45	TCRBV03						TCRBJ01	TCRBJ01-04	01	4	0	7	3	4	3	26	39	48	43	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGPPNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGACAGTGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	18	2.810085083131684E-4		37	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	2	5	1	0	1	26	-1	40	35	41		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGCCGGTGGGGACAACACTGAAGCTTTCTTTGGACAA	CSAGGDNTEAFF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	9	0	7	2	8	0	26	31	-1	39	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGGDNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCACCCACTAGCGGGAGGCGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	2.810085083131684E-4		46	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	3	1	4	6	2	26	37	55	43	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCACCGGGCGGGCCGGGAAGAGACCCAGTACTTCGGGCCA	CSAHRAGREETQYF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	7	4	3	6	5	26	35	46	41	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAHRAGREETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGTTTAGAAGGGCCTAGTGAGGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	2.810085083131684E-4		50	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	11	0	4	12	0	25	40	-1	52	57	TCRBV24,TCRBV28													X+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
SRGGGACTYRGCTGTGTAYYTCTGTGCCAGCAACGGGGACGTGATCCAGCCCCAGCATTTTGGTGAT	CASNGDVIQPQHF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	39	unresolved						TCRBJ01	TCRBJ01-05	01	7	0	7	7	3	6	22	32	40	35	46	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNGDVIQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCGAGGACTAGCGGGAGCGTATGAGCAGTTCTTCGGGCCA	CASSRGLAGAYEQFF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	2	8	3	3	22	34	50	37	53		TCRBV12-03,TCRBV12-04												CASSRGLAGAYEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTCTCCCCGGGACTAGCGGGAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSLSPGLAGGSYEQYF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	54	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	0	0	1	8	0	24	36	-1	44	60		TCRBV24-01,TCRBV24-or09_02												CASSLSPGLAGGSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTATTTAACGCGCAGGGGACAAGGCAGCCCCAGCATTTTGGTGAT	CASSLFNAQGTRQPQHF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	6	7	12	3	18	33	51	45	54	TCRBV07,TCRBV11													CASSLFNAQGTRQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCTGACAGGGAGGAAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	18	2.810085083131684E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	3	0	2	6	18	31	40	33	46	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCCGCCAAGAGGGAACAACTAATGAAAAACTGTTTTTTGGCAGT	CASRQEGTTNEKLFF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	8	11	0	0	6	2	23	32	43	38	45	TCRBV02,TCRBV12													CASRQEGTTNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGARGACTCRGCYSYKTATCTYTGCGCCAGCAGCTGAGGACTAGCGGGAGTGTACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	19	2.966200921083444E-4		49	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	1	2	5	3	3	23	35	51	38	54	TCRBV01,TCRBV05													X+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGACTCAGGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSDSGDTGELFF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	42							TCRBJ02	TCRBJ02-02	01	3	4	4	3	2	2	24	38	44	40	46	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-04,TCRBV06-05,TCRBV06-06,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSGDTGELFF+X+TCRBJ02-02			TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGTCCGGGGGCATACGAGCAGTACTTCGGGCCG	CASSGPGAYEQYF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	39	TCRBV03						TCRBJ02	TCRBJ02-07	01	5	6	0	4	5	1	26	38	49	43	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGPGAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAGGACTAGACAATGAGCAGTTCTTCGGGCCA	CSAKGLDNEQFF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	8	5	2	0	26	36	-1	38	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKGLDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAACCCTGGACAGGGGGTCAACGAGCAGTACTTCGGGCCG	CSARNPGQGVNEQYF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	1	5	6	3	26	38	54	44	57		TCRBV20-01,TCRBV20-or09_02												CSARNPGQGVNEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGGACCAGGGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	2.966200921083444E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	1	3	6	0	26	40	-1	46	53		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAATGGTGGGAGCCCGCGAGGAGCTGTTTTTTGGAGAA	CASSQMVGAREELFF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	9	2	10	5	7	23	38	48	43	55	TCRBV01,TCRBV04													CASSQMVGAREELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGAGGGATGGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASRGMGSNQPQHF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	6	0	8	1	1	5	22	33	38	34	43	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGMGSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCGGCAGGGAAAACCTACGAGCAGTACTTCGGGCCG	CASSPAGKTYEQYF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	3	2	4	4	24	36	45	40	49		TCRBV24-01,TCRBV24-or09_02												CASSPAGKTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAATATTCAGGGAGTACCTACGAGCAGTACTTCGGGCCG	CASSEYSGSTYEQYF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	2	4	3	2	4	4	23	38	47	42	51	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEYSGSTYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTGAGGACGGATACTTCGCTAACTATGGCTACACCTTCGGTTCG	CASSEDGYFANYGYTF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	48	unresolved						TCRBJ01	TCRBJ01-02	01	5	1	7	0	2	10	26	38	44	40	54	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEDGYFANYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCGGGGGTGGGAGAGACCCAGTACTTCGGGCCA	CASSPPGVGETQYF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	2	4	3	4	26	39	48	42	52		TCRBV03-01,TCRBV03-02												CASSPPGVGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGACAGGAACTATGGCTACACCTTCGGTTCG	CASSPDRNYGYTF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	2	2	0	26	39	-1	41	47		TCRBV03-01,TCRBV03-02												CASSPDRNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCGGGGCGGGAGTCGCTTTCTTTGGACAA	CSARSGAGVAFF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	7	2	11	6	2	26	38	51	44	53		TCRBV20-01,TCRBV20-or09_02												CSARSGAGVAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCCCACTATATAATGAGCAGTTCTTCGGGCCA	CSAIPLYNEQFF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	9	7	4	3	26	36	44	40	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSAIPLYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGAGAGGGGGGGAGAACACTGAAGCTTTCTTTGGACAA	CSAPRGGENTEAFF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	1	6	1	26	35	48	41	49		TCRBV20-01,TCRBV20-or09_02												CSAPRGGENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAGAGGGACTACTGGACGAGCAGTACTTCGGGCCG	CSAGEGLLDEQYF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	9	5	0	4	26	-1	47	40	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGEGLLDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCACAAACTAGCGGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHKLADSYNEQFF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	5	0	5	1	22	34	47	39	48		TCRBV12-03,TCRBV12-04				01,02								CASSHKLADSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGACCGGGGAGGGATCACTGAAGCTTTCTTTGGACAA	CASSDRGGITEAFF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	4	5	2	22	34	46	39	48	TCRBV09,TCRBV12													CASSDRGGITEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCATCCGAGGGGGAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	3.1223167590352044E-4		35	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	5	1	3	4	2	24	31	41	35	43		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGGACTCSGCCSTSTATCTCTGTGCCAGCAGCTCATACAGGAGGTCCGCTTCATACGAGCAGTACTTCGGGCCG	CASSSYRRSASYEQYF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	48	unresolved						TCRBJ02	TCRBJ02-07	01	3	3	4	4	3	12	19	32	40	35	52	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSYRRSASYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGTTTATGGCAGGGAGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSVYGRESNQPQHF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	48	unresolved						TCRBJ01	TCRBJ01-05	01	4	4	3	1	7	2	23	36	48	43	50	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVYGRESNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCAGGGAGTAGCTCCTACGAGCAGTACTTCGGGCCG	CASSPGSSSYEQYF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	6	4	3	0	2	5	26	37	44	39	49	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGSSSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTTCCAAGATTTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	21	3.2784325969869644E-4		44	TCRBV03						TCRBJ02	TCRBJ02-05	01	0	2	8	5	7	3	26	43	52	50	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGGCGAGTGATGAGCAGTTCTTCGGGCCA	CASSQVASDEQFF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	39	TCRBV03						TCRBJ02	TCRBJ02-01	01	1	9	0	8	1	5	26	42	46	43	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVASDEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSQGGETQYF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	9	1	4	0	0	26	-1	-1	40	46		TCRBV03-01,TCRBV03-02												CASSQGGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTCGACAGGGGTCCACAGATACGCAATATTTTGGCCCA	CASSPRQGSTDTQYF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	2	15	3	15	26	39	50	42	65		TCRBV03-01,TCRBV03-02												CASSPRQGSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCCCTAAGGGGCGAGCAGTACTTCGGGCCG	CSAPLRGEQYF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	5	2	6	7	0	26	34	-1	41	46		TCRBV20-01,TCRBV20-or09_02												CSAPLRGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGCCCCGGACTAGCGGGAGGTCGGATACGCAGTATTTTGGCCCA	CSAREPRTSGRSDTQYF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	1	1	6	5	3	26	40	59	45	62		TCRBV20-01,TCRBV20-or09_02												CSAREPRTSGRSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCGGGACGGCCCACTCCTACGAGCAGTACTTCGGGCCG	CASSGTAHSYEQYF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	42	TCRBV24						TCRBJ02	TCRBJ02-07	01	7	0	7	0	1	6	24	35	41	36	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGTAHSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCAAGGACAGGGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	21	3.2784325969869644E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	2	5	3	0	18	30	-1	33	42	TCRBV07,TCRBV11													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TCTGCTGTGTATTTCTGTGCCAGCAGCCGAAGTGGGAGTTTGGTAATAGTGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSRSGSLVIVGSYNEQFF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	60	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	2	0	5	15	15	28	38	33	53		TCRBV03-01,TCRBV03-02												CASSRSGSLVIVGSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTCGTCTACCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSFVYPSTDTQYF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	9	0	3	4	26	40	46	43	50		TCRBV12-03,TCRBV12-04				01,02								CASSFVYPSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGATAGGGTGGCTTTCTTTGGACAA	CASSQDRVAFF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	33	TCRBV03						TCRBJ01	TCRBJ01-01	01	3	5	3	11	4	2	26	40	48	44	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRVAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGTCCCACTGACAGTTACGGGTAACTATGGCTACACCTTCGGTTCG	CASSPVPLTVTGNYGYTF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	5	1	10	7	26	39	54	49	61		TCRBV03-01,TCRBV03-02												CASSPVPLTVTGNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGCCGGGGGGATTAACTATGGCTACACCTTCGGTTCG	CSAGGINYGYTF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	9	8	1	1	3	2	26	31	41	34	43		TCRBV20-01,TCRBV20-or09_02												CSAGGINYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGACGGGCCCTATACGCAGTATTTTGGCCCA	CSADGPYTQYF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	33	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	8	0	7	4	3	26	34	42	38	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSADGPYTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCGATGGGAACGGGGAGCTGTTTTTTGGAGAA	CSARVDGNGELFF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	39	TCRBV20						TCRBJ02	TCRBJ02-02	01	1	0	8	7	5	1	26	39	48	44	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVDGNGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCGACAGAATACAATGAGCAGTTCTTCGGGCCA	CSASPTEYNEQFF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	5	4	3	2	26	37	45	40	47		TCRBV20-01,TCRBV20-or09_02												CSASPTEYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGGACGGGAACACTGAAGCTTTCTTTGGACAA	CSAMDGNTEAFF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	4	1	7	1	1	2	26	36	41	37	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAMDGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCATGACTAGCGGGAGGGCAAATGAGCAGTTCTTCGGGCCA	CASMTSGRANEQFF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	2	0	7	1	2	22	32	47	33	49		TCRBV12-03,TCRBV12-04												CASMTSGRANEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTACCGGGAGCCGGGCGGGGAGCTGTTTTTTGGAGAA	CASSYREPGGELFF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	8	2	7	2	5	19	32	40	34	45	TCRBV05,TCRBV07													CASSYREPGGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGGGGACTCAGCTKTGTATYTCTGTGCCAGCAGCCGATTCTCAAGCGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSRFSSGSSYNEQFF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	5	0	9	3	22	34	48	43	51	TCRBV07,TCRBV09					01,02								CASSRFSSGSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACTGGAGGGAAGGTCCGCGAGCAGTACTTCGGGCCG	CASTGGKVREQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	10	0	6	2	8	26	36	44	38	52		TCRBV03-01,TCRBV03-02												CASTGGKVREQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTTGATCAAAGAGACCCAGTACTTCGGGCCA	CASSQDLIKETQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	42	TCRBV03						TCRBJ02	TCRBJ02-05	01	0	2	8	3	3	3	26	43	48	46	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLIKETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGACAGGGGGCTGGAGCACAGATACGCAGTATTTTGGCCCA	CSARTGGWSTDTQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	0	0	2	3	26	34	47	36	50		TCRBV20-01,TCRBV20-or09_02												CSARTGGWSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGGGGCGGGAGCGGCAATCAGCCCCAGCATTTTGGTGAT	CSARGGSGNQPQHF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	7	2	2	5	2	26	34	46	39	48		TCRBV20-01,TCRBV20-or09_02												CSARGGSGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGGGGCGCAAATGGACACTGAAGCTTTCTTTGGACAA	CSAKGAQMDTEAFF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	5	0	3	0	8	26	-1	43	36	51		TCRBV20-01,TCRBV20-or09_02												CSAKGAQMDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCTAGGGCGGGGGATCCAGTACTTCGGGCCA	CSATLGRGIQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	7	2	10	7	2	26	36	50	43	52		TCRBV20-01,TCRBV20-or09_02												CSATLGRGIQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTGAGGGAGGGCGAGAGACCCAGTACTTCGGGCCA	CSARDLEGGRETQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	9	0	4	6	2	26	40	53	46	55		TCRBV20-01,TCRBV20-or09_02												CSARDLEGGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCATGGGGGGTCTCTGGAAACACCATATATTTTGGAGAG	CSASPWGVSGNTIYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	3	9	1	0	5	1	26	37	48	42	49		TCRBV20-01,TCRBV20-or09_02												CSASPWGVSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGACGTGGGACTAGCGGGACGGGTGAGCAGTTCTTCGGGCCA	CSGRGTSGTGEQFF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	0	3	9	5	4	26	33	51	38	55		TCRBV20-01,TCRBV20-or09_02												CSGRGTSGTGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCAGGGGGCGCAGGTGGTACGCAGTATTTTGGCCCA	CASSLSGGAGGTQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	0	8	4	8	24	36	48	40	56	TCRBV24,TCRBV27													CASSLSGGAGGTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCGCGAGGCGGAGCGGCTATGGCTACACCTTCGGTTCG	CAARRSGYGYTF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	12	6	5	4	9	0	24	30	-1	39	44		TCRBV24-01,TCRBV24-or09_02				01,02								CAARRSGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCTTAGACAGCCGAAACACCATATATTTTGGAGAG	CASSLDSRNTIYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	3	5	5	0	2	18	-1	38	34	40	TCRBV05,TCRBV07,TCRBV11													CASSLDSRNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAGGGGGTGGGACTGAAGCTTTCTTTGGACAA	CASSLAGGGTEAFF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	5	1	5	0	4	18	-1	41	35	45	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGGGTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTCAGGGTATGGGGCTCCGAGCAGTACTTCGGGCCG	CASSFRVWGSEQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	6	0	10	19	-1	38	33	48	TCRBV05,TCRBV11													CASSFRVWGSEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGCGCCGGGACTAGCGGGTTCGCATTACGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	23	3.590664272890485E-4		55				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	4	5	4	11	26	37	53	41	64	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01				01,02								X+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTCCGGGACAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQDSGTSNQPQHF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	6	1	4	0	23	40	-1	44	50	TCRBV01,TCRBV04													CASSQDSGTSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAATGACTGGGGGAGCATAGATACGCAGTATTTTGGCCCA	CSARNDWGSIDTQYF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	2	6	1	5	7	5	26	38	50	45	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARNDWGSIDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCACCCGACTCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	3.746780110842245E-4		41	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	10	2	5	2	26	39	48	44	50		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCAAGCGCCCAAGCGGGTCTGGACCCTACGAGCAGTACTTCGGGCCG	CSAPKRPSGSGPYEQYF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	4	2	12	7	26	35	53	47	60		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPKRPSGSGPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCCAACAGGGCCAACTCCTACGAGCAGTACTTCGGGCCG	CSAANRANSYEQYF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	0	4	4	26	35	45	39	49		TCRBV20-01,TCRBV20-or09_02												CSAANRANSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACCTTAAGAGGGAGGGGAAACACCATATATTTTGGAGAG	CASTLRGRGNTIYF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	7	9	1	4	8	0	22	32	-1	40	46		TCRBV12-03,TCRBV12-04												CASTLRGRGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01*02	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGCTCGGACGGCTCTGACGCAGTATTTTGGCCCA	CATSEARTALTQYF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	4	1	7	9	5	7	24	38	47	43	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSEARTALTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCGGGGGGACAGGCCTCCGGTGCGCAGTATTTTGGCCCA	CASSPGGQASGAQYF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	10	5	9	18	30	43	35	52	TCRBV07,TCRBV11													CASSPGGQASGAQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGGAGACGAAGGTGGGCAGTACTTCGGGCCG	CASSRGDEGGQYF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	2	9	2	10	26	39	45	41	55		TCRBV03-01,TCRBV03-02												CASSRGDEGGQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTGACAGGGGGTATGGAGACCCAGTACTTCGGGCCA	CASSVTGGMETQYF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	1	5	2	4	26	38	49	40	53		TCRBV03-01,TCRBV03-02												CASSVTGGMETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCGCAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	3.902895948794005E-4		35	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	4	6	7	4	0	26	40	-1	44	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGGCGGGAGTGCCTACGAGCAGTACTTCGGGCCG	CSARDGGSAYEQYF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	2	2	2	2	26	40	49	42	51		TCRBV20-01,TCRBV20-or09_02												CSARDGGSAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACAACAGGGGGGAATCTACGAGCAGTACTTCGGGCCG	CASSLQQGGIYEQYF	In	VDJ	1	25	3.902895948794005E-4	4.606426886792453E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	1	3	5	4	24	36	49	41	53		TCRBV24-01,TCRBV24-or09_02												CASSLQQGGIYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTACGGGTGGACTACGAGCAGTACTTCGGGCCG	CASSLRVDYEQYF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	4	3	3	4	26	38	45	41	49		TCRBV03-01,TCRBV03-02				01,02								CASSLRVDYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAAAGCGGTTGAAAGGGACGTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	26	4.0590117867457656E-4		50	TCRBV20						TCRBJ02	TCRBJ02-02	01	4	0	7	4	14	2	26	36	55	50	57		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGAGGGGGGGGGAGAACACTGAAGCTTTCTTTGGACAA	CSAPRGGENTEAFF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	1	4	3	26	35	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSAPRGGENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGTAGCGGGAGGGCGTGGCGAGCAGTACTTCGGGCCG	CSAPVAGGRGEQYF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	0	6	4	5	26	35	50	39	55		TCRBV20-01,TCRBV20-or09_02												CSAPVAGGRGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGGCAGGGATCGCAGATACGCAGTATTTTGGCCCA	CATSDSAGIADTQYF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	3	4	3	4	24	40	48	43	52		TCRBV24-01,TCRBV24-or09_02												CATSDSAGIADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCGCCAGGCGGCCCCGCCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	4.0590117867457656E-4		43							TCRBJ02	TCRBJ02-05	01	4	4	4	5	2	10	18	30	36	32	46	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-05			TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGAATCAGACTAAGTAGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CARIRLSRQSRANVLTF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	51				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	9	2	9	5	5	13	18	26	36	31	49	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02				01,02								CARIRLSRQSRANVLTF+X+TCRBJ02-06		TCRBD02-01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCCCCAGACTAGTGGAGACCCAGTACTTCGGGCCA	CASSPRLVETQYF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	2	8	5	5	2	20	31	42	36	44	TCRBV07,TCRBV23					01,02								CASSPRLVETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGCGGCTGCCGAAGAGACCCAGTACTTCGGGCCA	CASSLAAAEETQYF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	9	0	3	0	5	19	-1	39	36	44	TCRBV07,TCRBV11													CASSLAAAEETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYGGCYSTSTATCTCTGTGCCAGCAGCTTAATCTTGGCTAGCGGGAGCCAGACCCAGTACTTCGGGCCA	CASSLILASGSQTQYF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	4	2	6	8	2	19	33	51	41	53	TCRBV05,TCRBV07													CASSLILASGSQTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCACGAATCGACAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPRIDSSYNEQFF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	5	0	9	0	24	36	-1	45	50	TCRBV09,TCRBV21													CASSPRIDSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGAGGGGAACTATGGCTACACCTTCGGTTCG	CASSPEGNYGYTF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	6	2	2	0	0	26	-1	-1	43	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPEGNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGGACTCSGCCGTGTATSTCTGTGCCAGCAGCTCGGACCCAGACGCCCTCTCCTACGAGCAGTACTTCGGGCCG	CASSSDPDALSYEQYF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	48	unresolved						TCRBJ02	TCRBJ02-07	01	4	1	7	0	1	11	20	33	38	34	49	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSDPDALSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGGAAAATCAGCCCCAGCATTTTGGTGAT	CSAQENQPQHF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	4	4	1	2	26	34	39	35	41		TCRBV20-01,TCRBV20-or09_02												CSAQENQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGGGAGGGCCCCGCAGTTCTTCGGGCCA	CSARDGRAPQFF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	0	12	0	4	26	-1	48	40	52		TCRBV20-01,TCRBV20-or09_02												CSARDGRAPQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTACGCCCTCCGAAGTGGAGGGCTACACCTTCGGTTCG	CSARATPSEVEGYTF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	10	2	8	16	0	26	39	-1	55	59		TCRBV20-01,TCRBV20-or09_02												CSARATPSEVEGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCTCGCGCGGCTAATGAAAAACTGTTTTTTGGCAGT	CATSDSRAANEKLFF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	7	5	3	7	0	24	38	-1	45	49		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDSRAANEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGGACAACCCAATGAGCAGTTCTTCGGGCCA	CASSFGQPNEQFF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	6	6	3	3	24	36	44	39	47		TCRBV24-01,TCRBV24-or09_02												CASSFGQPNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGACCTAGAGTGTTCGGGTTAAGTCGACCACCGGGGAGCTGTTTTTTGGAGAA	CSAPT*SVRVKSTTGELFF	Stop	VDJ	2	27	4.2151276246975256E-4		57	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	8	4	5	20	24	33	42	38	62		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPT*SVRVKSTTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCAAGGGACAGGGCGGCTGATCAGCCCCAGCATTTTGGTGAT	CASSPRDRAADQPQHF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	3	5	4	6	18	30	43	34	49	TCRBV07,TCRBV11													CASSPRDRAADQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTCTATGGGGGTCATAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFYGGHSSGANVLTF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	54	unresolved						TCRBJ02	TCRBJ02-06	01	3	6	1	0	4	6	18	32	41	36	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFYGGHSSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGTTAGGGACTATGGCTACACCTTCGGTTCG	CASSLVRDYGYTF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	39	TCRBV12						TCRBJ01	TCRBJ01-02	01	3	5	3	3	4	0	26	40	-1	44	48		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVRDYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ACGACTCGGCCSTGTATSTCTGTGCCAGCAGCATCGGACTAGCGGGAGGGCCAGTTGAGCAGTTCTTCGGGCCA	CASSIGLAGGPVEQFF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	1	0	9	3	5	20	32	50	35	55	TCRBV05,TCRBV11													CASSIGLAGGPVEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCAGTCGCTAGGTTCTTATACGCAGTATTTTGGCCCA	CASQSLGSYTQYF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	4	8	7	6	6	26	35	45	41	51		TCRBV03-01,TCRBV03-02				01,02								CASQSLGSYTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGGCTATTACAGGGCCGGCACTGAAGCTTTCTTTGGACAA	CASGYYRAGTEAFF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	3	4	7	4	26	35	48	42	52		TCRBV03-01,TCRBV03-02												CASGYYRAGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCACCTAGCGGGAGGGACAGATACGCAGTATTTTGGCCCA	CSAHLAGGTDTQYF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	4	0	3	4	0	26	34	-1	38	50		TCRBV20-01,TCRBV20-or09_02												CSAHLAGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCAGCGGGAGTCGGTACGAGCAGTACTTCGGGCCG	CSATSGSRYEQYF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	6	2	4	2	4	26	36	46	38	50		TCRBV20-01,TCRBV20-or09_02												CSATSGSRYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCACAGGTCTGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	28	4.3712434626492857E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	4	6	2	4	26	40	47	42	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCGACAGGAAAAGCAGATACGCAGTATTTTGGCCCA	CATSATGKADTQYF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	4	4	1	5	24	37	44	38	49		TCRBV24-01,TCRBV24-or09_02												CATSATGKADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTACCACGGGACAGTTCTCCTACGAGCAGTACTTCGGGCCG	CASSTTGQFSYEQYF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	0	6	2	26	37	50	43	52		TCRBV03-01,TCRBV03-02												CASSTTGQFSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACGGACTAGCGGGAACCCCTACAATGAGCAGTTCTTCGGGCCA	CSARTSGNPYNEQFF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	1	3	2	2	3	26	34	48	36	51		TCRBV20-01,TCRBV20-or09_02												CSARTSGNPYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGGGACTAGCGGGAGGAACCACAGATACGCAGTATTTTGGCCCA	CSAKGLAGGTTDTQYF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	0	1	2	3	3	26	34	52	37	55		TCRBV20-01,TCRBV20-or09_02												CSAKGLAGGTTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACTCGACAGGGGATACGCAGTATTTTGGCCCA	CSARDSTGDTQYF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	3	6	3	0	26	40	-1	43	50		TCRBV20-01,TCRBV20-or09_02												CSARDSTGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCCATAGGTGGGATCCGGAGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	29	4.527359300601046E-4		49	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	11	10	1	3	17	0	24	31	-1	48	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01*02	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCGGGACAGGGATTGGAGCTATGGCTACACCTTCGGTTCG	CASSRDRDWSYGYTF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	4	1	7	19	31	41	32	48		TCRBV05-06,TCRBV05-07												CASSRDRDWSYGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTAACCCGAGACTAGCGGGAGTCGACGAGCAGTACTTCGGGCCG	CASSNPRLAGVDEQYF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	2	2	5	8	3	23	34	54	42	57	TCRBV09,TCRBV12													CASSNPRLAGVDEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGGGTCTGACAGGGAAGGTCACGAGCAGTACTTCGGGCCG	CASSGSDREGHEQYF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	5	7	6	23	34	48	41	54	TCRBV02,TCRBV09													CASSGSDREGHEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGGACACGCGGGACTAGCGGGAGTTGAGCAGTTCTTCGGGCCA	CASSPGHAGLAGVEQFF	In	VDJ	2	30	4.683475138552806E-4	5.527712264150943E-4	51	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	2	9	11	1	26	38	63	49	64		TCRBV12-03,TCRBV12-04												CASSPGHAGLAGVEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAAGGTCAGGGACTAGTATCCGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	30	4.683475138552806E-4		47	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	0	8	5	6	7	26	36	50	42	57		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTGTTCTCCGCACAGATATGCAGTATTTTGGCCCA	CASSQVVLRTDMQYF	In	VDJ	2	30	4.683475138552806E-4	5.527712264150943E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	3	5	11	11	4	26	42	57	53	61		TCRBV03-01,TCRBV03-02												CASSQVVLRTDMQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAAAGGGCCCCTCTCTAAACACCATATATTTTGGAGAG		Out	VDJ	2	30	4.683475138552806E-4		41	TCRBV20						TCRBJ01	TCRBJ01-03	01	6	5	3	6	4	9	26	34	42	38	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGACATCCGCCCGGGGGGAGCAGTACTTCGGGCCG	CSARTSARGEQYF	In	VDJ	2	30	4.683475138552806E-4	5.527712264150943E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	2	7	12	0	26	35	-1	47	53		TCRBV20-01,TCRBV20-or09_02												CSARTSARGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGGCCGGAGGTTCCGAGCAGTACTTCGGGCCG	CSAWAGGSEQYF	In	VDJ	2	30	4.683475138552806E-4	5.527712264150943E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	1	6	6	3	26	35	46	41	49		TCRBV20-01,TCRBV20-or09_02												CSAWAGGSEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCCGTATGACGGGACAACCGGGATAGCCCCAGCATTTTGGTGAT	CASRMTGQPG*PQHF	Stop	VDJ	2	30	4.683475138552806E-4		45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	6	8	8	8	23	32	46	40	54	TCRBV06,TCRBV24													CASRMTGQPG*PQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCGCCGGAGGAGGGGGGCCTCCCCAGCATTTTGGTGAT	CASSAGGGGPPQHF	In	VDJ	2	30	4.683475138552806E-4	5.527712264150943E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	5	5	1	10	8	4	19	31	45	39	49	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAGGGGPPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAAGGTTAGGGGTAATGGGAGTGGGAACTGAAGCTTTCTTTGGACAA	CASSLRLGVMGVGTEAFF	In	VDJ	2	30	4.683475138552806E-4	5.527712264150943E-4	54	TCRBV05						TCRBJ01	TCRBJ01-01	01	2	5	2	5	6	14	19	33	44	39	58		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRLGVMGVGTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGAGAACCCTCCAGCATTTTGGTGAT	CASSQGRTLQHF	In	VDJ	2	31	4.8395909765045663E-4	5.711969339622641E-4	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	10	2	12	0	6	26	-1	46	42	52		TCRBV03-01,TCRBV03-02												CASSQGRTLQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*02	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCGATCTAGCGGGCCCCAAGAGACCCAGTACTTCGGGCCA	CASSRSSGPQETQYF	In	VDJ	2	31	4.8395909765045663E-4	5.711969339622641E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	4	4	1	5	2	26	37	50	42	52		TCRBV03-01,TCRBV03-02				01,02								CASSRSSGPQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGGCAGCCCGCAGGGGCCCAGCATTTTGGTGAT		Out	VDJ	2	31	4.8395909765045663E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	11	12	0	26	40	-1	52	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCTTCTGAGGTTGGCAATGAGCAGTTCTTCGGGCCA	CSARASEVGNEQFF	In	VDJ	2	31	4.8395909765045663E-4	5.711969339622641E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	11	1	6	5	4	26	39	48	44	52		TCRBV20-01,TCRBV20-or09_02												CSARASEVGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTACGACTAGCGCAGAAGGAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	31	4.8395909765045663E-4		49	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	6	2	4	9	26	35	47	39	56		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTGGACGAGAAAGAGACCCAGTACTTCGGGCCA	CSALDEKETQYF	In	VDJ	2	31	4.8395909765045663E-4	5.711969339622641E-4	36	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	1	7	3	2	4	26	35	41	37	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALDEKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGGGACTAGCGGGAGTCAATTCGGGTACAATGAGCAGTTCTTCGGGCCA	CASSGTSGSQFGYNEQFF	In	VDJ	2	32	4.995706814456326E-4	5.896226415094339E-4	54				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	1	2	4	0	10	24	-1	50	37	60	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03												CASSGTSGSQFGYNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCCAGCAGCTTGGATGAAGGACAGGGGGCGACGAGCAGTACTTCGGGCCG		Out	VDJ	2	32	4.995706814456326E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	0	5	9	1	26	38	58	47	59	TCRBV03,TCRBV05,TCRBV07													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGACAGGTGTCGGCTACGAGCAGTACTTCGGGCCG	CSAQTGVGYEQYF	In	VDJ	2	32	4.995706814456326E-4	5.896226415094339E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	4	3	2	6	26	35	43	37	49		TCRBV20-01,TCRBV20-or09_02												CSAQTGVGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGCGAAGGACAGGGATAACTATGGCTACACCTTCGGTTCG	CAISAKDRDNYGYTF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	3	1	4	1	24	37	49	41	50	TCRBV06,TCRBV10													CAISAKDRDNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGAAGACAGATCATCGGGAGATCTTCTTTGGACAA	CASSQAKTDHREIFF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	8	2	14	14	3	26	42	62	56	65		TCRBV03-01,TCRBV03-02												CASSQAKTDHREIFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACAGGGGGCGATCAGTGGCTACACCTTCGGTTCG	CASSQGQGAISGYTF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	0	7	0	6	26	-1	52	42	58		TCRBV03-01,TCRBV03-02												CASSQGQGAISGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAATGGACAGGAAAGTCAGCCCCAGCATTTTGGTGAT	CSANGQESQPQHF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	4	6	4	4	26	34	45	38	49		TCRBV20-01,TCRBV20-or09_02												CSANGQESQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGGCGGGGCTATGGCTACACCTTCGGTTCG	CSAGRGYGYTF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	7	3	4	3	0	26	34	-1	37	43		TCRBV20-01,TCRBV20-or09_02												CSAGRGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCAGGACTTAGTTCCGCGTCAGAGACCCAGTACTTCGGGCCA	CATSDPGLSSASETQYF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	10	4	4	12	24	38	47	42	59		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDPGLSSASETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCTCGACAGAAAAACCGGGGAGCTGTTTTTTGGAGAA	CASSLDRKTGELFF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	2	5	5	4	4	24	35	44	39	48		TCRBV24-01,TCRBV24-or09_02												CASSLDRKTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTCCAGACTCTACGAGCAGTACTTCGGGCCG	CASSSRLYEQYF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	10	3	4	0	24	36	-1	40	44	TCRBV24,TCRBV27					01,02								CASSSRLYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGACGGACGACTAGCCATAGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	34	5.307938490359847E-4		44	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	2	7	7	6	5	24	35	48	41	53		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACGACAGGGGGACACAGATACGCAGTATTTTGGCCCA	CASSERQGDTDTQYF	In	VDJ	2	34	5.307938490359847E-4	6.264740566037736E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	1	2	1	1	23	38	48	39	49		TCRBV06-01,TCRBV06-08												CASSERQGDTDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGGTTGTTTACCGGGAGGGCACAGATACGCAGTATTTTGGCCCA	CASSLVVYREGTDTQYF	In	VDJ	2	34	5.307938490359847E-4	6.264740566037736E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	8	1	1	10	0	18	32	-1	42	49	TCRBV07,TCRBV11													CASSLVVYREGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGACCGGGAGGGCCCGGACAATGAGCAGTTCTTCGGGCCA	CASSQDDREGPDNEQFF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	0	5	4	5	26	43	55	47	60		TCRBV03-01,TCRBV03-02												CASSQDDREGPDNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACTCGGATGGGATGGGCTACACCTTCGGTTCG	CASSHSDGMGYTF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	3	0	8	8	7	2	26	40	51	47	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHSDGMGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGGGGACAGGGGTAACCGAGCAGTACTTCGGGCCG	CASRGTGVTEQYF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	6	1	4	22	33	44	34	48	TCRBV02,TCRBV12													CASRGTGVTEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCCAAACAGGGCGGGGACTGAAGCTTTCTTTGGACAA	CASSPNRAGTEAFF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	3	3	5	4	5	22	34	44	38	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPNRAGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAACGGCCCAAAGATACGCAGTATTTTGGCCCA	CSAKRPKDTQYF	In	VDJ	2	36	5.620170166263368E-4	6.633254716981132E-4	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	4	9	0	5	3	4	26	36	42	39	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKRPKDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGATGACAGTCGACGATGGCTAGGGCAGTACTTCGGGCCG	CSATDDSRRWLGQYF	In	VDJ	2	36	5.620170166263368E-4	6.633254716981132E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	5	9	5	15	26	36	46	41	61		TCRBV20-01,TCRBV20-or09_02												CSATDDSRRWLGQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGAACTTGGACAGGGGGTTTGTTCGCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	36	5.620170166263368E-4		53	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	1	2	5	10	24	35	50	40	60		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCCCGACTAGCGCAGAGGTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	36	5.620170166263368E-4		53	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	6	4	4	7	24	40	52	44	59		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTAGGACTAGCGGGCTACGAGCAGTACTTCGGGCCG	CASSLGLAGYEQYF	In	VDJ	2	36	5.620170166263368E-4	6.633254716981132E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	4	3	1	0	19	33	-1	34	45	TCRBV05,TCRBV11					01,02								CASSLGLAGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGGGGGGAGTGGCCAAGAGACCCAGTACTTCGGGCCA	CASSLGGSGQETQYF	In	VDJ	2	37	5.776286004215128E-4	6.81751179245283E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	1	1	1	5	26	39	47	40	52		TCRBV03-01,TCRBV03-02												CASSLGGSGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATGGGCGGTACAGCCTACGAGCAGTACTTCGGGCCG	CSARMGGTAYEQYF	In	VDJ	2	37	5.776286004215128E-4	6.81751179245283E-4	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	2	3	5	2	9	0	26	38	-1	47	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARMGGTAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTAAGAAGGGGAGATACGCAGTATTTTGGCCCA	CASSLRRGDTQYF	In	VDJ	2	38	5.932401842166888E-4	7.001768867924528E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	5	3	0	26	41	-1	44	49	TCRBV12,TCRBV21													CASSLRRGDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAACGGGACAGGGGTGGCTACACCTTCGGTTCG	CASSQERDRGGYTF	In	VDJ	2	38	5.932401842166888E-4	7.001768867924528E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	2	7	2	0	26	43	-1	45	55		TCRBV03-01,TCRBV03-02												CASSQERDRGGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAACCCGGGACAGCTACGAGCAGTACTTCGGGCCG	CASSLTRDSYEQYF	In	VDJ	2	38	5.932401842166888E-4	7.001768867924528E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	3	6	0	26	39	-1	45	52		TCRBV03-01,TCRBV03-02												CASSLTRDSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGAGGGGAACCGAGCAATACTTCGGGCCG	CSARDLRGTEQYF	In	VDJ	2	38	5.932401842166888E-4	7.001768867924528E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	0	5	2	13	4	10	26	40	49	44	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLRGTEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGCGGGAGGGCAAGAGACCCAGTACTTCGGGCCA	CSARGAGGQETQYF	In	VDJ	2	38	5.932401842166888E-4	7.001768867924528E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	7	0	2	2	0	26	39	-1	41	50		TCRBV20-01,TCRBV20-or09_02												CSARGAGGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGCAAAACGAGAGAGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	38	5.932401842166888E-4		44	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	11	2	2	8	4	26	37	48	45	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCTGCGAGCGGGAGAGGCAGTTGAGCAGTTCTTCGGGCCA	CASSLRAGEAVEQFF	In	VDJ	2	38	5.932401842166888E-4	7.001768867924528E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	2	9	5	7	18	30	43	35	50	TCRBV05,TCRBV11													CASSLRAGEAVEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGAACGGGAAATCCCAGCCACAATGAGCAGTTCTTCGGGCCA	CASRTGNPSHNEQFF	In	VDJ	2	38	5.932401842166888E-4	7.001768867924528E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	3	5	2	10	22	33	40	35	50	TCRBV07,TCRBV11													CASRTGNPSHNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGAGGAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSQGGGSYEQYF	In	VDJ	2	39	6.088517680118648E-4	7.186025943396226E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	10	0	1	2	0	23	39	-1	41	47	TCRBV01,TCRBV04													CASSQGGGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGTCGAAGGGAGGGGAGACCCAGTACTTCGGGCCA	CASSQSKGGETQYF	In	VDJ	2	39	6.088517680118648E-4	7.186025943396226E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	9	0	5	6	0	26	40	-1	46	53		TCRBV03-01,TCRBV03-02												CASSQSKGGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCGCGGAGCTATTAGGGACGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	39	6.088517680118648E-4		47	TCRBV20						TCRBJ02	TCRBJ02-05	01	1	0	7	5	14	0	26	39	-1	53	58		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCTTTGAAACCTACGAGCAGTACTTCGGGCCG	CSAPFETYEQYF	In	VDJ	2	39	6.088517680118648E-4	7.186025943396226E-4	36	TCRBV20						TCRBJ02	TCRBJ02-07	01	5	2	8	2	6	2	26	35	43	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPFETYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGGATAGGGTTATGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	39	6.088517680118648E-4		46	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	5	3	3	8	6	24	36	48	44	54		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTAGGCGGGATGGAGATACGCAGTATTTTGGCCCA	CASSRRDGDTQYF	In	VDJ	2	39	6.088517680118648E-4	7.186025943396226E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	7	3	5	2	3	23	35	43	37	46	TCRBV06,TCRBV10													CASSRRDGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGCGGTCAGGGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASSLAVRGTYNEQFF	In	VDJ	2	39	6.088517680118648E-4	7.186025943396226E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	1	2	4	1	19	35	46	39	47	TCRBV07,TCRBV11													CASSLAVRGTYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCATCGGGGACCTACGAGCAGTACTTCGGGCCG	CASSLASGTYEQYF	In	VDJ	2	39	6.088517680118648E-4	7.186025943396226E-4	42				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	2	2	1	18	35	42	37	43	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLASGTYEQYF+X+TCRBJ02-07		TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
RGGGGACTYRGCYSTGTATCTCTGTGCCAGCAGCCCCACTCGGGAAGCGGGGCAGTACTTCGGGCCG	CASSPTREAGQYF	In	VDJ	2	40	6.244633518070409E-4	7.370283018867925E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	6	4	9	13	0	22	32	-1	45	51	TCRBV05,TCRBV07					01,02								CASSPTREAGQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCGGGACTAGCGGGAAATTTCACGAGCAGTACTTTGGGCCG	CSATGTSGKFHEQYF	In	VDJ	2	40	6.244633518070409E-4	7.370283018867925E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	0	3	19	4	20	26	34	51	38	71		TCRBV20-01,TCRBV20-or09_02												CSATGTSGKFHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAAGGTTAGGGGAGGTGAATGAGCAATTCTTCGGGCCA	CSAKRLGEVNEQFF	In	VDJ	2	40	6.244633518070409E-4	7.370283018867925E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	9	1	16	9	11	26	36	51	45	62		TCRBV20-01,TCRBV20-or09_02												CSAKRLGEVNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACCCAAAACTTRCAGCGGGCACCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	40	6.244633518070409E-4		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	6	4	2	12	2	23	33	51	45	53	TCRBV06,TCRBV10					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACGGACAGGAAAGCATGCCGCCGCTGAAGCTTTCTTTGGACAA	CASSERTGKHAAAEAFF	In	VDJ	2	40	6.244633518070409E-4	7.370283018867925E-4	51	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	4	6	1	14	23	38	46	39	60		TCRBV06-01,TCRBV06-08												CASSERTGKHAAAEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACAACCCGGGGAGCTGTTTTTTGGAGAA	CASSLQPGELFF	In	VDJ	2	41	6.400749356022168E-4	7.554540094339623E-4	36	TCRBV12						TCRBJ02	TCRBJ02-02	01	2	3	7	6	2	0	26	41	-1	43	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQPGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAACCCCTCCTATGGCTACACCTTCGGTTCG	CASSQNPSYGYTF	In	VDJ	2	41	6.400749356022168E-4	7.554540094339623E-4	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	2	3	7	4	1	5	26	41	44	42	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQNPSYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTAGAGGACTAGCGGGAGAGGTGGAGCTGTTTTTTGGAGAA	CSARDLRGLAGEVELFF	In	VDJ	2	41	6.400749356022168E-4	7.554540094339623E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	1	2	10	7	4	26	40	60	47	64		TCRBV20-01,TCRBV20-or09_02												CSARDLRGLAGEVELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCGGGGGTAGCGGGAGTAGAGACCCAGTACTTCGGGCCA	CATSDSGVAGVETQYF	In	VDJ	2	41	6.400749356022168E-4	7.554540094339623E-4	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	5	2	4	8	1	24	38	55	46	56		TCRBV24-01,TCRBV24-or09_02												CATSDSGVAGVETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTTAGGAAGGGTTGGCCAGCCCCAGCATTTTGGTGAT	CASSLGRVGQPQHF	In	VDJ	2	41	6.400749356022168E-4	7.554540094339623E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	1	5	3	7	2	5	18	34	40	36	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRVGQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTATCCAGCTCGTCCTACGAGCAGTACTTCGGGCCG	CASSLSSSSYEQYF	In	VDJ	2	41	6.400749356022168E-4	7.554540094339623E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	2	4	5	1	2	4	18	33	38	35	42	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSSSSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAACTCTGGGGCCAACATCCTGACTTTCGGGGCC	CASSQNSGANILTF	In	VDJ	2	42	6.556865193973929E-4	7.738797169811321E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	7	0	14	6	5	26	41	52	47	57		TCRBV03-01,TCRBV03-02												CASSQNSGANILTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGCTAGCGGGTCCCAAGAGACCCAGTACTTCGGGCCA	CSASGASGSQETQYF	In	VDJ	2	42	6.556865193973929E-4	7.738797169811321E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	4	1	5	2	26	37	50	42	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGASGSQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCACGGGACAGGGGGCCTCTATGGCTACACCTTCGGTTCG	CSAHGTGGLYGYTF	In	VDJ	2	42	6.556865193973929E-4	7.738797169811321E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	0	4	3	2	26	35	50	38	52		TCRBV20-01,TCRBV20-or09_02												CSAHGTGGLYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGAGGCCAGATACGCAGTATTTTGGCCCA	CASSLSRPDTQYF	In	VDJ	2	42	6.556865193973929E-4	7.738797169811321E-4	39				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	11	1	4	5	1	24	36	45	41	46	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSRPDTQYF+X+TCRBJ02-03		TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCATCTCGGGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASISGTVNTEAFF	In	VDJ	2	42	6.556865193973929E-4	7.738797169811321E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	0	5	0	23	33	-1	38	45	TCRBV09,TCRBV12													CASISGTVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGGCAGCCGCACAATGAGCAGTTCTTCGGGCCA	CASSQDGQPHNEQFF	In	VDJ	2	43	6.712981031925689E-4	7.923054245283019E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	8	0	5	1	6	26	43	48	44	54		TCRBV03-01,TCRBV03-02												CASSQDGQPHNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGACGAGGACAGGGGGCGGGGAATGAGCAGTTCTTCGGGCCA	CASRRGQGAGNEQFF	In	VDJ	2	43	6.712981031925689E-4	7.923054245283019E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	0	7	4	4	23	34	49	38	53	TCRBV01,TCRBV04													CASRRGQGAGNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCACTCCCTAGTCCGGGACTAGCGGGAAATGGGTGGGGGGTGAGCAGTTCTTCGGGCCA	CATP*SGTSGKWVGGEQFF	Stop	VDJ	2	43	6.712981031925689E-4		57	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	0	3	9	11	13	22	29	53	40	66		TCRBV12-03,TCRBV12-04												CATP*SGTSGKWVGGEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCGGCGATCTGGGGGGCACAGATACGCAGTATTTTGGCCCA	CAGDLGGTDTQYF	In	VDJ	2	43	6.712981031925689E-4	7.923054245283019E-4	39	unresolved						TCRBJ02	TCRBJ02-03	01	11	6	1	1	8	0	22	28	-1	36	41	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAGDLGGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGACTAGCGGGAGCCTCGGCAATGAGCAGTTCTTCGGGCCA	CATSDLTSGSLGNEQFF	In	VDJ	2	43	6.712981031925689E-4	7.923054245283019E-4	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	3	2	6	0	6	24	-1	53	42	59		TCRBV24-01,TCRBV24-or09_02												CATSDLTSGSLGNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTCTCCGGGACAGGTTACGAGCAGTACTTCGGGCCG	CASSFSGTGYEQYF	In	VDJ	2	44	6.869096869877449E-4	8.107311320754717E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	4	4	1	19	33	45	37	46	TCRBV05,TCRBV11													CASSFSGTGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGAGAATCGAGGGGCCTACGAGCAGTACTTCGGGCCG	CASRENRGAYEQYF	In	VDJ	3	45	7.025212707829209E-4	8.291568396226415E-4	42	TCRBV12						TCRBJ02	TCRBJ02-07	01	6	5	2	2	9	0	26	37	-1	46	51		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRENRGAYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGACCCTCGGATCGCGGGAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	45	7.025212707829209E-4		40	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	9	7	2	3	12	0	26	31	-1	43	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCAATTTAATGAACACTGAAGCTTTCTTTGGACAA	CASSPNLMNTEAFF	In	VDJ	3	46	7.18132854578097E-4	8.475825471698113E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	4	6	0	2	6	26	38	42	40	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPNLMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGGGGACTCGAAACTACAATGAGCAGTTCTTCGGGCCA	CSARDQGTRNYNEQFF	In	VDJ	3	46	7.18132854578097E-4	8.475825471698113E-4	48	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	4	2	3	1	8	26	40	47	41	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDQGTRNYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGTAGGGCGCATTGGCAGCATTTTGGTGAT	CSARDRRAHWQHF	In	VDJ	3	46	7.18132854578097E-4	8.475825471698113E-4	39	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	5	3	13	4	8	26	40	48	44	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDRRAHWQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTGACTAGCGGGAGTGCGGGAGAGACCCAGTACTTCGGGCCA	CSVTSGSAGETQYF	In	VDJ	3	46	7.18132854578097E-4	8.475825471698113E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	7	2	2	4	1	6	26	33	46	34	52		TCRBV20-01,TCRBV20-or09_02												CSVTSGSAGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGAGCCACACCGGGGAGCTGTTTTTTGGAGAA	CASSQESHTGELFF	In	VDJ	3	47	7.337444383732729E-4	8.660082547169812E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	6	7	3	1	1	26	43	47	44	48		TCRBV03-01,TCRBV03-02				01,02								CASSQESHTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGCACCCACCAAGAGACCCAGTACTTCGGGCCA	CSARSTHQETQYF	In	VDJ	3	47	7.337444383732729E-4	8.660082547169812E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	6	7	0	0	4	26	-1	41	38	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSTHQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCCACAGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSPQSSGNTIYF	In	VDJ	3	48	7.49356022168449E-4	8.84433962264151E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	5	0	2	2	18	30	36	32	38	TCRBV07,TCRBV11													CASSPQSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGAGGGACAGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLEGQGYNEQFF	In	VDJ	3	48	7.49356022168449E-4	8.84433962264151E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	3	3	3	0	19	33	-1	36	45	TCRBV05,TCRBV11													CASSLEGQGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTATGAGGTTCCCTCTACGGAGCAGTACTTCGGGCCG	CSARDYEVPSTEQYF	In	VDJ	3	49	7.649676059636251E-4	9.028596698113208E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	1	7	4	11	26	40	48	44	59		TCRBV20-01,TCRBV20-or09_02												CSARDYEVPSTEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCGGAATCAGCCCCAGCATTTTGGTGAT	CSARDRNQPQHF	In	VDJ	3	50	7.80579189758801E-4	9.212853773584906E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	8	5	4	1	0	26	40	-1	41	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTAGCGGGAGACTACAATGAGCAGTTCTTCGGGCCA	CATSDLAGDYNEQFF	In	VDJ	3	50	7.80579189758801E-4	9.212853773584906E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	6	2	3	0	1	24	-1	49	41	50		TCRBV24-01,TCRBV24-or09_02												CATSDLAGDYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGTAGACTAGCGGGAGTCTCGATGGGTGTGGATGAGCAGTTCTTCGGGCCA	CASRLAGVSMGVDEQFF	In	VDJ	3	50	7.80579189758801E-4	9.212853773584906E-4	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	2	2	8	3	15	24	31	46	34	61	TCRBV24,TCRBV27													CASRLAGVSMGVDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGTTAAGGGAGGAGAGGATGAGCAGTTCTTCGGGCCA	CASSVKGGEDEQFF	In	VDJ	3	50	7.80579189758801E-4	9.212853773584906E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	1	8	5	5	23	35	46	40	51	TCRBV06,TCRBV10													CASSVKGGEDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTCAAAGGGGGCTAATGAAAAACTGTTTTTTGGCAGT	CSASSKGANEKLFF	In	VDJ	3	51	7.961907735539771E-4	9.397110849056604E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	5	1	3	5	0	26	37	-1	42	48		TCRBV20-01,TCRBV20-or09_02												CSASSKGANEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCCAGGGAAGGGAGGACCCATACTCTACAATGAGCAGTTCTTCGGGCCA	CASSPGKGGPILYNEQFF	In	VDJ	3	51	7.961907735539771E-4	9.397110849056604E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	1	3	9	9	20	31	46	40	55	TCRBV01,TCRBV23													CASSPGKGGPILYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGACCTACAGGTAACACTGAAGCTTTCTTTGGACAA	CASRPTGNTEAFF	In	VDJ	3	53	8.274139411443291E-4	9.765625E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	4	2	4	1	24	35	44	39	45	TCRBV06,TCRBV10													CASRPTGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTYTCGGGGGCTCTAACACTGAAGCTTTCTTTGGACAA	CSASXGGSNTEAFF	In	VDJ	3	53	8.274139411443291E-4	9.765625E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	6	0	2	4	3	26	37	47	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASXGGSNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAAAGGGGTCCCCAAGAGACCCAGTACTTCGGGCCA	CASSQERGPQETQYF	In	VDJ	3	53	8.274139411443291E-4	9.765625E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	2	1	1	3	23	40	46	41	49	TCRBV01,TCRBV04													CASSQERGPQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAGGCCCCACACCGAGACTACATAATGAGCAGTTCTTCGGGCCA	CASRGPTPRLHNEQFF	In	VDJ	3	53	8.274139411443291E-4	9.765625E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	2	9	7	14	3	24	35	54	49	57		TCRBV24-01,TCRBV24-or09_02				01,02								CASRGPTPRLHNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGGAGTCCCCGAGCAGTTCTTCGGGCCA	CASSQAGVPEQFF	In	VDJ	3	55	8.586371087346812E-4	0.0010134139150943396	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	8	2	10	0	5	26	-1	48	42	53		TCRBV03-01,TCRBV03-02												CASSQAGVPEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTCACGGAAAGCTTACCTACGAGCAGTACTTCGGGCCG	CASSQVHGKLTYEQYF	In	VDJ	3	55	8.586371087346812E-4	0.0010134139150943396	48	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	1	8	2	5	7	26	42	50	47	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVHGKLTYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTGGGGGTGGAAACACCATATATTTTGGAGAG	CASSGGGNTIYF	In	VDJ	3	55	8.586371087346812E-4	0.0010134139150943396	36	TCRBV03						TCRBJ01	TCRBJ01-03	01	6	6	1	3	1	0	26	37	-1	38	43		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGGGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCAACAGGGGGCTATTTGAGTGAGCAGTTCTTCGGGCCA	CSARDPTGGYLSEQFF	In	VDJ	3	56	8.742486925298571E-4	0.0010318396226415094	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	0	9	4	8	26	40	53	44	61		TCRBV20-01,TCRBV20-or09_02												CSARDPTGGYLSEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTKGGKGACTCWGCTGTGTATYTCTGTGCCAGCAGCTTAGCTAGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	57	8.898602763250332E-4		38	unresolved						TCRBJ02	TCRBJ02-03	01	5	5	3	5	6	0	26	38	-1	44	48	TCRBV03,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGTGGACAGGGGATTAGTTCCTACAATGAGCAGTTCTTCGGGCCA	CSARGQGISSYNEQFF	In	VDJ	3	57	8.898602763250332E-4	0.0010502653301886792	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	2	1	3	6	26	35	47	38	53		TCRBV20-01,TCRBV20-or09_02												CSARGQGISSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAATTTCGTGTTAGACGAGCAGTACTTCGGGCCG	CASSNFVLDEQYF	In	VDJ	3	58	9.054718601202092E-4	0.001068691037735849	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	10	0	26	38	-1	48	51		TCRBV03-01,TCRBV03-02				01,02								CASSNFVLDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTGACAGGGGTCCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLDRGPGANVLTF	In	VDJ	3	58	9.054718601202092E-4	0.001068691037735849	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	2	4	2	4	26	39	49	41	53		TCRBV03-01,TCRBV03-02												CASSLDRGPGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCTCATCGGGAATGAGCAGTTCTTCGGGCCA	CASLIGNEQFF	In	VDJ	3	59	9.210834439153852E-4	0.0010871167452830188	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	8	4	7	5	0	26	35	-1	40	44		TCRBV03-01,TCRBV03-02				01,02								CASLIGNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCACAACGGGAGGGCCTGTGAATGAGCAGTTCTTCGGGCCA	CASSSTTGGPVNEQFF	In	VDJ	3	59	9.210834439153852E-4	0.0010871167452830188	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	8	0	7	7	6	24	36	51	43	57		TCRBV24-01,TCRBV24-or09_02												CASSSTTGGPVNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARGGSSYNEQFF	In	VDJ	3	60	9.366950277105613E-4	0.0011055424528301887	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	7	2	0	0	0	26	-1	-1	39	46		TCRBV20-01,TCRBV20-or09_02												CSARGGSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGTGATTCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG	CASSQVIHFVLDEQYF	In	VDJ	3	61	9.523066115057373E-4	0.0011239681603773585	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	5	8	5	17	0	26	40	-1	57	60		TCRBV03-01,TCRBV03-02				01,02								CASSQVIHFVLDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGGACTAGCCCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAKGLAPSYNEQFF	In	VDJ	3	61	9.523066115057373E-4	0.0011239681603773585	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	7	0	1	3	26	36	46	37	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKGLAPSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGGAGGGCACAAGAGACCCAGTACTTCGGGCCA	CATSDWRAQETQYF	In	VDJ	3	61	9.523066115057373E-4	0.0011239681603773585	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	10	0	2	0	2	24	-1	46	40	48		TCRBV24-01,TCRBV24-or09_02												CATSDWRAQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCCCTCCCCTCCACCGGGTATACGAGCAGTACTTCGGGCCG	CASPPLHRVYEQYF	In	VDJ	3	61	9.523066115057373E-4	0.0011239681603773585	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	11	8	4	4	14	2	24	31	49	45	51	TCRBV24,TCRBV27					01,02								CASPPLHRVYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCCCCTTCGGGGGGAACCAAGAGACCCAGTACTTCGGGCCA	CSVPFGGNQETQYF	In	VDJ	4	62	9.679181953009133E-4	0.0011423938679245283	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	8	1	0	7	1	26	33	47	40	48		TCRBV20-01,TCRBV20-or09_02												CSVPFGGNQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGATAGTAGCGGAGCCCTCCTACGAGCAGTACTTCGGGCCG	CASSPIVAEPSYEQYF	In	VDJ	4	64	9.991413628912653E-4	0.0011792452830188679	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	5	5	0	6	4	26	39	51	45	55		TCRBV03-01,TCRBV03-02				01,02								CASSPIVAEPSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCGGGAGCAGCCCCAGCATTTTGGTGAT	CASSQGREQPQHF	In	VDJ	4	65	0.0010147529466864413	0.0011976709905660377	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	8	2	7	2	0	26	42	-1	44	50		TCRBV03-01,TCRBV03-02												CASSQGREQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*02	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATTGAGGCGGGAGAGGTCGAGCAGTACTTCGGGCCG	CSARDIEAGEVEQYF	In	VDJ	4	67	0.0010459761142767934	0.0012345224056603773	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	2	6	7	4	26	40	54	47	58		TCRBV20-01,TCRBV20-or09_02												CSARDIEAGEVEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCTCGGGTCAGAGAAACACCATATATTTTGGAGAG	CSASSGQRNTIYF	In	VDJ	4	67	0.0010459761142767934	0.0012345224056603773	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	8	4	5	2	5	26	37	43	39	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSGQRNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGACAGCGGGAGGGCCAGGTGAGCAGTTCTTCGGGCCA	CSARTAGGPGEQFF	In	VDJ	4	67	0.0010459761142767934	0.0012345224056603773	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	0	9	5	5	26	35	50	40	55		TCRBV20-01,TCRBV20-or09_02												CSARTAGGPGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCTCACAGGGTCGGAGCAGTACTTCGGGCCG	CATSLTGSEQYF	In	VDJ	4	67	0.0010459761142767934	0.0012345224056603773	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	3	3	7	4	3	24	35	45	39	48		TCRBV24-01,TCRBV24-or09_02												CATSLTGSEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGTCACTATAGCGGGTTCGAGACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	4	68	0.0010615876980719695		49	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	5	4	0	8	6	26	34	49	42	55		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGTTGGGAGAAACACCGGGGAGCTGTTTTTTGGAGAA	CATSDVGRNTGELFF	In	VDJ	4	70	0.0010928108656623214	0.0012897995283018867	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	9	2	2	3	1	24	39	47	42	48		TCRBV24-01,TCRBV24-or09_02												CATSDVGRNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCAATCCACGGGGAGCTGAAGCTTTCTTTGGACAA	CSARANPRGAEAFF	In	VDJ	4	73	0.0011396456170478496	0.0013450766509433961	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	3	6	8	2	26	39	52	47	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSARANPRGAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCGGCGTACAAGGGGTCCAAGAGACCCAGTACTTCGGGCCA	CASGVQGVQETQYF	In	VDJ	4	73	0.0011396456170478496	0.0013450766509433961	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	5	2	1	8	1	22	31	44	39	45		TCRBV12-03,TCRBV12-04												CASGVQGVQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCAAGGCCCTAGCCTAGTTCACGAGCAGTACTTCGGGCCG	CASSQGPSLVHEQYF	In	VDJ	4	74	0.0011552572008430256	0.001363502358490566	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	7	5	7	7	18	30	42	37	49	TCRBV05,TCRBV11					01,02								CASSQGPSLVHEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTATCCCCAGGGGGCCAGCCCCAGCATTTTGGTGAT	CASSLSPGGQPQHF	In	VDJ	4	74	0.0011552572008430256	0.001363502358490566	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	0	7	4	0	18	33	-1	37	45	TCRBV07,TCRBV11													CASSLSPGGQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGGGCAAAGTGAGCAGTTCTTCGGGCCA	CSARVGQSEQFF	In	VDJ	4	75	0.0011708687846382015	0.0013819280660377358	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	8	0	9	2	4	26	39	45	41	49		TCRBV20-01,TCRBV20-or09_02												CSARVGQSEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGCCTCCAGCCCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	4	75	0.0011708687846382015		44	TCRBV24						TCRBJ02	TCRBJ02-05	01	5	4	5	1	6	3	24	37	46	43	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCGAGATTCCGGGGAGCTGTTTTTTGGAGAA	CASSHRDSGELFF	In	VDJ	5	82	0.0012801498712044336	0.0015109080188679246	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	11	2	6	2	3	26	40	45	42	48		TCRBV03-01,TCRBV03-02												CASSHRDSGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGCGATAACGGAGGGCCAGCAGATACGCAGTATTTTGGCCCA	CATSGDNGGPADTQYF	In	VDJ	5	82	0.0012801498712044336	0.0015109080188679246	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	0	4	8	4	24	37	51	45	55		TCRBV24-01,TCRBV24-or09_02												CATSGDNGGPADTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCTGGGGCTAGCGGGAGTTAGATCTCTCTTCGGGCCA	CASSLGLAGVRSLF	In	VDJ	5	83	0.0012957614549996097	0.0015293337264150944	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	4	2	17	7	9	26	37	54	44	63		TCRBV03-01,TCRBV03-02												CASSLGLAGVRSLF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAACACGGACAGGGTACAGATACGCAGTATTTTGGCCCA	CATSEHGQGTDTQYF	In	VDJ	5	85	0.0013269846225899618	0.001566185141509434	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	3	3	4	1	24	38	50	42	51		TCRBV24-01,TCRBV24-or09_02												CATSEHGQGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCCTAGTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	87	0.0013582077901803137		37	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	9	4	8	0	2	1	24	33	39	35	40		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGCTTATCTGGGACTAGCGGGCAAGGGGGTGAGCAGTTCTTCGGGCCA	CASSLSGTSGQGGEQFF	In	VDJ	5	87	0.0013582077901803137	0.0016030365566037737	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	4	9	5	8	22	35	52	40	60	TCRBV07,TCRBV12					01,02								CASSLSGTSGQGGEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACTAGCGGGATCAGATACGCAGTATTTTGGCCCA	CASRLAGSDTQYF	In	VDJ	5	92	0.001436265709156194	0.0016951650943396227	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	3	3	4	0	1	24	-1	45	35	46		TCRBV24-01,TCRBV24-or09_02												CASRLAGSDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGGGGGCCCATGAGCAGTTCTTCGGGCCA	CASSLSGAHEQFF	In	VDJ	5	92	0.001436265709156194	0.0016951650943396227	39							TCRBJ02	TCRBJ02-01	01	6	6	0	8	5	2	24	36	47	41	49	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGAHEQFF+X+TCRBJ02-01			TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAACGACGACAGGGGGCCTCCAAGAGACCCAGTACTTCGGGCCA	CSATTTGGLQETQYF	In	VDJ	5	96	0.001498712044336898	0.001768867924528302	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	0	1	6	2	26	34	50	40	52		TCRBV20-01,TCRBV20-or09_02												CSATTTGGLQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGATTGACTAGCGGGAGTGGCCACGAGCAGTACTTCGGGCCG	CASRLTSGSGHEQYF	In	VDJ	5	96	0.001498712044336898	0.001768867924528302	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	2	2	5	3	5	18	29	44	32	49	TCRBV05,TCRBV11													CASRLTSGSGHEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTCCGCAGCTTGGTAGGCTACACCTTCGGTTCG	CASSLVRSLVGYTF	In	VDJ	5	97	0.001514323628132074	0.0017872936320754717	42	TCRBV12						TCRBJ01	TCRBJ01-02	01	1	4	5	8	4	7	26	42	49	46	56		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVRSLVGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGCCTCCATGTTCAATGAGCAGTTCTTCGGGCCA	CSARRASMFNEQFF	In	VDJ	5	97	0.001514323628132074	0.0017872936320754717	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	2	5	3	6	0	10	26	-1	42	38	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRASMFNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACGACAGGGGAAGGCAGATACGCAGTATTTTGGCCCA	CSAGRQGKADTQYF	In	VDJ	5	97	0.001514323628132074	0.0017872936320754717	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	2	4	4	4	26	35	47	39	51		TCRBV20-01,TCRBV20-or09_02												CSAGRQGKADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGACAGGGTAAAGACCCAGTACTTCGGGCCA	CSATDRVKTQYF	In	VDJ	6	98	0.0015299352119272501	0.0018057193396226415	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	3	6	1	3	26	36	45	37	48		TCRBV20-01,TCRBV20-or09_02												CSATDRVKTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAAATGAAAAACTGTTTTTTGGCAGT	CSARENEKLFF	In	VJ	6	98	0.0015299352119272501	0.0018057193396226415	33	TCRBV20						TCRBJ01	TCRBJ01-04	01	0	0	0	5	0	1	26	-1	40	-1	41		TCRBV20-01,TCRBV20-or09_02												CSARENEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACACACCCGGGACTAGTGGCCCACGAGCAGTACTTCGGGCCG	CSATHPGLVAHEQYF	In	VDJ	6	99	0.001545546795722426	0.0018241450471698113	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	8	5	7	6	26	36	51	43	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSATHPGLVAHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACGGGAGAAGGACGAGCAGTACTTCGGGCCG	CASSQREKDEQYF	In	VDJ	6	101	0.001576769963312778	0.001860996462264151	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	2	5	0	4	26	-1	47	41	51		TCRBV03-01,TCRBV03-02												CASSQREKDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAAGGACTAGCGGGAGTCGCCAGATACGCAGTATTTTGGCCCA	CSASKD*RESPDTQYF	Stop	VDJ	6	103	0.0016079931309031302		48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	1	2	4	3	4	26	37	53	40	57		TCRBV20-01,TCRBV20-or09_02												CSASKD*RESPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGGGACGGACTAGCGGGAGGTCTCAACGAGCAGTACTTCGGGCCG	CAIRDGLAGGLNEQYF	In	VDJ	6	103	0.0016079931309031302	0.0018978478773584906	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	1	1	5	4	5	23	34	52	38	57	TCRBV06,TCRBV10													CAIRDGLAGGLNEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCTTGACAGGGGTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRLTGVGANVLTF	In	VDJ	6	107	0.0016704394660838342	0.00197155070754717	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	2	3	4	1	26	39	51	43	52		TCRBV03-01,TCRBV03-02												CASSRLTGVGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCTACTGGAGGTATGGCTACACCTTCGGTTCG	CASYWRYGYTF	In	VDJ	6	107	0.0016704394660838342	0.00197155070754717	33	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	8	10	1	5	4	0	26	35	-1	39	44		TCRBV03-01,TCRBV03-02												CASYWRYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCTTAGAGGCCGTCGCCACTGAAGCTTTCTTTGGACAA	CASSLEAVATEAFF	In	VDJ	6	109	0.0017016626336741863	0.0020084021226415096	42	unresolved						TCRBJ01	TCRBJ01-01	01	1	5	4	4	0	7	18	-1	37	34	44	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEAVATEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACATAGCGGGAGGGCCTACAATGAGCAGTTCTTCGGGCCA	CSAHSGRAYNEQFF	In	VDJ	6	110	0.0017172742174693624	0.0020268278301886792	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	0	2	3	0	26	34	-1	37	48		TCRBV20-01,TCRBV20-or09_02												CSAHSGRAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGACCGGGACAGGGAACGTTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	6	110	0.0017172742174693624		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	3	4	5	6	26	36	50	41	56		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTCAATAGCGGACCCCTACAATGAGCAGTTCTTCGGGCCA	CASSSIADPYNEQFF	In	VDJ	6	113	0.0017641089688548903	0.002082104952830189	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	5	5	2	4	3	24	36	46	40	49	TCRBV24,TCRBV27					01,02								CASSSIADPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTAAGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CASSKTGNEKLFF	In	VDJ	7	119	0.0018577784716259464	0.0021926591981132077	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	5	2	0	22	34	-1	36	43	TCRBV02,TCRBV12													CASSKTGNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTGGGACAGGGTCTCGACAGCCCCAGCATTTTGGTGAT	CASSPGTGSRQPQHF	In	VDJ	7	124	0.0019358363906018265	0.0022847877358490565	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	3	7	3	6	24	36	48	39	54		TCRBV24-01,TCRBV24-or09_02												CASSPGTGSRQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAATTGGAGAGACCCAGTACTTCGGGCCA	CASSEIGETQYF	In	VDJ	7	126	0.0019670595581921784	0.002321639150943396	36	unresolved						TCRBJ02	TCRBJ02-05	01	5	0	10	4	7	0	23	34	-1	41	43	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEIGETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTACAGGGGTGGAGACCCAGTACTTCGGGCCA	CASSLTGVETQYF	In	VDJ	7	127	0.0019826711419873547	0.002340064858490566	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	2	5	2	2	26	39	48	41	50		TCRBV03-01,TCRBV03-02												CASSLTGVETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGGGCCGACTATGGCTACACCTTCGGTTCG	CSASRADYGYTF	In	VDJ	8	137	0.002138786979939115	0.0025243219339622642	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	3	8	0	3	2	2	26	37	43	39	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRADYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCTAACAACGGGGGAGACCCAGTACTTCGGGCCA	CASSLTTGETQYF	In	VDJ	8	137	0.002138786979939115	0.0025243219339622642	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	8	3	5	7	0	23	35	-1	42	47	TCRBV09,TCRBV21													CASSLTTGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAATACTGGGGGTTTGGGACACAATGAGCAGTTCTTCGGGCCA	CASSLNTGGLGHNEQFF	In	VDJ	8	139	0.002170010147529467	0.002561173349056604	51	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	0	7	5	17	0	24	36	-1	53	58		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNTGGLGHNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGACTAGCGGGATAAGGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	8	141	0.002201233315119819		44	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	2	3	4	1	6	24	33	45	34	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTAGCGGGACAGTATGAGCAGTTCTTCGGGCCA	CASSLLAGQYEQFF	In	VDJ	8	149	0.002326125985481227	0.002745430424528302	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	3	8	4	4	24	36	48	40	52		TCRBV24-01,TCRBV24-or09_02												CASSLLAGQYEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCAAAGGCGGGAGGAGGCAATGAGCAGTTCTTCGGGCCA	CSASKAGGGNEQFF	In	VDJ	9	151	0.002357349153071579	0.0027822818396226415	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	7	1	6	7	3	26	34	49	41	52		TCRBV20-01,TCRBV20-or09_02												CSASKAGGGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGACCGGGACAGAAGAATGAAAAACTGTTTTTTGGCAGT	CASRPGQKNEKLFF	In	VDJ	11	188	0.0029349777534930918	0.0034640330188679246	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	5	3	3	23	34	44	37	47	TCRBV02,TCRBV09													CASRPGQKNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCAAGCGGATCCCCCAAAGAGACCCAGTACTTCGGGCCA	CASSPSGSPKETQYF	In	VDJ	11	194	0.003028647256264148	0.0035745872641509435	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	6	5	3	2	8	23	36	43	38	51	TCRBV01,TCRBV04					01,02								CASSPSGSPKETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGATGGGGTGGGCTCCTACGAGCAGTACTTCGGGCCG	CSADGVGSYEQYF	In	VDJ	14	239	0.0037311685270470687	0.004403744103773585	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	6	6	2	0	4	4	26	34	42	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSADGVGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGTCGGGACAGGTTATGAAAAACTGTTTTTTGGCAGT	CASSVGTGYEKLFF	In	VDJ	15	258	0.004027788619155414	0.0047538325471698116	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	4	6	2	2	23	36	46	38	48	TCRBV02,TCRBV09													CASSVGTGYEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGTGGACAGGGCCCCACCCTTCCCCCTACGAGCAGTACTTCGGGCCG	CSAEWTGPHPSPYEQYF	In	VDJ	18	313	0.004886425727890094	0.005767246462264151	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	2	4	13	26	35	47	39	60		TCRBV20-01,TCRBV20-or09_02												CSAEWTGPHPSPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCACCCGACAGGGTAAGGGGAGCCAAGCTTTCTTTGGACAA	CASTRQGKGSQAFF	In	VDJ	18	327	0.005104987901022559	0.0060252063679245285	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	9	3	11	23	33	43	36	54	TCRBV01,TCRBV04													CASTRQGKGSQAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCCGGGGGGTCAGAACACTGAAGCTTTCTTTGGACAA	CSAPPGGQNTEAFF	In	VDJ	19	341	0.005323550074155023	0.006283166273584905	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	1	1	4	3	26	35	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSAPPGGQNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAAATGGGGGTAATGGCTACACCTTCGGTTCG	CASSLNGGNGYTF	In	VDJ	19	342	0.005339161657950199	0.006301591981132075	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	4	6	1	6	5	2	26	39	49	44	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNGGNGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCTCAAGCGGGGGGAGACCCAGTACTTCGGGCCA	CSLKRGETQYF	In	VDJ	23	411	0.006416360939817345	0.007572965801886792	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	6	2	5	4	0	26	32	-1	36	44		TCRBV20-01,TCRBV20-or09_02												CSLKRGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
TTTCTGTGCCATGGCTCCCCTTAAGCCCGGGACGGACAACTAGCGGGAGGATGTACGAGCAGTACTTCGGGCCG		Out	VDJ	23	414	0.006463195691202872		64	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	10	3	1	4	27	3	4	11	50	38	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAAAAACCGGAACGAGTTATGGCTACACCTTCGGTTCG	CASRKTGTSYGYTF	In	VDJ	27	471	0.007353055967527906	0.008678508254716982	42	TCRBV24						TCRBJ01	TCRBJ01-02	01	7	1	8	5	7	6	24	35	45	42	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRKTGTSYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCATGGCGGGGTAGGGGAGGTCGGGTTATATGAGCAGTTCTTCGGGCCA	CSARDHGGVGEVGLYEQFF	In	VDJ	47	826	0.012895168214815393	0.015219634433962265	57	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	7	3	8	5	18	24	38	49	43	67		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDHGGVGEVGLYEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCTGGACAGAGGTCCGGGGAGCTGTTTTTTGGAGAA	CASSPGQRSGELFF	In	VDJ	53	938	0.014643665599875108	0.017283313679245283	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	5	6	4	4	26	37	47	41	51		TCRBV03-01,TCRBV03-02												CASSPGQRSGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
AGCCACGTTTGGTSMSMSMSASMYMTCTGTACCWCTGTGGCAGCACATCGTAGGGCTAGTATTGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	54	8.430255249395051E-4		46	TCRBV08	TCRBV08-02	01				TCRBJ02	TCRBJ02-01	01	0	5	3	5	2	9	22	36	42	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV08-02+TCRBJ02-01	TCRBV08-02*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACCCCGGGGGGAGCTAATGAAAAACTGTTTTTTGGCAGT	CASRTPGGANEKLFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	8	1	3	5	2	23	34	46	39	48														CASRTPGGANEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCTGGTGGGGGGGACTATGGCTACACCTTCGGTTCG	CASRPGGGDYGYTF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	9	0	3	7	0	23	34	-1	41	48														CASRPGGGDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATTCGACATTAGGGAGGCTACACCTTCGGTTCG	CASSIRH*GGYTF	Stop	VDJ	1	5	7.805791897588011E-5		39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	0	8	8	12	0	23	34	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIRH*GGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAAGCGGGGTCCCTACGAGCAGTACTTCGGGCCG	CASSKRGPYEQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	6	3	2	1	2	23	35	43	36	45														CASSKRGPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAATACGGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSNTGQGNTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	1	5	0	23	35	-1	40	49														CASSNTGQGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTCAGCGGGGGGGCTCTGCGGGAGCAGTACTTCGGGCCG	CASSLSGGALREQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	6	0	7	3	8	23	35	48	38	56														CASSLSGGALREQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCAGACAGGGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSDQTGANEKLFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	2	3	5	0	23	35	-1	40	48														CASSDQTGANEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACAAGGGTTTTCGGCGGACCATCCAATGAGCAGTTCTTCGGGCCA	CASSYTRVFGGPSNEQFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	54	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	2	1	7	6	15	4	23	38	57	53	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTRVFGGPSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGGGCCTGGAAACACCATATATTTTGGAGAG	CASSYQGPGNTIYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	2	2	0	1	23	-1	44	38	45														CASSYQGPGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGGACTAGCGGGGCTTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYSGLAGLSNTGELFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	1	3	0	1	4	23	40	53	41	57														CASSYSGLAGLSNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTAACCGGGACAGGGACCCCTACGAGCAGTACTTCGGGCCG	CAISNRDRDPYEQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	2	4	3	23	35	48	39	51														CAISNRDRDPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGAACTAGCGGACTCCTACGAGCAGTACTTCGGGCCG	CASKELADSYEQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	3	5	0	4	1	23	33	45	37	46						01,02								CASKELADSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTAAAATCGGGAGGTACAATGAGCAGTTCTTCGGGCCA	CASTKIGRYNEQFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	8	1	4	7	0	23	33	-1	40	47														CASTKIGRYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGTACTCCCGGGACAGGGAGGCTTTCTTTGGACAA	CASSRYSRDREAFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	11	11	2	23	34	54	45	56														CASSRYSRDREAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCGCAGGGGCTGGCTACACCTTCGGTTCG	CASSYPAGAGYTF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	2	7	4	1	23	38	48	42	49														CASSYPAGAGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTATTTCCTACAACCTACGAGCAGTACTTCGGGCCG	CASSLFPTTYEQYF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	4	3	6	2	8	1	23	36	47	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFPTTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCACGGGACAGGGATAAACACTGAAGCTTTCTTTGGACAA	CASSFHGTGINTEAFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	2	5	3	23	36	50	41	53														CASSFHGTGINTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACCGAAGAGGGCTGGGCACTGAAGCTTTCTTTGGACAA	CANRRGLGTEAFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	10	11	0	4	6	5	23	30	41	36	46														CANRRGLGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGACTAGCGGGAGCAATGAGCAGTTCTTCGGGCCA	CASSDSTSGSNEQFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	2	2	6	0	0	23	-1	-1	40	52														CASSDSTSGSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACCGATAGCGGAGGGGGCACAGATACGCAGTATTTTGGCCCA	CAITDSGGGTDTQYF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	10	5	5	1	7	5	23	30	43	37	48						01,02								CAITDSGGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTAGCGGGCCTATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	8	1.2489267036140816E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	6	4	1	0	4	23	-1	45	39	49						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTTACTTACCGGGACTTGGGACCTACGAGCAGTACTTCGGGCCG	CASSVYLPGLGTYEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	10	2	11	5	23	35	52	46	57						01,02								CASSVYLPGLGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAACTAGCGGGAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	8	1.2489267036140816E-4		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	3	2	5	0	0	23	-1	-1	37	48														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCCGACAGGGGAAGCCTACGAGCAGTACTTCGGGCCG	CASSYSPTGEAYEQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	2	2	3	3	23	40	51	43	54														CASSYSPTGEAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGTCAGCAGTTTAAAGGGTGAACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	8	1.2489267036140816E-4		41	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	4	5	3	3	3	3	23	36	43	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCAAATATGGTGGGACAGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATKYGGTGSYNEQFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	0	4	0	11	0	23	30	-1	41	49														CATKYGGTGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCACGGGACAGGGTTAGACTACGAGCAGTACTTCGGGCCG	CASSHGTGLDYEQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	3	4	5	23	34	47	38	52														CASSHGTGLDYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCATTCAAGCCAACACTGAAGCTTTCTTTGGACAA	CASSSIQANTEAFF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	6	7	2	7	1	23	36	46	43	47						01,02								CASSSIQANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATAGGACAGGGTAATATGGATGGCTACACCTTCGGTTCG	CAIGQGNMDGYTF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	1	3	6	2	8	23	30	40	32	48														CAIGQGNMDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCAACAGACCTACGAGCAGTACTTCGGGCCG	CAISQQTYEQYF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	5	2	3	1	23	34	41	37	42														CAISQQTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCCCGGTAGGAAAGGTCAGCCCCAGCATTTTGGTGAT	CAISPGRKGQPQHF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	5	1	8	6	7	4	23	35	45	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISPGRKGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGTATCTCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGISGANVLTF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	5	0	10	4	0	7	23	-1	37	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGISGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGGGGAGAGGCACTGAAGCTTTCTTTGGACAA	CASSYQGRGTEAFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	4	0	5	23	-1	44	38	49														CASSYQGRGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGACAAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSYGGQGNQPQHF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	6	2	2	2	23	38	46	40	48														CASSYGGQGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCGACAGGGCTATGAGCAGTTCTTCGGGCCA	CASSYRQGYEQFF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	3	8	2	2	23	37	46	39	48														CASSYRQGYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGCCGGGACGGCAATCAGCCCCAGCATTTTGGTGAT	CASGRDGNQPQHF	In	VDJ	1	10	1.5611583795176022E-4	1.8425707547169813E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	8	0	7	2	4	1	23	32	41	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGRDGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAAAGACAGCGGGAGGGACCCCCCGATACGCAGTATTTTGGCCCA		Out	VDJ	1	10	1.5611583795176022E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	10	6	0	6	8	7	23	30	48	38	55														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAAACTAGCGACACCGGGGAGCTGTTTTTTGGAGAA	CASSETSDTGELFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	3	6	3	4	0	23	34	-1	38	45						01,02								CASSETSDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCAGGCTGACAACTATGGCTACACCTTCGGTTCG	CASSQADNYGYTF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	4	2	0	5	23	-1	39	35	44														CASSQADNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCTGATGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSDSDGSYNEQFF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	0	10	0	4	0	23	40	-1	44	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSDGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCGTCCCGGCCCCAGCATTTTGGTGAT	CASSYPSRPQHF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	8	6	9	1	5	23	38	41	39	46						01,02								CASSYPSRPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGCAGCCTCAATCAGCCCCAGCATTTTGGTGAT	CASSYRSLNQPQHF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	2	4	5	3	2	3	23	38	43	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRSLNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGACCGAGACAGGGTGTTCGCGAGCAGTACTTCGGGCCG	CASGPRQGVREQYF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	2	3	6	7	6	23	32	46	39	52														CASGPRQGVREQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCGGGGAGAGACCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSRGETSNQPQHF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	8	3	1	2	7	23	36	43	38	50						01,02								CASSSRGETSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTCGGGACATGAACACTGAAGCTTTCTTTGGACAA	CASSSRDMNTEAFF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	6	0	3	0	23	36	-1	39	45														CASSSRDMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCCAGTACAGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	1.8733900554211225E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	4	0	6	0	23	35	-1	41	46														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCGTCAGGGGGCGGGAGAGGAGACCCAGTACTTCGGGCCA	CAIRQGAGEETQYF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	4	0	5	5	7	23	30	43	35	50														CAIRQGAGEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTATGCAGGGCAGGGTTTTTCGTACGAGCAGTACTTCGGGCCG	CASSYAGQGFSYEQYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	3	4	5	12	23	34	44	39	56														CASSYAGQGFSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACGAGTGGGTCAGATACGCAGTATTTTGGCCCA	CASRTSGSDTQYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	0	9	4	7	1	23	34	44	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTSGSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTACTAGCGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLLAGSYNEQFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	4	0	2	0	23	35	-1	37	46						01,02								CASSLLAGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCGTGCTAGCGGGAACCGACAGTTCTTCGGGCCA		Out	VDJ	1	13	2.0295058933728828E-4		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	3	13	5	5	23	38	52	43	57														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCAACAGGGCTACACTGAAGCTTTCTTTGGACAA	CASSYQQGYTEAFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	3	3	2	23	37	46	40	48														CASSYQQGYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCTCCAGGGGGCATGATACAGAAAACATTCAGTACTTCGGCGCC	CASRGHDTENIQYF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	11	4	0	5	2	9	23	29	39	31	48														CASRGHDTENIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGAGCACAGATACGCAGTATTTTGGCCCA	CASSDSSTDTQYF	In	VJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	0	0	0	0	1	23	-1	40	-1	41														CASSDSSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGAAGGGACAGGGGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	15	2.341737569276403E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	1	6	5	0	23	35	-1	40	51														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGACTAGCGCGGGCTACGAGCAGTACTTCGGGCCG	CASSETSAGYEQYF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	6	3	2	4	23	35	45	37	49						01,02								CASSETSAGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCCCCGGGGGGAGGAGAATACTTCGGGCCG	CAISAPGGGEYF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	1	13	4	7	23	35	46	39	53														CAISAPGGGEYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGACTAGCGGGAGTAAGAAGTTCCTACAATGAGCAGTTCTTCGGGCCA	CAISGLAGVRSSYNEQFF	In	VDJ	1	15	2.341737569276403E-4	2.7638561320754716E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	2	1	0	8	23	-1	48	35	56														CAISGLAGVRSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCAGAACTTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRAELNSNQPQHF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	4	5	0	2	7	23	34	39	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRAELNSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGACAATGGGACAGCCGGGAGGGCTACACCTTCGGTTCG	CASRGQWDSREGYTF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	8	8	7	23	34	49	42	56														CASRGQWDSREGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTAGCGGGATCAGGCACGCAGTATTTTGGCCCA	CASSLAGSGTQYF	In	VDJ	1	16	2.497853407228163E-4	2.9481132075471697E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	4	3	9	0	6	23	-1	44	35	50														CASSLAGSGTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTTATAAGGTCGTCAGGGTGTGCCCCAGCATTTTGGTGAT		Out	VDJ	1	16	2.497853407228163E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	9	13	3	23	35	53	48	56														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CTCCCAGACATCTGTGTACTTGTGTGCCAGCACCAACTAGCGGGAGGGTGTCGAAGGGATGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	16	2.497853407228163E-4		59	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	7	3	0	3	3	11	22	32	48	35	59														X+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCTCCTGGGAGAAGATACGCAGTATTTTGGCCCA	CASNLLGEDTQYF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	9	2	5	7	1	23	33	45	40	46														CASNLLGEDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGAGCGGGAGAACCTACAATGAGCAGTTCTTCGGGCCA	CASSGSGRTYNEQFF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	2	2	3	2	23	35	46	38	48														CASSGSGRTYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGGGGTTCGGTCAATGAGCAGTTCTTCGGGCCA	CAISGGSVNEQFF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	6	1	6	0	6	23	-1	40	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISGGSVNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAGGGGGTTTGACCACGAGCAGTACTTCGGGCCG	CASRRGFDHEQYF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	5	1	5	1	7	23	34	41	35	48														CASRRGFDHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGACAGCACAGATACGCAGTATTTTGGCCCA	CASSRDSTDTQYF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	0	7	0	2	0	23	34	-1	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCACAAGCCTACGAGCAGTACTTCGGGCCG	CASSSQAYEQYF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	6	2	1	2	23	36	40	37	42														CASSSQAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGTTGGACAGGGTGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSLDRVGNQPQHF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	2	4	3	23	36	48	40	51														CASSSLDRVGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTCACAGGGAAATCAGCCCCAGCATTTTGGTGAT	CAISSQGNQPQHF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	3	4	1	1	23	36	43	37	44														CAISSQGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCTCTAGTAGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	19	2.966200921083444E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	8	2	2	4	23	40	46	42	50						01,02								X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGGAATCTTGAGACCCAGTACTTCGGGCCA	CAISGNLETQYF	In	VDJ	1	19	2.966200921083444E-4	3.500884433962264E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	0	8	5	0	5	23	-1	39	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISGNLETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGCCCCCGGGGGACAGGGGGTTCGAACGAGCAGTACTTCGGGCCG	CASSRPRGTGGSNEQYF	In	VDJ	1	20	3.1223167590352044E-4	3.6851415094339625E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	5	10	5	23	34	55	44	60														CASSRPRGTGGSNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAAGGCGGGAGGGGGGGAGACCCAGTACTTCGGGCCA	CASRKAGGGETQYF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	7	0	5	4	3	23	34	47	38	50														CASRKAGGGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCAGGGAGCGGAGCTAAAGAGACCCAGTACTTCGGGCCA	CASSSGSGAKETQYF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	4	4	3	3	0	10	23	-1	41	36	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGSGAKETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGTCAGCATCAGGACTAGCGGGAGGAACGAGCAGTATTTCGGGCCG	CVSIRTSGRNEQYF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	1	1	16	3	12	23	33	50	36	62														CVSIRTSGRNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGTACAAGGACGCTACGAGCAGTACTTCGGGCCG	CASRVQGRYEQYF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	1	7	3	7	1	23	34	45	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVQGRYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTCCAGGACCGCTATTACGAGCAGTACTTCGGGCCG	CASSYLQDRYYEQYF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	1	7	4	5	6	23	38	47	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLQDRYYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCTACTAGCGGGAGACAGCAGTTCTTCGGGCCA	CASSSPTSGRQQFF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	3	2	11	5	2	23	36	52	41	54														CASSSPTSGRQQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGACAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSDSSGANVLTF	In	VDJ	1	26	4.0590117867457656E-4	4.790683962264151E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	5	0	2	0	23	36	-1	38	43														CASSSDSSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGCACAGGGGGAGAAACTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	27	4.2151276246975256E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	1	6	4	6	23	35	47	39	53														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCTCCAGAGACCCAGTACTTCGGGCCA	CASSYPPETQYF	In	VDJ	2	29	4.527359300601046E-4	5.343455188679245E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	4	10	4	1	2	23	38	41	39	43						01,02								CASSYPPETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGAGGGGAGTGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSRGVGNQPQHF	In	VDJ	2	30	4.683475138552806E-4	5.527712264150943E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	4	5	2	2	2	5	23	36	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRGVGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCCGGGACTAGCGGGACAGATACGCAGTATTTTGGCCCA	CASSAGTSGTDTQYF	In	VDJ	2	31	4.8395909765045663E-4	5.711969339622641E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	4	3	4	0	23	34	-1	38	50						01,02								CASSAGTSGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACTTCCCTCAGATGGGGTGAATACACTGAAGCTTTCTTTGGACAA	CATSLRWGEYTEAFF	In	VDJ	2	32	4.995706814456326E-4	5.896226415094339E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	10	6	2	3	12	5	23	30	46	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSLRWGEYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAGGCAAAGCATAGATACGCAGTATTTTGGCCCA	CASSDRQSIDTQYF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	4	5	0	8	23	-1	41	35	49														CASSDRQSIDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCAGGACTAGCGGGAGGAACGAGCAGTACTTCGGGCCG	CASIRTSGRNEQYF	In	VDJ	2	33	5.151822652408087E-4	6.080483490566037E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	1	1	5	3	1	23	33	50	36	51														CASIRTSGRNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGACAGGGGGCTTCCATGAGCAGTTCTTCGGGCCA	CASSYWTGGFHEQFF	In	VDJ	2	34	5.307938490359847E-4	6.264740566037736E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	0	8	0	4	23	-1	50	39	54														CASSYWTGGFHEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGTACAGCAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSGTADTGELFF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	5	3	3	3	23	35	42	38	45														CASSGTADTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATAGGGGGCGCCGGGACTAGGGGCGGCACCGGGGAGCTGTTTTTTGGAGAA	CAIGGAGTRGGTGELFF	In	VDJ	2	41	6.400749356022168E-4	7.554540094339623E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	0	8	4	11	6	23	30	49	41	55						01,02								CAIGGAGTRGGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGTATTGGGCGTACCCCCATCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	47	7.337444383732729E-4		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	8	0	1	7	9	23	35	46	42	55														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCTAGCGGGAGGGTCGCGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	48	7.49356022168449E-4		55	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	4	0	1	3	5	23	40	55	43	60														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCKAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSDSSGSTDTQYF	In	VDJ	3	56	8.742486925298571E-4	0.0010318396226415094	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	4	0	0	0	23	-1	-1	40	47						01,02								CASSDSSGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAGGGAGGGATGGGGTGACCCAGTACTTCGGGCCA	CASSVGRDGVTQYF	In	VDJ	3	57	8.898602763250332E-4	0.0010502653301886792	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	9	0	7	3	7	23	35	45	38	52														CASSVGRDGVTQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATAAGCCAGCGGGTCTATGGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	4	65	0.0010147529466864413		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	10	6	4	5	6	7	23	30	42	36	49						01,02								X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGAGCTTCTAGCCGTAGTACCCGGAGCTCCTACGAGCAGTACTTCGGGCCG	CARASSRSTRSSYEQYF	In	VDJ	4	66	0.0010303645304816174	0.0012160966981132075	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	4	7	0	5	14	23	31	41	36	55						01,02								CARASSRSTRSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAACAGGGGGCGGGGACACCATATATTTTGGAGAG	CASSLTGGGDTIYF	In	VDJ	4	68	0.0010615876980719695	0.0012529481132075471	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	0	8	2	4	23	36	47	38	51														CASSLTGGGDTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAAGCGGGAGTACAATGAGCAGTTCTTCGGGCCA	CASSYKREYNEQFF	In	VDJ	5	84	0.0013113730387947858	0.0015477594339622642	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	2	4	1	0	23	38	-1	39	47														CASSYKREYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTGGCTAGCGAATGAGCAGTTCTTCGGGCCA	CASSDWLANEQFF	In	VDJ	6	98	0.0015299352119272501	0.0018057193396226415	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	4	6	7	2	0	23	39	-1	41	47						01,02								CASSDWLANEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSGTSGSTDTQYF	In	VDJ	6	108	0.0016860510498790103	0.0019899764150943396	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	4	0	0	0	23	-1	-1	35	47						01,02								CASSGTSGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGACAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDSDNTGELFF	In	VDJ	8	142	0.002216844898914995	0.002616450471698113	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	0	1	7	2	0	0	23	-1	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSDNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACAAGGGCGACAGGAGCTCAAGAGACCCAGTACTTCGGGCCA	CASTRATGAQETQYF	In	VDJ	9	161	0.0025134649910233393	0.0029665389150943396	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	2	4	2	7	4	23	33	46	40	50														CASTRATGAQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGTCTAGCGGGAGAAGGGGAGCAGTACTTCGGGCCG	CASSYGLAGEGEQYF	In	VDJ	14	246	0.003840449613613301	0.004532724056603774	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	4	2	7	4	5	23	37	51	41	56														CASSYGLAGEGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCSGGGACCTACGAGCAGTACTTCGGGCCG	CAISAGTYEQYF	In	VDJ	20	355	0.0055421122472874874	0.006541126179245283	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	3	2	0	1	23	-1	41	35	42						unresolved								CAISAGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGGACAGGGGTCTTCGTGCATGAGCAGTTCTTCGGGCCA	CASSSGTGVFVHEQFF	In	VDJ	21	369	0.005760674420419952	0.00679908608490566	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	8	2	9	23	36	48	38	57														CASSSGTGVFVHEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACGGGAGGCCCCTCCGAGCAGTACTTCGGGCCG	CASSTGGPSEQYF	In	VDJ	23	412	0.006431972523612521	0.007591391509433962	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	1	6	1	6	23	35	43	36	49														CASSTGGPSEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCGCCTAGCGGGACTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	31	544	0.008492701584575756		56	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	0	4	3	0	6	2	23	40	55	46	57														X+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATTAGGACTAGCGGGAGTGCGGGCTCAACCGGGGAGCTGTTTTTTGGAGAA	CAIRTSGSAGSTGELFF	In	VDJ	72	1268	0.019795488252283194	0.02336379716981132	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	10	1	2	5	3	10	23	30	46	33	56														CAIRTSGSAGSTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAAGCCAAACCGGGGAGCTGTTTTTTGGAGAA	CASSLSQTGELFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	6	7	5	2	3	24	37	42	39	45						01,02							Vb 18	CASSLSQTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCCGGACAGCCCAACACTGAAGCTTTCTTTGGACAA	CASSPGQPNTEAFF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	2	4	3	24	35	45	39	48													Vb 18	CASSPGQPNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCGGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSRDSSYEQYF	In	VDJ	1	5	7.805791897588011E-5	9.212853773584906E-5	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	0	2	0	24	35	-1	37	44													Vb 18	CASSRDSSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGAGGTCCGCGGTGGTGGCTTTCTTTGGACAA	CASSPRSAVVAFF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	7	5	11	7	5	24	38	49	45	54						01,02							Vb 18	CASSPRSAVVAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGCGGGTCAGCCCCAGCATTTTGGTGAT	CASSPAGQPQHF	In	VDJ	1	6	9.366950277105613E-5	1.1055424528301887E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	7	4	6	1	0	24	38	-1	39	44						01,02							Vb 18	CASSPAGQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCACTCTTCCCCCTGCGGTCACCGGGGAGCTGTTTTTTGGAGAA	CATLPPAVTGELFF	In	VDJ	1	7	1.0928108656623214E-4	1.2897995283018868E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	7	5	4	11	1	24	31	46	42	47						01,02							Vb 18	CATLPPAVTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGGAGGTCTCCCTCTATGGCTACACCTTCGGTTCG	CASSPREVSLYGYTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	9	1	4	0	7	24	-1	46	40	53													Vb 18	CASSPREVSLYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTGAACAATGAGCAGTTCTTCGGGCCA	CASSPLNNEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	2	2	8	5	2	0	24	39	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLNNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCGAGAGCACCTACAATGAGCAGTTCTTCGGGCCA	CASSPPESTYNEQFF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	7	2	7	1	24	38	48	45	49						01,02							Vb 18	CASSPPESTYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGCGGAGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSPGGASTDTQYF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	3	8	0	0	0	6	24	-1	42	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGGASTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTCTTACACAGGGTAATTATGGCTACACCTTCGGTTCG	CASSLLTQGNYGYTF	In	VDJ	1	8	1.2489267036140816E-4	1.4740566037735848E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	5	7	4	24	37	50	44	54													Vb 18	CASSLLTQGNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGACGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQTDSNQPQHF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	4	1	8	0	4	0	24	37	-1	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSQTDSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTCGGACAGGGGGCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	9	1.405042541565842E-4		44	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	0	7	3	0	24	39	-1	42	53													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCTCGGATCAGGGCCGATTTAACTATGGCTACACCTTCGGTTCG	CASSLSDQGRFNYGYTF	In	VDJ	1	9	1.405042541565842E-4	1.658313679245283E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	1	8	6	24	37	50	45	56													Vb 18	CASSLSDQGRFNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAAGGCGGATCCCATGGCTACACCTTCGGTTCG	CASSPQGGSHGYTF	In	VDJ	1	11	1.7172742174693622E-4	2.0268278301886793E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	7	5	6	5	5	24	38	47	43	52						01,02							Vb 18	CASSPQGGSHGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATATGCGGGGAACATTTGAAAGACCTATGGCTACACCTTCGGTTCG	CASSYAGNI*KTYGYTF	Stop	VDJ	1	11	1.7172742174693622E-4		51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	7	3	4	3	14	24	36	45	39	59													Vb 18	CASSYAGNI*KTYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGTCCGGGACAGTGGCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	12	1.8733900554211225E-4		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	5	8	5	4	24	39	51	44	55													Vb 18	X+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGAGAAAATCAGCCCCAGCATTTTGGTGAT	CASSPGENQPQHF	In	VDJ	1	12	1.8733900554211225E-4	2.2110849056603774E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	9	2	4	0	2	24	-1	43	38	45													Vb 18	CASSPGENQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGACCCGGAGGGGGAGCTGTTTTTTGGAGAA	CASSQDPEGELFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	4	1	7	8	1	6	24	37	42	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSQDPEGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGATATAGGGGTAAGCTACAATGAGCAGTTCTTCGGGCCA	CASSPDIGVSYNEQFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	5	2	3	5	4	24	39	49	44	53													Vb 18	CASSPDIGVSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
GGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCGGCAGGGGCGGAAACCGGATCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPSAGAETGSTNEKLFF	In	VDJ	1	13	2.0295058933728828E-4	2.3953419811320755E-4	60	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	2	0	4	12	21	36	46	40	58													Vb 18	CASSPSAGAETGSTNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAATTCAGAGAACCGTCCACTGAAGCTTTCTTTGGACAA	CASSQFREPSTEAFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	4	4	5	4	4	9	24	37	44	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSQFREPSTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGACGAGACCCAGTACTTCGGGCCA	CASSPPDETQYF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	0	1	7	5	0	0	24	-1	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPDETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGACAGGCAGGCACTGAAGCTTTCTTTGGACAA	CASSPGQAGTEAFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	4	4	0	4	24	-1	46	39	50													Vb 18	CASSPGQAGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTATAAGCCTCAGCGGTGGGGACAAGCAGTTCTTCGGGCCA	CASSPISLSGGDKQFF	In	VDJ	1	14	2.1856217313246428E-4	2.5795990566037736E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	6	11	17	0	24	38	-1	55	61													Vb 18	CASSPISLSGGDKQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAAAGCGAGTTAGTGGCAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	2.341737569276403E-4		56	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	6	0	4	12	24	38	46	42	58						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCCCCAGGGGCAGATACGCAGTATTTTGGCCCA	CASSPAPGADTQYF	In	VDJ	1	17	2.6539692451799237E-4	3.132370283018868E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	4	4	0	24	39	-1	43	49													Vb 18	CASSPAPGADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGGGACCCCTCAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSPRDPSGAGELFF	In	VDJ	1	18	2.810085083131684E-4	3.316627358490566E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	2	6	11	0	24	38	-1	49	55													Vb 18	CASSPRDPSGAGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCTAGCTCACCGCGGGGCAGCCTTGAAGCTTTCTTTGGACAA	CASSPRGSLEAFF	In	VDJ	1	21	3.2784325969869644E-4	3.8693985849056606E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	7	3	7	0	6	24	-1	44	38	50													Vb 18	CASSPRGSLEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCACGGACCCCGCGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSHGPRGSTDTQYF	In	VDJ	1	22	3.4345484349387244E-4	4.0536556603773587E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	6	1	7	0	4	8	24	35	43	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSHGPRGSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCAAGCTAGACAGGGGAACTGAAGCTTTCTTTGGACAA	CASKLDRGTEAFF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	2	2	5	6	1	24	33	47	39	48													Vb 18	CASKLDRGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACCGGGACTAGCGGGAACAATGAGCAGTTCTTCGGGCCA	CASSTGTSGNNEQFF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	3	5	3	0	24	36	-1	39	52													Vb 18	CASSTGTSGNNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAATACCCACTAGCGGCACCCTACGAGCAGTACTTCGGGCCG	CASSQYPLAAPYEQYF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	3	5	2	7	3	24	37	52	44	55						01,02							Vb 18	CASSQYPLAAPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01	TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCAGGACAGGCGGAGCAGTTCTTCGGGCCA	CASSSGQAEQFF	In	VDJ	1	23	3.590664272890485E-4	4.237912735849057E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	4	10	3	2	24	36	46	39	48													Vb 18	CASSSGQAEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGACGAAAAACTGTTTTTTGGCAGT	CASSPPDEKLFF	In	VDJ	1	24	3.746780110842245E-4	4.422169811320755E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	0	1	7	8	0	0	24	-1	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPDEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACACAGAAGTCTGAAGCTTTCTTTGGACAA		Out	VDJ	2	27	4.2151276246975256E-4		35	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	5	6	0	4	24	-1	41	37	45													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGACAGAGCCAAGGTGAGCAGTTCTTCGGGCCA	CASSPRQSQGEQFF	In	VDJ	2	27	4.2151276246975256E-4	4.974941037735849E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	5	9	1	8	24	39	45	40	53													Vb 18	CASSPRQSQGEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTATCGTCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSPLSSVNTEAFF	In	VDJ	2	28	4.3712434626492857E-4	5.159198113207547E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	5	0	6	0	24	40	-1	46	49						01,02							Vb 18	CASSPLSSVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCCGTGGACAGGGGCAATGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	30	4.683475138552806E-4		44	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	1	2	5	4	7	24	33	46	37	53													Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCGGGACCCGAGGGGGCAGATACGCAGTATTTTGGCCCA	CASSPGPEGADTQYF	In	VDJ	2	30	4.683475138552806E-4	5.527712264150943E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	1	4	11	0	24	35	-1	46	52													Vb 18	CASSPGPEGADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGCGGGAGGGCACAGATACGCAGTATTTTGGCCCA	CASSPRREGTDTQYF	In	VDJ	2	31	4.8395909765045663E-4	5.711969339622641E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	7	1	1	1	0	24	40	-1	41	49													Vb 18	CASSPRREGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTACCCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	32	4.995706814456326E-4		35	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	7	3	7	0	0	3	24	-1	36	34	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCAAAGGGGGCCCGACTTTAGATGAGCAGTTCTTCGGGCCA	CASSPKGGPTLDEQFF	In	VDJ	2	32	4.995706814456326E-4	5.896226415094339E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	5	0	8	3	10	24	38	48	41	58													Vb 18	CASSPKGGPTLDEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGGGAGTGGCCCCAGAGATACGCAGTATTTTGGCCCA	CASSPGSGPRDTQYF	In	VDJ	2	32	4.995706814456326E-4	5.896226415094339E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	2	5	1	9	24	38	44	39	53													Vb 18	CASSPGSGPRDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTAGGGAGGGCTACACCTTCGGTTCG	CASSPPREGYTF	In	VDJ	2	35	5.464054328311607E-4	6.448997641509434E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	2	8	2	0	24	41	-1	43	48													Vb 18	CASSPPREGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTGGGACAGCCAAAGAAGAAGCTTTCTTTGGACAA	CASSPPGTAKEEAFF	In	VDJ	2	36	5.620170166263368E-4	6.633254716981132E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	5	8	1	8	24	41	49	42	57													Vb 18	CASSPPGTAKEEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTGCGACTAGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLRLGNTGELFF	In	VDJ	2	36	5.620170166263368E-4	6.633254716981132E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	2	8	2	5	2	24	38	49	43	51						01,02							Vb 18	CASSPLRLGNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCGAAAACCGGGACTAGCGGGAGGCCATGAGCAGTTCTTCGGGCCA	CASRKPGLAGGHEQFF	In	VDJ	2	39	6.088517680118648E-4	7.186025943396226E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	0	1	8	8	2	24	33	56	41	58													Vb 18	CASRKPGLAGGHEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTCTCGAGAAGGGATGGACTGAAGCTTTCTTTGGACAA	CASSPPLEKGWTEAFF	In	VDJ	2	39	6.088517680118648E-4	7.186025943396226E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	0	0	8	5	9	3	24	41	54	50	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPLEKGWTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGACAGGGGTATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	40	6.244633518070409E-4		41	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	2	5	0	1	24	-1	47	37	48													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGGGTGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	42	6.556865193973929E-4		37	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	3	0	9	2	1	2	24	38	42	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGGGGTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSPQGSSTDTQYF	In	VDJ	2	43	6.712981031925689E-4	7.923054245283019E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	5	2	0	0	3	24	-1	45	40	48													Vb 18	CASSPQGSSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGAGCTCGACTATGGCTACACCTTCGGTTCG	CASSPELDYGYTF	In	VDJ	3	48	7.49356022168449E-4	8.84433962264151E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	6	7	3	1	3	24	39	43	40	46						01,02							Vb 18	CASSPELDYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGGGAAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	49	7.649676059636251E-4		40	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	1	0	8	2	1	1	24	40	45	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTCCCCAGGGGACCTCCATACGCAGTATTTTGGCCCA	CASSPSPGDLHTQYF	In	VDJ	3	53	8.274139411443291E-4	9.765625E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	2	7	5	6	24	38	49	43	55													Vb 18	CASSPSPGDLHTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCAGGAGGAGGATCCAATGAGCAGTTCTTCGGGCCA	CASSSGGGSNEQFF	In	VDJ	3	54	8.430255249395051E-4	9.949882075471698E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	10	1	6	3	6	24	36	44	39	50													Vb 18	CASSSGGGSNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTGGGGTCAAGAGACCCAGTACTTCGGGCCA	CASSPPWGQETQYF	In	VDJ	3	55	8.586371087346812E-4	0.0010134139150943396	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	0	6	2	2	2	1	24	41	47	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPWGQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGGGGGGCCCAATCTGAGCAGTTCTTCGGGCCA	CASSPRGAQSEQFF	In	VDJ	4	64	9.991413628912653E-4	0.0011792452830188679	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	2	5	1	9	0	8	24	-1	45	39	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRGAQSEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTCCTACACAGGGTAACTATGGCTACACCTTCGGTTCG	CASSLPTQGNYGYTF	In	VDJ	4	64	9.991413628912653E-4	0.0011792452830188679	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	1	7	0	24	37	-1	44	50													Vb 18	CASSLPTQGNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTACAGGGCACTGAAGCTTTCTTTGGACAA	CASSPLQGTEAFF	In	VDJ	4	70	0.0010928108656623214	0.0012897995283018867	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	4	2	0	24	39	-1	41	47													Vb 18	CASSPLQGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCCTCCGGGGGCTGGGAAGCTTTCTTTGGACAA	CASSSSGGWEAFF	In	VDJ	4	75	0.0011708687846382015	0.0013819280660377358	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	5	6	0	8	6	3	24	36	48	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSSSGGWEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGACTAGCGGGGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSPPGLAGSYNEQFF	In	VDJ	5	80	0.0012489267036140817	0.001474056603773585	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	3	0	2	24	-1	54	41	56													Vb 18	CASSPPGLAGSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCAGCTAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPANSGANVLTF	In	VDJ	5	97	0.001514323628132074	0.0017872936320754717	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	4	9	0	1	1	24	39	43	40	44						01,02							Vb 18	CASSPANSGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD02-01	TCRBJ02-06*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACTCGACAGGGAGGGGACTACGAGCAGTACTTCGGGCCG	CASSTRQGGDYEQYF	In	VDJ	8	140	0.0021856217313246428	0.0025795990566037734	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	5	2	3	3	4	6	24	36	47	40	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSTRQGGDYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAATACAGGGGAATGGCTACACCTTCGGTTCG	CASSIQGNGYTF	In	VDJ	9	159	0.002482241823432987	0.0029296875	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	6	2	1	24	36	45	38	46													Vb 18	CASSIQGNGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTATAAGCCTCAGCGGTGGGGACGAGCAGTTCTTCGGGCCA	CASSPISLSGGDEQFF	In	VDJ	10	183	0.0028569198345172117	0.0033719044811320754	48	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	0	7	10	17	0	24	38	-1	55	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPISLSGGDEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	3418B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				3981	3372	564	43	0	1713	1412	272	29	0	64055	54272	9088	695	0	0.118773818	9.22073174	0.112456597	9.53426552				93494	0.0371367931	0.0267541278	0.0226680189	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:45	Age (Range):45-65 Years (Late Adulthood),Age:45 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 2194,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 848,type of chemo:carbo/taxol	0.847023337877756	MSKCC- Snyder- P01-02		3472.0	
